Annual Report • Apr 2, 2024
Annual Report
Open in ViewerOpens in native device viewer
STATEMENTS 2022

CONSOLIDATED FINANCIAL

Improving the future
of businesses, our partners and people
1 TABLE OF CONTENTS
Registered office: Viale dell'Agricoltura 7, 37135 Verona, Italy Operational headquarters: Via Monte Rosa 91, 20149 Milan, Italy Via Cesarea 12, 16121 Genoa, Italy
Tax code/VAT No. and Verona Companies Register No. 05850710962 An insurance company authorised by ISVAP Order No. 2610 of 3 June 2008 listed in Section I of the Register of Insurance and Reinsurance Companies kept by IVASS, at No. 1.00167; Parent Company of the REVO Insurance Group, listed in the IVASS Register of Groups at No. 059
ANNUAL REPORT 2023
2 TABLE OF CONTENTS
| Corporate officers and Directors 6 |
|
|---|---|
| General information8 | |
| Corporate information8 | |
| Group structure and scope of consolidation9 | |
| Group business area9 | |
| Report on Operations11 | |
| Market scenario 11 | |
| Industry regulations 13 | |
| Main corporate events 14 | |
| General performance 15 | |
| Alternative performance indicators15 | |
| Group performance15 | |
| Evolution of the insurance portfolio and the sales network18 | |
| Insurance revenues deriving from insurance contracts written18 | |
| Insurance costs deriving from insurance contracts written21 | |
| Foreign business 24 | |
| Reinsurance policy 24 | |
| Main new products launched on the market24 | |
| Investment policy guidelines and profitability achieved26 | |
| Remuneration policies and employee information 27 | |
| Performance of the Subsidiary 28 | |
| Group summary data for 2023 29 | |
| Solvency II – Solvency margin 30 | |
| Risk management objectives and policy and hedging policy of the companies included in the scope of consolidation 31 | |
| Ongoing disputes 34 | |
| Capital and financial transactions with parent companies, associates, affiliates and other related parties 34 | |
| Other significant events during the year 35 | |
| Events after the reporting date 35 | |
| Business outlook 35 | |
| Treasury shares held and related movements 36 | |
| Relations with public authorities and other entities 36 | |
| Report on corporate governance and ownership structure pursuant to Article 123 of Legislative Decree No. 58 of 24 | |
| February 1998 36 | |
| Methodological note on alternative performance indicators 37 | |
| Consolidated financial statements 40 |
|
| Statement of financial position 41 | |
| Income statement 43 | |
| Statement of comprehensive income 44 | |
| Statement of changes in equity 45 | |
| Statement of cash flows (indirect method) 46 | |
| Statement of financial position by business segment 47 | |
| Income statement by business segment 48 | |
| Notes to the consolidated financial statements 49 |
|
| General section50 | |
| Part A – General basis of preparation51 |
|
| Scope of consolidation 51 | |
| Consolidation method 52 | |
| Share-based payments 52 | |
|---|---|
| Earnings per share 52 | |
| Foreign-currency transactions 52 | |
| New standards in force 53 | |
| IFRS 17 - Insurance Contracts 53 | |
| New standards that have not yet entered into force 63 | |
| Part B – Accounting policies65 |
|
| Statement of financial position - assets 65 | |
| Intangible assets65 | |
| Property, plant and equipment65 | |
| Insurance assets66 | |
| Investments66 | |
| Other financial assets 68 | |
| Other assets69 | |
| Cash and cash equivalents69 | |
| Statement of financial position - liabilities 70 | |
| Equity 70 | |
| Provisions for risks and charges 71 | |
| Insurance liabilities 71 | |
| Financial liabilities 71 | |
| Liabilities71 | |
| Other liabilities 72 | |
| Other information72 | |
| Income statement 75 | |
| Insurance revenues deriving from insurance contracts written75 | |
| Costs of insurance services deriving from insurance contracts written75 | |
| Insurance revenues deriving from cessions to reinsurance 75 | |
| Costs for insurance services deriving from cessions to reinsurance75 | |
| Net fair value gains (losses) on financial instruments measured at fair value through profit or loss 75 | |
| Gains (losses) on investments in subsidiaries, associates and joint ventures75 | |
| Income and expenses deriving from other financial instruments and investment property76 | |
| Net financial expenses and revenues from insurance contracts 76 | |
| Net financial income and costs from reinsurance contracts76 | |
| Other income and costs76 | |
| Operating expenses77 | |
| Net accruals to provisions for risks and charges77 | |
| Depreciation and net impairment losses on property, plant and equipment77 | |
| Amortisation and impairment losses on intangible assets77 | |
| Other operating income and expenses77 | |
| Taxes77 | |
| Statement of comprehensive income 77 | |
| Statement of changes in equity 77 | |
| Statement of cash flows 78 | |
| Use of estimates 78 | |
| Part C – Information on the statement of financial position79 |
|
| Assets 79 | |
| Item 1. Intangible assets79 | |
| Item 2. Property, plant and equipment82 | |
| Item 3. Insurance assets 84 | |
| Item 4. Investments86 | |
| Item 5. Other financial assets93 | |
| Item 6. Other assets 93 | |
| Item 7. Cash and cash equivalents93 | |
| Liabilities 94 | |
| Item 1. Equity94 |

| Earnings per share 96 | |
|---|---|
| Dividends96 | |
| Item 2. Provisions for risks and charges96 | |
| Item 3. Insurance liabilities96 | |
| Item 4. Financial liabilities101 | |
| Item 5. Payables103 | |
| Item 6. Other liabilities103 | |
| Part D – Information on the income statement |
104 |
| Result of insurance services 104 | |
| Item 1. Insurance revenue deriving from insurance contracts written104 | |
| Item 2. Costs of insurance services deriving from insurance contracts written104 | |
| Item 3. Insurance revenues deriving from cessions to reinsurance107 | |
| Item 4. Costs of insurance services deriving from cessions to reinsurance107 | |
| Investment result110 | |
| Item 6. Net fair value gains (losses) on financial instruments measured at fair value through profit or loss110 | |
| Item 7. Gains (losses) on investments in subsidiaries, associates and joint ventures110 | |
| Item 8. Income and expenses deriving from other financial instruments and investment property 110 | |
| Item 10. Net financial expenses/income from insurance contracts written 111 | |
| Item 11. Net financial income/expenses from reinsurance contracts 111 | |
| Item 13. Other costs, net113 | |
| Item 14. Operating expenses 113 | |
| Item 16. Depreciation and net impairment losses on property, plant and equipment 113 | |
| Item 17 Amortisation and net impairment losses on intangible assets113 | |
| Item 18. Other operating expenses, net113 | |
| Item 20. Taxes 114 | |
| Fair value measurement116 | |
| Breakdown of other comprehensive income120 | |
| Part F – Other information |
121 |
| Nature and extent of risks that arise from contracts within the scope of IFRS 17121 | |
| Revenue or cost elements of exceptional size or impact126 | |
| Long-term incentives – LTI Plan 126 | |
| Contingent liabilities, purchase commitments, guarantees, pledged assets and collateral 127 | |
| Leases127 | |
| Information on employees, directors and statutory auditors128 | |
| Fees for auditing and services other than auditing128 | |
| Certification of the consolidated financial statements pursuant to Article 81-ter of Consob |
| Regulation 11971/1999 193 129 |
|
|---|---|
| Board of Statutory Auditors' Report130 | |
| Independent Auditor's Report131 | |
| Glossary 132 |
Chairman Antonia Boccadoro
&KLHI([HFXWLYH2IĆFHU Alberto Minali
Ezio Bassi (OHQD%LIĆ Claudio Giraldi Elena Pistone Ignazio Maria Rocco di Torrepadula
(OHQD%LIĆ&KDLUZRPDQ Claudio Giraldi Ignazio Maria Rocco di Torrepadula 1
Ezio Bassi (Chairman) Elena Pistone Claudio Giraldi 2
Antonia Boccadoro (Chairwoman) Alberto Minali Ezio Bassi Elena Pistone
Elena Pistone (Chairwoman) (OHQD%LIĆ Ignazio Maria Rocco di Torrepadula
1 Appointed as a member of the Internal Control and Risks Committee with effect from 1 July 2023 to replace Ezio Bassi, who ceased to be a member of the Committee on the same date.
2 Appointed as a member of the Appointments and Remuneration Committee with effect from 1 July 2023 to replace Elena Biffi, who ceased to serve on the Committee on the same date.

Chairman Saverio Ugolini 3
Statutory Auditors Rosella Colleoni Alessandro Copparoni
Alternate Auditors Francesco Rossetti Paola Mazzucchelli
GENERAL MANAGER
Alberto Minali
******
INDIPENDENT AUDITORS
KPMG S.p.A.
3 Appointed by the Shareholders' Meeting on 19 April 2023 following the resignation of Alfredo Michele Malguzzi.
These consolidated financial statements have been prepared pursuant to ISVAP Regulation No. 7 of 13 July 2007 and have been prepared in accordance with applicable legal provisions, according to the measurement criteria and international reporting standards referred to below, and corresponding to the accounting records that reflect the transactions carried out by the Revo Insurance Group (hereinafter also the "Group") as at 31 December 2023, supplemented by internal management data not directly identifiable in the accounts.
The Group consists of the Parent, Revo Insurance S.p.A. (hereinafter also "REVO", "the Parent Company" or "the Company"), and the subsidiary, Revo Underwriting s.r.l. (hereinafter also "the Subsidiary").
The consolidated financial statements consist of the:
In accordance with industry regulations, the Italian Civil Code and Consob regulations, the following file is also supplemented with the following documents:
The official document containing the 2023 consolidated financial statements, accompanied by the relevant report on operations, prepared in accordance with the technical requirements established in Commission Delegated Regulation (EU) 2019/815 (European Single Electronic Reporting Format - ESEF), is available, in accordance with the law, on the Company's website (www.revoinsurance.com).
The REVO Insurance Group, entered in the register of insurance groups under No. 059, consists of a Parent Company, REVO Insurance S.p.A., an insurance company created through the reverse merger between Elba Assicurazioni S.p.A. and the Parent Company, Revo S.p.A., and an insurance brokerage company, Revo Underwriting s.r.l., operational since July 2022.
Revo Insurance S.p.A. is an insurance company operating in the non-life business with its registered office at Viale dell'Agricoltura 7, Verona.
Revo Underwriting, an insurance brokerage and advisory services company, operates as an MGA (managing general agency), i.e. an agency authorised to underwrite, issue and manage insurance policies, under licences and authorisations held by the insurance company. The Subsidiary, with its registered office at Via Dei Bossi 2/A, Milan, and share capital of €150,000, has been operating as an agency since 6 July 2022 (date of entry in the register).
At 31 December 2023, the Parent Company held a portfolio of treasury shares (totalling 850,700 shares) equal to 3.46% of the share capital including only ordinary shares, and is a company listed on the Euronext STAR Milan market, to which the rules of the Euronext Milan Issuers' Regulations apply.

There are no associates or companies under joint control.
The Group is overseen by IVASS, the Italian insurance supervisory authority, which has its registered office at Via del Quirinale 21, Rome.
The consolidated financial statements have been audited by the Independent Auditors, KPMG S.p.A., engaged to audit the accounts for the financial years 2017-2025.
In these consolidated financial statements, the comparison with data for 2022 was made on the basis of the consolidated statement of financial position as at 31 December 2022 and consolidated income statement for the year then ended, adjusting the values under IFRS 4 as required by the entry into force of IFRS 17 on 1 January 2023.
The legal, organisational and management structure of the REVO Insurance Group is linear, with the Parent Company holding 100% of the share capital of Revo Underwriting S.r.l., an insurance brokerage firm.
Pursuant to IVASS Regulation No. 30, the main intragroup entries recorded during the year are shown below, regardless of their materiality.
The REVO Insurance Group operates exclusively in the non-life business in the insurance market.
The insurance business is carried out by the Parent Company, REVO Insurance S.p.A.
With reference to 31 December 2023, the Revo Insurance Group operates in Italy and abroad in LPS, in the following business areas, as defined by Article 2, paragraph 3, of the Private Insurance Code, Decree-Law No. 209 of 7 September 2005: 1. Accident, 2. Health, 3. Land vehicles (other than railway rolling stock), 4. Railway rolling stock, 5. Aviation hull, 6. Marine hull (sea, lake and river and canal vessels) liability, 7. Goods in transit, 8. Fire and natural forces, 9. Other damage to property, 11. Aviation liability, 12. Marine hull (sea, lake and river and canal vessels) liabilities, 13. General liability, 14. Credit, 15. Suretyship, 16. Miscellaneous financial loss, 17. Legal expenses, 18. Assistance.

10 TABLE OF CONTENTS
7KH HIIHFWV RI WKH SURIRXQG FKDQJH LQ WKHPDFURHFRQRPLF DQG ĆQDQFLDO ODQGVFDSH REVHUYHG GXULQJ FRQWLQXHG throughout 2023. In particular, the year was characterised by the continuation of the monetary tightening cycle by central banks and renewed tensions in the geopolitical context.
0RYLQJLQSDUDOOHOEXWUHYHUVLQJWKHWUHQGRIWKHSUHYLRXV\HDUJURZWKDQGLQćDWLRQPRGHUDWHGLQWKHPDLQHFRQRPLF DUHDVRIWKHSODQHWLQWKHĆUVWKDOIRIDOEHLWDWGLIIHUHQWUDWHVDQGLQWHQVLWLHV:KDWPDGHWKHPDFURHFRQRPLFSLFWXUH more uncertain was the sequence of banking crises that occurred in the spring. In particular, US regional banks, which IRUPDVLJQLĆFDQWSURSRUWLRQRIWKH86ĆQDQFLDOV\VWHPVXIIHUHGORVVHVDQGRXWćRZVWKDWFDXVHGVRPHRIWKHPWRIDLO\$W the same time, in Europe, Credit Suisse experienced a liquidity crisis that prompted the Swiss authorities to organise an emergency bailout by UBS. Therefore, the sharp rate-hiking cycle, triggered in the spring of last year after years of zero or negative rates, has challenged somHRIWKHPRUHIUDJLOHFRPSRQHQWVRIWKHLQWHUQDWLRQDOĆQDQFLDOV\VWHP
In the second half of the year, the geopolitical picture became even more complicated as the Middle East crisis escalated DORQJVLGHWKHRQJRLQJFRQćLFWEHWZHHQ5XVVLDDQG8NUDLQH,QćDWLRQFRQWLQXHGWRHDVHRQWKHRQHKDQGZLWKPXFKOHVV intense effects on the real economy than feared, but on the other, more rapidly than expected, thereby creating the FRQGLWLRQVIRULPPLQHQWPRQHWDU\SROLF\HDVLQJLQ(XURSHDQG1RUWK\$PHULFD7KHGLVLQćDWLRQSURFHVVZDVERRVWHGE\ external factors, primarily the stability of energy, oil and natural gas prices, but also by the moderation of wage increases and the decline in global demand for manufactured goods.
The slowdown in GDP growth was well below expectations in the US, where the risk of recession receded, while in the euro area, the economy was sluggish (only in Germany did the data show a contraction in economic activity). The resistance of the advanced economies to higher rates is due to a number of structural and cyclical factors, such as labour shortages, which reduced the elasticity of employment to GDP, the stronger balance sheets of households, businesses and banks compared with previous periods of mRQHWDU\WLJKWHQLQJDQGWKHORZHULQFLGHQFHRIćRDWLQJ-rate borrowing.
Against this backdrop, the central banks continued their restrictive monetary policy, raising their respective base rates LQRUGHUWREDODQFHWKHREMHFWLYHRIPRGHUDWLQJLQćDWLRQZLWKWKDWRIĆQDQFLDOVWDELOLW\
The Federal Reserve increased its key rate four times over the year, from 4.5% at the start of the year to 5.5% in July, SXWWLQJDQHQGWRWKHKLNHVLQWKHIDFHRIHDVLQJLQćDWLRQ7KH(XURSHDQ&HQWUDO%DQNIXUWKHUEDFNLQWKHWLJKWHQLQJF\FOH raised the deposit rate by a total of 200 basis points, from 2% at the beginning of the year to 4% at the end of September.
Growth dynamics followed a better-than-H[SHFWHGWUDMHFWRU\LQWKHĆUVWSDUWRIWKH\HDUZLWKDPRUHJUDGXDOVORZGRZQ DFURVVDOORIWKHGHYHORSHGHFRQRPLHV7KHĆJXUHIRUWKHWKLUGTXDUWHUFRPSDUHGZLWKWKHSUHYLRXV\HDUZDVIRU the United States, ZLWKDQRYHUDOOSURMHFWLRQRIIRU
:KLOHWKHHXURDUHDFRQWLQXHGWRJURZDWDKHDOWK\SDFHLQWKHĆUVWKDOIRIWKH\HDUDOVRFRPSDUHGZLWKDVROLG growth in 2022, it suffered in the second half of the year from the slowing of the German engine, declining in the third quarter and thus projecting a 0.5% increase at the end of the year. Italian growth has developed in line with that of the HXURDUHDDOWKRXJKWKHRYHUDOOUHVXOWIRULVH[SHFWHGWREHDURXQG
,QćDWLRQ UHWUHDWHGDFURVV WKH ERDUGDOWKRXJK WKHYDULRXVPHDVXUHVZHUHDSSOLHGDWGLIIHUHQW VSHHGVLQ(XURSH WKH headline measure (comprising volatile components such as food and energy) fell sharply over the year, from 9.2% at the HQGRIWRLQ1RYHPEHUFRUHLQćDWLRQFDPHGRZQPRUHVORZO\PDLQO\GULYHQE\WKHVHUYLFHVVHFWRU,Q,WDO\ the harmonised price index fell even more sharply, from 12.3% at the end of 2022 to 0.6% at the end of November.
According to industry studies 4, at the end of the third quarter of 2023, total premiums in the non-life segment of insurance companies and Italian direct insurance portfolios amounted to €31.2 billion, up by 7,5% compared with the end of the same period in 2022, when written premiums totalled €29.0 billion and the sector recorded growth of 6.3%. The third quarter of 2023 was the eleventh consecutive positive quarterly change, raising premium income above €30 billion for the first time at the end of the third quarter of the year.
The increase in total non-life premiums was due, in particular, to the continued growth of the non-motor sector, the Company's core market, which recorded an increase of 8%.
This growth benefited from the positive contribution of all the main insurance classes: health and credit insurance were the best performing sectors, with growth of 13.3% and 14.4%, respectively, while general liability rose by 7.3%. The increase in the accident class was more modest at 4.3%, while the other damage to property and fire classes increased by 7.7% and 9.1% respectively.
The ANIA data for the first half of the year relating to the suretyship business showed an increase in premiums written of 12.4% compared with the same period of 2022, with an absolute value of €396.0 million in the first six months of the year. One of the reasons for this result is the start of work financed by the National Recovery and Resilience Plan (NRRP), as well as the agreements included in the SACE Reinsurance Convention to support companies. The volume of new business premiums written during the half-year came to €221.6 million, up 14.8% on the previous period. The figure is driven by increased underwriting of contract-UHODWHGJXDUDQWHHVWKHSUHPLXPVIRUZKLFKURVHE\PLOOLRQ and procurement-UHODWHG JXDUDQWHHV RI WRWDO SUHPLXPV Premiums written for guarantees related to FRQWULEXWLRQVDOVRLQFUHDVHGDVGLGSUHPLXPVUHODWHGWRSD\PHQWJXDUDQWHHVDQGSUHPLXPVUHODWHG WRFXVWRPVWUDQVDFWLRQV%\FRQWUDVWJXDUDQWHHVUHODWHGWRZDVWHPDQDJHPHQW-1.2%) and tax refunds (-2.9% of total premiums) declined slightly.
The 2022 IVASS annual report, presented to the market on 19 June 2023, also shows a consolidation of premium income growth in other non-OLIHFODVVHVWKHPRVWUHSUHVHQWDWLYHVHFWRUVEHLQJKHDOWKDQGSURSHUW\ZKLFKDFFRXQWIRU 39.6% of non-life business, up 8.5%. In the health VHJPHQWSUHPLXPVIRUWKHKHDOWKFODVVFRPSDUHGZLWK grew, due to the increased use of private insurance, particularly in the corporate sector. In the property sector, the LQFUHDVHLQSUHPLXPLQFRPHLQ WKH ê2WKHUGDPDJH WRSURSHUW\ë DQG ê)LUHDQGQDWXUDO IRUFHVë FODVVHV reflects the increase in demand for asset protection. In Fire and natural element cover, the retail and corporate segments are growing, while in Other damage to property, the corporate segment is expanding, particularly for hail cover. Growth in general third-SDUW\ OLDELOLW\ VWUHQJWKHQHG DFFRXQWLQJ IRU RI WRWDO QRQ-life business), mainly due to business related to Superbonus 110% returns and the recovery of the corporate sector. Legal expenses and Assistance JUHZWKHODWWHUPDLQO\GXHWRWKHUHFRYHU\LQWKHWRXULVPVHFWRUDIWHUWKHSDQGHPLFDVGLG&UHGLWDQG 6XUHW\VKLSUHVSHFWLYHO\GXHWRWKHUHFRYHU\LQHFRQRPLFDFWLYLW\DQGWKHKLJKQXPEHURIWHQGHUVLQFOXGLQJZLWKLQ the scope of the NRRP.
With regard to the distribution channel, the main form of brokerage of the entire non-life segment in terms of market share (69.9%) is still the agency network, which is particularly successful in the Suretyship, General liability, Motor liability, Marine hull and Other damage to property classes. The broker channel holds a 10.6% share. The classes in which brokers' intermediation is significant are Aviation hull, Marine hull, Railway rolling stock and Goods in transit.
4Monthly report issued by the industry association ANIA

The most significant trends in the insurance sector, identified by the main consulting firms and by the companies themselves, include:
This section describes some of the new legislation that affected the insurance sector during the year:

employment permits, state treasury and other financial and social provisions converted, with amendments, by Law No.122 of 4 August 2022;
x Commission Regulation (EU) 2023/2822 of 19 December 2023 amending Regulation (EU) 2023/1803 as regards International Accounting Standard (IAS) 1, in order to specify how an undertaking shall determine, in its statement of financial position, debt and other liabilities with an uncertain settlement date. Under these amendments, the debt or other liabilities must be classified as current (with an effective or potential settlement date within one year) or non-current.
A number of corporate events took place in 2023, the most significant of which are outlined below:

| Alternative performance indicators | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Loss ratio 5 | 42.0% | 20.3% |
| Combined ratio 6 | 85.8% | 75.8% |
At Group level, operating performance in the 2023 financial year was characterised by the Group's pursuit of its own strategic plan, which envisaged the further development of its existing insurance business and the broadening of its offer, with the launch of new lines and products focused on specialty and parametric risks.
The consolidated financial statements at 31 December 2023 show a pre-tax profit of €10,141,000. After taxes of €424,000, the profit amounted to €10,566,000.
This result was determined by the IAS profit, net of the taxes recorded by Revo Insurance S.p.A., amounting to €10,445,000 and increased by the IAS profit of Revo Underwriting, amounting to €120,000.
The Group's income statement 7 is set out below, including the contribution of each individual company within the scope of consolidation.
| Income statement | REVO Insurance |
REVO Underwriting |
Total | |
|---|---|---|---|---|
| 1. | Insurance revenues deriving from insurance contracts written | 146,911 | 2,038 | 148,949 |
| 2. | Costs of insurance services deriving from insurance contracts written | -118,677 | - | -118,677 |
| 3. | Insurance revenues deriving from cessions to reinsurance | 69,748 | - | 69,748 |
| 4. | Costs of insurance services deriving from cessions to reinsurance | -81,087 | - | -81,087 |
| 5. | Result of insurance services | 16,896 | 2,038 | 18,933 |
| 6. | Fair value gains (losses) on financial assets and liabilities measured at FVTPL | - | - | - |
| Net fair value on financial assets and liabilities measured at FVTPL | 178 | - | 178 | |
| Fair value gains (losses) on financial assets and liabilities measured at FVTPL | - | - | - | |
| 7. | Gains (losses) on investments in subsidiaries, associates and joint ventures | - | - | - |
| 8. | Income/expenses from other financial assets and liabilities and from investment property |
3,073 | - | 3,073 |
| 9. | Investment result | 3,252 | - | 3,252 |
| 10. | Net financial expenses relating to ins. contracts written | -393 | - | -393 |
| 11. | Net financial income relating to cessions to reinsurance | 119 | - | 119 |
| 12. | Net financial result | 2,978 | - | 2,978 |
| 13. | Other revenues/costs | 70 | -1,591 | -1,521 |
5 Profitability indicator calculated as the ratio of claims-related expenses gross of reinsurance to insurance revenues, gross of commissions and the value of the acquired portfolio (ex. VoBA).
6Profitability indicator calculated as the ratio between the sum of the costs for insurance services issued and the result of reinsurance and insurance revenues gross of the value of the acquired portfolio (ex. VoBA).
7 The prospectus is presented in the format provided for by IVASS Regulation No. 7/2007 as amended following the entry into force of the new IFRS 17.

| 14. | Operating expenses: | -6,489 | -226 | -6,715 |
|---|---|---|---|---|
| 14.1 | - Investment management service expenses | -25 | - | -25 |
| 14.2 | - Other administrative expenses | -6,464 | -226 | -6,690 |
| 15. | Net accruals to provisions for risks and charges | - | - | - |
| 16. | Depreciation and net impairment losses on property, pland and equipment | -1,767 | - | -1,767 |
| 17. | Amortisation and net impairment losses on intangible assets | -148 | -1 | -149 |
| 18. | Other operating income/expenses | -1,575 | -43 | -1,618 |
| 19. | Profit for the year before tax | 9,964 | 177 | 10,141 |
| 20. | Taxes | 481 | -57 | 424 |
| 21. | Profit for the year after tax | 10,445 | 120 | 10,566 |
At year-end, the adjusted operating profit amounted to €21,279,000. This figure has undergone the following adjustments compared with the operating result in that it:
The following table summarises the components of the adjusted operating result for 2023:
| Adjusted operating profit | 2023 |
|---|---|
| Insurance result | 18,933 |
| Operating expenses 8 | -8,305 |
| LTI | -1,659 |
| Amortisation of intangible assets transferred to the technical part | 2,936 |
| Interest income - expense | 3,620 |
| Operating profit | 15,525 |
| One-off costs | 1,288 |
| LTI | 1,659 |
| Settlement of agents'severance indemnity | 30 |
| Depreciation of property, plant and equipment (no IFRS 16) | 124 |
| Depreciation of value of acquired portfolio (ex. VoBA) | 2,583 |
| Adjustments of interest on loan | 70 |
| Adjusted operating profit | 21,279 |
For the sake of completeness, the adjusted profit for the yearis shown below. It includes the same adjustment measures made to the operating profit shown above but excludes the provision for LTI incentive plans:
| Adjusted net profit | 31.12.2023 |
|---|---|
| Profit | 10,566 |
| Unrealised and realised capital gains/losses | 368 |
| Adjustments of interest on loan | 70 |
| Listing and other one-off costs | 1,288 |
| Depreciation of property, plant and equipment (no IFRS 16) | 124 |
| LTI | 1,659 |
8 The item includes the commissions that REVO Underwriting S.r.l. paid to its commercial network in 2023.
| Agency liquidation | 30 |
|---|---|
| Depreciation of value of acquired portfolio (ex. VoBA) | 2,583 |
| Tax adjustment | -1,887 |
| Adjusted profit | 14,801 |
The total value of the technical balance, net of reinsurance, was €18,933,000, representing an increase on the same period in 2022, when it was €13,724,000.
The technical performance of the insurance portfolio during the year was characterised by:
At 31 December 2023, management increased the claims provision, increasing IBNR by a total of €2,916,000 compared with 31 December 2022, with €1,289,000 ceded to reinsurance. Total IBNRs at 31 December 2023 amounted to €4,556,000 (€1,640,000 at 31 December 2022). The net loss ratio of the Suretyship class confirmed the extremely positive trend, at 12.5%.
Due to the above performance, the adjusted COR9 (combined operating ratio) was 85.8% (75.7% for 2022).
The positive investment result of €3,252,000 (€1,756,000 for 2022), was positively affected by the reduction of €497,000 in impairment losses on investments measured at fair value. These impairment losses recognised in 2022 were due to the sharp rise in reference rates during the period.
Added to this effect was the increase of €1,718,000 in interest on coupons in the 2023 financial year, partially offset by the €719,000 decrease in net gains on disposals compared with 2022.
| Insurance sector | Other | Total | ||||
|---|---|---|---|---|---|---|
| 31.12.2023 | 31.12.2022 | 31.12.2023 | 31.12.2022 | 31.12.2023 | 31.12.2022 | |
| Intangible assets | 88,412 | 83,071 | 3 | - | 88,415 | 83,071 |
| Property, plant and equipment | 13,926 | 14,448 | - | - | 13,926 | 14,448 |
| Insurance assets | 68,750 | 45,805 | - | - | 68,750 | 45,805 |
| Investments | 223,677 | 188,531 | - | - | 223,677 | 188,531 |
| Other financial assets | 4,735 | 4,018 | -511 | -183 | 4,224 | 3,835 |
| Other assets | 19,698 | 19,032 | - | 17 | 19,698 | 19,049 |
| Cash and cash equivalents | 5,456 | 4,445 | 946 | 207 | 6,402 | 4,652 |
| Total assets | 424,654 | 359,350 | 438 | 41 | 425,092 | 359,391 |
| Equity | 225,377 | 216,367 | 248 | 128 | 225,625 | 216,495 |
| Provision for risks and charges | 2,988 | 3,243 | - | - | 2,988 | 3,243 |
| Insurance liabilities | 156,308 | 101,473 | - | -108 | 156,308 | 101,365 |
| Financial liabilities | 14,503 | 14,448 | - | - | 14,503 | 14,448 |
9Profitability indicator, calculated as the ratio of the sum of the costs of insurance services issued and the result of reinsurance and insurance revenues gross of VoBA.

| Liabilities | 14,657 | 18,149 | 103 | 18 | 14,760 | 18,167 |
|---|---|---|---|---|---|---|
| Other liabilities | 10,821 | 5,670 | 87 | 3 | 10,908 | 5,673 |
| Total equity and liabilities | 424,654 | 359,350 | 438 | 149 | 425,092 | 359,391 |
| Insurance sector | Other | Total | ||||
|---|---|---|---|---|---|---|
| 31.12.2023 | 31.12.2022 | 31.12.2023 | 31.12.2022 | 31.12.2023 | 31.12.2022 | |
| Result of insurance services | 16,895 | 13,656 | 2,038 | 67 | 18,933 | 13,723 |
| Investment result | 3,252 | 1,756 | - | - | 3,252 | 1,756 |
| Net financial income | 2,978 | 3,088 | - | - | 2,978 | 3,088 |
| Other revenues/costs | 70 | - | -1,591 | -51 | -1,521 | -51 |
| Operating expenses | -6,489 | -8,840 | -226 | -16 | -6,715 | -8,856 |
| Net accruals to provisions for risks and charges |
- | -320 | - | - | - | -320 |
| Depreciation and net impariment losses on property, plant and equipment |
-1,767 | -916 | - | - | -1,767 | -916 |
| Amortisation and net impairment losses on intangible assets |
-148 | -3 | -1 | -1 | -149 | -4 |
| Other operating income/expenses | -1,575 | -156 | -43 | -28 | -1,618 | -184 |
| Profit/Loss for the year before tax | 9,964 | 6,509 | 177 | -29 | 10,141 | 6,480 |
Insurance revenues deriving from insurance contracts written
The sections on the performance of insurance operations concern the performance of the insurance company only. The following table sets out the reconciliation between the classification of the business by groups of contracts (Revo LoB) and IFRS 17 portfolios for the purposes of comparison:
| IFRS 17 portfolio | Contract group - REVO LoB | ||||
|---|---|---|---|---|---|
| Property | Engineering | ||||
| Property | |||||
| FI | |||||
| Indirect Property | Property Cat | ||||
| Parametric | Parametric Cat | ||||
| Parametric Agro | |||||
| Parametric Financial Loss | |||||
| Accident & Health | PA | ||||
| Other Motor | Land Vehicles | ||||
| MAT Specialty Lines | Aviation | ||||
| FA&S | |||||
| Marine | |||||
| Liability | |||||
| General Liability | PI | ||||
| D&O | |||||
| Cyber | |||||
| Credit | Credit | ||||
| Agro | Agro | ||||
| Suretyship | Bond | ||||
| Legal | Legal |
Insurance revenues from insurance contracts written by REVO Insurance alone amounted to €146,911,000 for 2023, up by €78,245 compared with 2022 (€68,666,000 for 2022)
Premiums written, gross of reinsurance and net of current year cancellations, totalled €216,239,000 in 2023, a significant increase compared with the €131,388,000 recorded at 31 December 2022 (an increase of 64.6%).
The following is a presentation of direct and indirect premium income, first by Revo LoB and then by IFRS 17 portfolio:
| Revo LoB | 31.12.2023 | % | 31.12.2022 | % |
|---|---|---|---|---|
| Bond | 85,176 | 39.4% | 73,229 | 55.7% |
| Property | 28,106 | 13.0% | 14,681 | 11.2% |
| Engineering | 20,887 | 9.7% | 13,634 | 10.4% |
| Marine | 17,485 | 8.1% | 4,102 | 3.1% |
| Agro | 13,803 | 6.4% | 3,898 | 3.0% |
| PI | 13,499 | 6.2% | 7,362 | 5.6% |
| Aviation | 8,322 | 3.8% | 921 | 0.7% |
| Casualty | 7,989 | 3.7% | 6,641 | 5.1% |
| PA | 5,786 | 2.7% | 964 | 0.7% |
| Cyber | 4,173 | 1.9% | 1,394 | 1.1% |
| D&O | 3,222 | 1.5% | 2,689 | 2.0% |
| Land Vehicles | 2,701 | 1.2% | 0 | 0.0% |
| Property CAT | 1,897 | 0.9% | 377 | 0.2% |
| FA&S | 1,002 | 0.5% | 386 | 0.3% |
| FI | 823 | 0.4% | 890 | 0.7% |
| Legal | 555 | 0.3% | 0 | 0.0% |
| Credit | 507 | 0.2% | 0 | 0.0% |
| Parametric Financial Loss | 191 | 0.1% | 0 | 0.0% |
| Parametric Agro | 115 | 0.1% | 220 | 0.2% |
| Total gross premiums | 216,239 | 100.00% | 131,388 | 100.00% |
| IFRS 17 portfolio | 31.12.2023 | % | 31.12.2022 | % |
|---|---|---|---|---|
| Suretyship | 85,176 | 39.4% | 73,229 | 55.70% |
| Property | 49,817 | 23.0% | 29,205 | 22.20% |
| General Liability | 28,883 | 13.4% | 18,073 | 13.80% |
| MAT Specialty lines | 26,808 | 12.4% | 5,421 | 4.10% |
| Agro | 13,803 | 6.4% | 3,898 | 3.00% |
| Accident & Health | 5,786 | 2.7% | 964 | 0.70% |
| Other Motor | 2,701 | 1.2% | - | 0.00% |
| Indirect Property | 1,897 | 0.9% | 377 | 0.30% |
| Legal | 555 | 0.3% | - | 0.00% |
| Credit | 507 | 0.2% | - | 0.00% |
| Parametric | 306 | 0.1% | 221 | 0.20% |
| Total gross premiums | 216,239 | 100.00% | 131,388 | 100.00% |
The following is a breakdown of insurance revenues deriving from insurance contracts written per IFRS 17 portfolio:
| Insurance revenues deriving from insurance contracts written | 31.12.2023 | % | 31.12.2022 | % |
|---|---|---|---|---|
| Suretyship | 52,525 | 35.8% | 42,979 | 62.6% |
| Property | 33,273 | 22.6% | 13,699 | 20.0% |
| General Liability | 22,002 | 15.0% | 6,048 | 8.8% |
| MAT Specialty lines | 19,690 | 13.4% | 2,037 | 3.0% |
| Agro | 12,115 | 8.2% | 3,277 | 4.8% |
| Accident & Health | 4,536 | 3.1% | 270 | 0.4% |
| Indirect Property | 1,412 | 1.0% | 168 | 0.2% |
| Other Motor | 856 | 0.6% | - | - |
| Parametric | 237 | 0.2% | 188 | 0.3% |
| Credit | 224 | 0.2% | - | - |
| Legal | 42 | 0.0% | - | - |
| Total | 146,911 | 100% | 68,666 | 100% |

The income statement item described above also includes (with a negative sign) the commissions paid to the sales network. The following table sets out the amount of revenues gross of the share of commissions of REVO Insurance alone:
| Insurance revenue deriving from insurance contracts after commissions | 31.12.2023 | % | 31.12.2022 | % |
|---|---|---|---|---|
| Suretyship | 73,118 | 38.4% | 62,118 | 63.1% |
| Property | 44,224 | 23.2% | 19,824 | 20.1% |
| General Liability | 26,688 | 14.0% | 8,965 | 9.1% |
| MAT Specialty lines | 23,107 | 12.2% | 2,878 | 2.9% |
| Agro | 13,822 | 7.3% | 3,813 | 3.9% |
| Accident & Health | 5,362 | 2.8% | 422 | 0.4% |
| Indirect Property | 1,599 | 0.8% | 168 | 0.2% |
| Other Motor | 1,491 | 0.8% | - | - |
| Credit | 382 | 0.2% | - | - |
| Parametric | 288 | 0.2% | 221 | 0.3% |
| Legal | 129 | 0.1% | - | - |
| Total | 190,212 | 100.0% | 98,409 | 100.0% |
For presentation purposes and in order to ensure continuity with the information provided up to 31 December 2022, the following table summarises gross premiums written by regulatory class:
| Gross premiums | 31.12.2023 | % | 31.12.2022 | % | |
|---|---|---|---|---|---|
| 1 | Accident | 1,916 | 0.9% | 973 | 0.7% |
| 2 | Health | 4311 | 2.0% | 15 | 0.0% |
| 3 | Land vehicles | 2,732 | 1.3% | - | 0.0% |
| 4 | Railway rolling stock | 1,789 | 0.8% | - | 0.0% |
| 5 | Aviation hull | 5,652 | 2.6% | 261 | 0.2% |
| 6 | Marine hull (sea, lake and river and canal vessels) | 10,318 | 4.8% | 2,205 | 1.7% |
| 7 | Goods in transit | 4,936 | 2.3% | 2,008 | 1.5% |
| 8 | Fire and natural forces | 28,010 | 13.0% | 14,730 | 11.2% |
| 9 | Other damage to property | 34,018 | 15.7% | 15,918 | 12.1% |
| 11 | Aviation liability | 935 | 0.4% | 99 | 0.1% |
| 12 | Marine liability (sea, lake and river and canal vessels) | 359 | 0.2% | 70 | 0.1% |
| 13 | General liability | 31,846 | 14.7% | 20,977 | 16.0% |
| 14 | Credit | 507 | 0.2% | 289 | 0.2% |
| 15 | Suretyship | 85,176 | 39.4% | 73,229 | 55.7% |
| 16 | Financial loss | 3,161 | 1.5% | 602 | 0.5% |
| 17 | Legal expenses | 558 | 0.3% | - | 0.0% |
| 18 | Assistance | 13 | 0.0% | 10 | 0.0% |
| Total | 216,239 | 100.0% | 131,388 100.0% |
In this regard, it should be noted that during the year WKHUHZDVDQLQFUHDVHQRWRQO\LQ6XUHW\VKLS.3% compared with 2022), which remained the main business class, but also a significant increase in the other classes, mainly due to the impetus provided by the expansion of the product range and the distribution network.
At the end of the year, the insurance portfolio was more diversified, with Suretyship accounting for 39.4% of total premiums (55.7% at 31 December 2022), due to greater exposure to other classes, the proportion of which increased from 44.3% for 2022 to 60.6% for 2023.
To complete the description of premium income for the year, a breakdown of premium income by geographical area is shown below:
| Geographical area | 31.12.2023 | % | 31.12.2022 | % |
|---|---|---|---|---|
| Northern Italy | 148,665 | 69% | 91,811 | 70% |

| Central Italy | 34,318 | 16% | 25,118 | 19% |
|---|---|---|---|---|
| Southern Italy and Islands | 28,867 | 13% | 14,082 | 11% |
| Foreign under FPS and Indirect | 4,389 | 2% | 377 | 0% |
| Total | 216,239 | 100% | 131,388 | 100% |
In 2023, the Company continued its efforts to strengthen and optimise, where necessary, measures to increase the number of agency mandates and the number of non-exclusive agency agreements with brokers, in order to boost overall production and the productivity of individual intermediaries.
At 31 December 2023, the sales network consisted of 111 multi-firm agents (116 at 31 December 2022) and 67 brokers (53 at 31 December 2022).
During 2023, the Company, as part of a process aimed at strengthening its commercial structure, embarked on a harmonisation of the agency network that entailed the opening of 10 new agency mandates, 15 new free cooperation agreements with brokers and the closure of 1 free cooperation agreement and 15 agency mandates.
The distribution of agencies/brokers and the average premiums written at 31 December 2023 by geographical area in Italy are as follows:
| Geographical area | No. of agencies/brokers by geographical area |
Overall premiums |
Average premiums per Agency/Broker 2023 |
Average premiums per Agency/Broker 2022 |
|---|---|---|---|---|
| North | 89 | 148,665 | 1,670 | 1,208 |
| Centre | 48 | 34,318 | 715 | 534 |
| South and Islands | 41 | 28,867 | 704 | 306 |
| Total | 178 | 211,850 | 1,190 | 775 |
A breakdown of the components of the item "Insurance costs deriving from insurance contracts written by the Parent Company" is provided below:
| Insurance costs deriving from insurance contracts written | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Amounts paid | 67,288 | 15,985 | 51,303 |
| Amounts to be recovered | -36,572 | -7,530 | -29,042 |
| Change in LIC | 49,501 | 11,499 | 38,002 |
| Costs attributed to insurance contracts | 34,591 | 24,259 | 10,332 |
| Non-distinct investment component | -256 | -29 | -227 |
| Loss component | - | - | - |
| Other technical items | 4,125 | 1,096 | 3,029 |
| Total | 118,677 | 45,280 | 73,397 |
In particular, claims-related expenses for direct and indirect business amounted to €79,961,000 gross of reinsurance (€19,925,000 for 2022). Operating expenses and other technical items totalled €38,716,000 (€25,355,000 for 2022).
| Claims for the period | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Property | 26,511 | 4,997 |
| Indirect Property | 1,659 | - |
| Parametric | 123 | 259 |
| Accident & Health | 3,712 | 225 |
| Other Motor | 590 | - |
10 Calculated as the sum of the amounts paid net of recoveries, including the change in LIC, the investment component and the loss component (if any).

| MAT Specialty lines | 22,350 | 1,463 |
|---|---|---|
| General Liability | 2,703 | 3,328 |
| Credit | 16 | - |
| Agro | 13,862 | 2,425 |
| Suretyship | 8,437 | 7,228 |
| Legal | - | - |
| Total | 79,961 | 19,925 |
The overall performance of claims-related expenses at 31 December 2023, measured in terms of loss ratio, was, although it increased, appropriate in view of the development and diversification of other lines of production, standing at 42.0% 11(20.3% at 31 December 2022).
In absolute terms, claims-related expenses increased by €60,037,000, mainly due to the effect of the Property portfolio (€21,514,000), the Suretyship portfolio (€11,437,000) and the MAT Specialty Lines portfolio, which had been negligible in the 2022 half-year, and increased by €20,887,000, due to the reporting of six large claims, amounting to a claims expense net of reinsurance totalling around €2,790,000. At the end of the year, the MAT Specialty portfolio was fully overhauled.
The General Liability portfolio decreased by €625,000.
The technical performance in 2023, due to the Company's particular focus on customer retention and risk assessment during the underwriting phase, once again proved profitable. The ratio, net of reinsurance, of claims for the period to insurance revenues, was 12.5% at 31 December 2023, unchanged compared with 2022.
Net claims for the yearincreased by €892,000 compared with 31 December 2022, due to the increase in claims paid and proveded for in the current year.
In the other portfolios, the ratio, gross of reinsurance, of claims paid and provided for net of recoveries (including an IBNR provision of €4,556,000, up from €1,640,000 at 31 December 2022) to earned premiums net of commissions totalled 61.1% overall (35% in 2022). Excluding reinsurance, the ratio was 54.4%, compared with 39.7% in 2022.
An analysis of the claims performance of the main portfolios is shown below:
11 The loss ratio is obtained by comparing claims for the yearrelating to direct and indirect business to insurance revenues gross of the share of commissions and the share of amortisation of the portfolio acquired (former Elba Assicurazioni S.p.A.).

With regard to the largest claims, with an impact net of cession of more than €200,000, the following should be noted:
According to the new IFRS 17, the item "insurance costs deriving from insurance contracts written" includes the Company's operating expenses attributable to insurance contracts.
The following table shows the breakdown of operating expenses allocated to insurance contracts:
| Total costs attributed to insurance contracts | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Portion of operating expenses allocated to insurance contracts | 24,002 | 16,926 |
| Other acquisition expenses | 7,653 | 5,917 |
| Amortisation of intangible assets | 2,936 | 1,416 |
| Total | 34,591 | 27,057 |
The portion of operating expenses by type allocated to the insurance business was €24,002,000, in addition to €7,653,000 relating to other acquisition expenses, such as additional commissions and commission bonuses, and €2,936,000 for the amortisation of intangible assets.
The following table shows the split of operating expenses by type between the various items of the income statement:
| Breakdown of operating expenses by type | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Costs attributed to insurance contracts written | 24,002 | 16,926 |
| Costs not allocated to insurance contracts | 7,114 | 10,385 |
| Costs attributed to claims settlement expenses | 806 | 627 |
| Total | 31,922 | 27,938 |
The following table contains a breakdown by type of the Company's total operating expenses, compared with operating expenses at 31 December 2022, showing the share allocated to insurance management. Costs have been allocated based on their nature and the relevant cost centre and distributed by portfolio based on earned premiums.
| Operating expenses by type | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Personnel | 17,824 | 15,038 | 2,785 |
| Travel/Company car expenses | 1,020 | 708 | 311 |
| Depreciation of property, plant and equipment | 124 | 134 | -10 |
| BoD-Board of Statutory Auditors-Various Committees | 948 | 644 | 304 |
| Ind. Auditor | 395 | 271 | 125 |
| Rents and condominium expenses/cleaning | 892 | 752 | 140 |
| Legal expenses | 368 | 407 | -39 |
| EDP services/maintenance | 4,388 | 2,382 | 2,006 |
| Policies | 487 | 347 | 140 |
| Advisory services | 2,682 | 3,298 | -616 |
| One-off costs | 1,288 | 2,864 | -1,576 |
| Corporate events/agents and advertising | 678 | 330 | 348 |
| Other expenses | 829 | 763 | 66 |
| 31,922 | 27,938 | 3,985 |

The main changes compared with costs at 31 December 2022 relate to payroll costs, which rose by €2,785,000, mainly GXHWRWKHPDUNHGLQFUHDVHLQWKHQXPEHURISHRSOHFRPSDUHGZLWKUHVRXUFHVDQGWKHFRVWVRI('3VHUYLFHV related to the continuation of the technological development project.
The total costs attributed to insurance management thus amounted to €24,002,000 for 2023 (€16,926,000 for 2022).
During the year, the Company carried out insurance activities under the freedom to provide services scheme in the territory of the Member States of the European Community, including States in the European Economic Area, following the authorisation received from IVASS on 4 July 2022.
The table below sets out the most substantial operating amounts relating to foreign business, separated into direct and indirect business:
| Foreign business | Direct 31.12.2023 | Indirect 31.12.2023 |
|---|---|---|
| Premiums | 15,183 | 3,064 |
| Change in premium provision | -2,792 | -497 |
| Claims paid | -3,055 | -1,075 |
| Change in claims provision | -5,583 | -574 |
| Operating expenses | -3,638 | -917 |
| - o/w commissions |
-1,601 | -495 |
| Total | 115 | 1 |
In 2023, the Company's reinsurance policy pursued the aim of optimising the overall risk profile and protecting the Company from unexpected/unforeseen events such as "large" claims, including catastrophe claims.
Treaties continued to be signed with leading reinsurance companies, significantly reducing the Group's counterparty risk. The minimum rating of the companies included in the panel was greater than or equal to an A- rating from Standard & Poor's and an A- rating from A.M. Best.
Quota and excess of loss treaties were agreed for Suretyship policies (as in previous years) and quota and excess of loss treaties for other non-life policies, (except for Assistance, Cyber and Fine Art policies, for which quota share treaties were signed). For LoB Engineering, Agro and D&O policies it was decided to retain pure excess of loss coverage.
The following table shows a breakdown of the balance of ceded business compared with the previous year:
| Technical reinsurance account | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Insurance revenues deriving from reinsurance contracts | 69,749 | 24,211 |
| Insurance costs deriving from reinsurance contracts | -81,087 | -33,967 |
| Loss of insurance services deriving from cessions to reinsurance | -11,338 | -9,756 |
Premiums ceded, which equalled €99,954,000 (€53,823,000 for 2022) increased due to both new business and the new proportional, non-proportional and optional treaties entered into, primarily from the second half of 2022 and in 2023.
In 2023, the REVO product range was further expanded:
x Property: new cover to protect manufacturing companies and their property assets against the risk of fire and other damage to property, theft and robbery, catastrophic events and indirect damage, and income protection. In the catastrophic event insurance, activating the earthquake cover provides parametric cover for initial expenses,

with prompt automatic compensation provided if an earthquake occurs that exceeds a given parameter: this cover is completely new on the market;
Revo Insurance S.p.A. has further developed the new proprietary technological platform, OverX. The tool, which is fundamental for structuring and creating new insurance products, significantly simplifies underwriting and distribution processes, partly thanks to automated reading of broker communications, the use of external databases and the structuring of information needed to assess risk and draw up insurance contracts.
OverX was developed natively in the cloud environment, using cutting-edge technologies, such as artificial intelligence, micro-services, APIs (application programming interfaces) and paradigms of privacy and security by design; it is based on a simple and efficient data structure, which facilitates information collection by brokers and stands out as it is highly innovative in terms of flexibility and efficiency in product personalisation.
During 2023, in addition to the implementations necessary for the development of the above-mentioned products, various new features were enhanced and provided, and specifically:

In 2023, the Company's investment policy was based on prudent criteria. The guidelines also take account of the framework resolution referred to in Article 8 of IVASS Regulation No. 24/2016, updated by the Board of Directors on 28 March 2023. It should be noted that updates to the framework resolution are designed to ensure both greater flexibility in investments in securities and greater diversification of portfolio instruments.
In the first half of the year, in particular, Italian and foreign government securities with high credit ratings were purchased, including from Germany, the Netherlands, France and Spain, as well as from supranational issuers. In the same period, to a lesser extent, highly rated corporate bonds were also purchased.
In the second half of the year, the diversification process continued with the purchase of core government bonds and highly rated corporate bonds (covered bonds). In the phase of volatility on the spread, the domestic government bond component was tactically increased on medium-term maturities. Operations in the equity segment are purely tactical in nature.
The asset portfolio has a particularly low duration of approximately two years and an excellent level of liquidity. All portfolio positions are denominated in euro.
The Company's prudent policy in terms of investments and issuer quality serves to protect it from market risk and liquidity risk, despite the current fragile economic scenario. The ongoing increased diversification in terms of asset class and issuers is intended to make the portfolio more resistant to market fluctuations and increased volatility in domestic government bond spreads.
Total investments at 31 December 2023 amounted to €223,677,000 (€188,531,000 for 2022), including €217,811,000 in bonds and other listed fixed-rate securities (including 37.7% in Italian government securities and other bonds and 42.3% in foreign government securities and other bonds), in addition to €2,775,000 relating to units in bond funds. Shares and quotas of companies include a €556,000 investment in Mangrovia Blockchain Solutions S.r.l. and €3,000 in MedInsure S.r.l.
This item includes, in assets measured at amortised cost, the escrow account set up following the acquisition of Elba Assicurazioni S.p.A., amounting to €3,088,000 (€4,016,000 for 2022). The escrow account was reduced by €1,000,000 in December. This reduction will continue annually until the escrow account is exhausted (30 December 2026).
Total cash and cash equivalents amounted to €6,402,000 for 2023 (€4,652,000 for 2022).
The following table sets out the breakdown of investments compared with the previous year:
| Investments and cash and cash equivalents | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Investment property | - | - |
| Investments in subsidiaries, associates and joint ventures | 3 | - |
| Financial assets measured at amortised cost | 3,088 | 4,016 |
| Financial assets measured at fair value through OCI | 217,811 | 181,895 |
| Financial assets measured at fair value through profit or loss | 2,775 | 2,620 |
| Total investments (excluding cash and cash equivalents) | 223,677 | 188,531 |
| Cash and cash equivalents | 6,402 | 4,652 |
| Total (including cash and cash equivalents) | 230,079 | 193,183 |
| Investments by type – excluding escrow | 31.12.2023 | % | 31.12.2022 | % |
|---|---|---|---|---|
| Shares and quotas | 560 | 0.2% | 556 | 0.3% |
| Foreign corporate bonds | 28,966 | 12.8% | 22,480 | 11.9% |
| Italian corporate bonds | 6,740 | 3.0% | 4,861 | 2.6% |
| Italian government bonds | 85,481 | 37.7% | 97,987 | 51.8% |
| Foreign state/government bonds | 96,067 | 42.3% | 56,011 | 29.6% |
| Mutual fund units | 2,775 | 1.2% | 2,620 | 1.4% |
| Total investments (excluding cash and cash equivalents) | 220,589 | 184,515 | ||
| Cash at bank and in hand | 6,402 | 2.8% | 4,652 | 2.5% |

At 31 December 2023, the internal structure consisted of 189 resources, as well as four external contractors (at 31 December 2022, there were 151 plus six external contractors).
7KHVXEVWDQWLDOLQFUHDVHFRPSDUHGZLWKUHVRXUFHVLVPDLQO\GXHto the recruitment of new staff to develop the Company's new business lines, authorised by IVASS at the end of March 2022, and the strengthening of the Operations structures, with the simultaneous strengthening of staff structures and key functions.
The internal structure by area of expertise breaks down as follows:
| 31.12.2023 | 31.12.2022 | |
|---|---|---|
| CEO/GM | 1 | 1 |
| Specialty Insurance Solutions | 98 | 98 |
| Operations | 41 | 19 |
| Finance Planning and Control | 16 | 11 |
| Legal & Corporate Affairs | 11 | 10 |
| Risk Management | 4 | 3 |
| Human Resources and Organisation – General/Centralised Services | 7 | 3 |
| Communications & ESG | 3 | - |
| Internal Audit | 3 | 1 |
| Actuarial | 2 | 1 |
| Compliance | 2 | 2 |
| Staff | 1 | 2 |
| Total | 189 | 151 |
Also during 2023, staff training continued with the aim of promoting professional and managerial growth. In particular, a training course was set up for Parent Company managers who took part in this 40h course entitled "Leadership training: the strategic role of the manager". Managers are one of the cornerstones of an organisation. Their daily work is essential for interpreting and passing on the Company's values.
In addition, in December, the development programme was launched, which will run in 2024 under the title "Taking care of value: growth and development of skills in REVO", aimed at further delineating the attention and importance that REVO places on staff growth pathways.
In April 2023, the Company opened its new operational headquarters in Milan, at Via Monte Rosa 91, with collaborative workspaces and a strong sustainability footprint.
REVO also decided to open an additional operational headquarters in the city of Genoa, a choice dictated by the growing need for proximity to business, particularly Marine insurance.
During the year, two changes were made to REVO's organisation, involving the Claims team and the Parametric team. In particular:

Total labour costs, including the reimbursement of expenses (employees and contractors on project-based contracts) at 31 December 2023 came to €17,824,000 (€15,038,000 at 31 December 2022). The change compared with 2022 mainly reflects the increase in total remuneration due to the recruitment of a further 38 resources since 31 December 2022.
At the Shareholders' Meeting of 19 April 2023, the Company approved a remuneration policy in accordance with the provisions of the legislation applicable to listed companies and in compliance with the specific provisions in this regard set out in IVASS Regulation No. 38. 38.
The management remuneration system comprises the following main elements:
In particular, the remuneration system for top management, in addition to the Chief Executive Officer and employees of the Company who perform managerial roles or functions, consists of a fixed and a variable component, the latter with an annual component and a deferred long-term incentive plan, in line with best practice at national and international level.
The annual variable component consists of the "MbO" system, which provides for the payment of a cash bonus, subject to the achievement of predetermined annual objectives - both quantitative (operating result and premium income) and qualitative (on a personalised basis) - that are commensurate with the specific role and activities performed by the individual beneficiary.
On 4 April 2022, the Company's Shareholders' Meeting also approved a performance share plan called the "2022-2024 Performance Share Plan" (hereinafter, the "Plan"), the rules of which were drawn up and approved by the Board of Directors on 26 May 2022.
The Plan is a valid tool for retaining and motivating individuals who play a key role in achieving the Company's objectives, and for aligning the interests of key company resources with those of other stakeholders, with a view to long-term sustainable development.
The value of the LTI item at 31 December 2023 was €1,659,000.
Employees and contractors are required to scrupulously observe the rules of conduct established in the Code of Ethics updated by resolution of the Board of Directors of 13 July 2023.
This document establishes the specific rules and procedures of conduct which, in line with principles of a commitment to fairness and consistency of approach, must be observed by employees and contractors in their multiple relationships with policyholders, agents, suppliers, service providers and any other company or entity, whether public or private, that comes into contact with the Company.
No cases of non-compliance in this regard were reported or discovered during 2023.
The Subsidiary, Revo Underwriting, which is responsible for insurance brokerage and advisory services and operates as the Group's MGA (managing general agency), has been active since 6 July 2022, the date of entry in the Single Register of Insurance and Reinsurance Intermediaries (RUI) with registration number A000711224.

During the year, the subsidiary activated 165 mandates, including the 69 that were opened during the second half of 2022, bringing the total number of active mandates to 234.
At 31 December 2023, the subsidiary posted revenues of €2,038,000, costs associated with the marketing of insurance products of €1,591,000 and costs associated with administrative services of €270,000. The result for the period was a profit after tax of €120,000.
Further to the above, the figures are summarised below, in thousands of euro, for the year ended 31 December 2023 compared with 2022 for the income statement and for statement of financial position items:
| Assets | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Intangible assets | 88,415 | 83,071 |
| Property, pland and equipment | 13,926 | 14,448 |
| Insurance assets | 68,750 | 45,805 |
| Investments | 223,677 | 188,531 |
| Other financial assets | 4,224 | 3,835 |
| Other assets | 19,699 | 19,049 |
| Cash and cash equivalents | 6,402 | 4,652 |
| Total assets | 425,093 | 359,391 |
| Equity and liabilities | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Equity | 225,625 | 216,495 |
| Provision for risks and charges | 2,988 | 3,243 |
| Insurance liabilities | 156,308 | 101,365 |
| Financial liabilities | 14,503 | 14,448 |
| Payables | 14,760 | 18,167 |
| Other liabilities | 10,909 | 5,673 |
| Total liabilities and equity | 425,093 | 359,391 |
| Income statement | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Result of insurance services | 18,933 | 13,723 |
| Net financial income | 2,978 | 3,088 |
| - o/w gains oninvestments |
3,252 | 1,756 |
| Other costs net | -1,521 | -51 |
| Operating expenses | -6,715 | -8,856 |
| Net accruals to provisions for risks and charges | - | -320 |
| Depreciation and net impaiment losses on property, plant and equipment | -1,767 | -917 |
| Amortisation and impaiment losses on intangible assets | -149 | -3 |
| Other operating expenses, net | -1,618 | -184 |
| Profit (loss) for the year before tax | 10,141 | 6,480 |
| Taxes | 424 | -287 |
| Profit (loss) for the year after tax | 10,565 | 6,193 |
For presentation purposes and to ensure continuity with the information provided up to 31 December 2022, the restated statement of financial position and income statement, setting out figures in accordance with the old IFRS 4 (superseded by the introduction, on 1 January 2023, of IFRS 17), are set out below:
| Assets | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Intangible assets | 94,878 | 92,128 |
| Property, plant and equipment | 13,926 | 14,448 |
| Investments | 223,677 | 188,531 |
| Reinsurers' share of technical provisions | 96,331 | 55,737 |
| Receivables | 70,952 | 52,856 |
| Other assets | 5,193 | 7,528 |

| Cash and cash equivalents | 6,402 | 4,654 |
|---|---|---|
| Total assets | 511,359 | 415,882 |
| Equity and liabilities | 31.12.2023 | 31.12.2022 |
| Equity | 225,760 | 216,632 |
| Technical provisions | 196,427 | 140,074 |
| Provisions | 2,988 | 3,176 |
| Financial liabilities | 17,171 | 16,048 |
| Payables | 61,151 | 31,613 |
| Other liabilities | 7,862 | 8,340 |
| Total liabilities and equity | 511,359 | 415,882 |
| Income statement | 31.12.202 3 |
31.12.202 2 |
|---|---|---|
| Net premiums | 99,458 | 56,704 |
| Commission income | 0 | 0 |
| Net fais value gains (losses) deriving from financial instruments measured at fair value through profit or loss |
178 | -172 |
| Reclassification according to the overlay approach (*) | 0 | 0 |
| Income deriving from investments in subsidiaries, associates and joint ventures | 0 | 0 |
| Income deriving from other financial instruments and investment property | 4,940 | 3,720 |
| Other revenue | 3,687 | 2,018 |
| Total revenue and income | 108,263 | 62,272 |
| Net claims-related expenses | -38,170 | -14,010 |
| Commission expenses | 0 | 0 |
| Expenses deriving from investments in subsidiaries, associates and joint ventures | 0 | 0 |
| Expenses deriving from other financial instruments and investment property | -1,850 | -1,839 |
| Operating expenses | -40,820 | -33,213 |
| Other costs | -17,284 | -7,998 |
| Total costs and expenses | -98,124 | -57,059 |
| Profit for the year before tax | 10,139 | 5,213 |
| Taxes | 425 | 103 |
| Profit for the year after tax | 10,564 | 5,316 |
The difference, gross of taxes, of €3,000 between the IFRS 17 and IFRS 4 result is mainly due to the effect of the use of the present value of future cash flows of -€59,000 and the elimination of the €62,000 change in the profit-sharing reserve and the liability for adequacy test.
The IFRS 4 adjusted operating profit was €21,000,000, while the IFRS 4 adjusted profit was €14,800,000.
Information on the Group's Solvency II solvency margin, calculated on the basis of the information available at the date of preparation of this report, compared with the annual 2022 data, is provided below:
| Information on the solvency margin - Solvency II | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Solvency Capital Requirement | 72,422 | 52,895 |
| Eligible Own Funds to meet the SCR (Tier 1) | 153,543 | 142,463 |
| Solvency Ratio | 212.0% | 269.3% |
| Minimum capital requirement | 20,767 | 14,652 |
| MCR Coverage Ratio | 739.3% | 972.3% |
The Solvency II Ratio was 212.0% at 31 December 2023, down compared with 31 December 2022, due to the growth in business volumes affecting non-life premiums and reserves, partially offset by an increase in own funds due to the profit for the year and expected future earnings.

It should be noted that the Solvency II Ratio does not take into account the organisational provision of €8.150 million to cover start-up expenses (set aside in response to the authorisation to operate in the new insurance classes), which has to be excluded from the calculation of own funds for the first three financial years. Treasury shares are also not included in own funds. The amount of treasury shares increased in the first half of 2023 as a result of the public tender offer. For details, see the section on treasury shares held and changes in treasury shares in the Report on Operations. The solvency situation will be specifically reported to the Supervisory Authority within the deadlines established by the
applicable legislation.
The Group's risk management is designed to comply with regulatory provisions, including constant monitoring according to the provisions of IVASS Regulation No. 24/20216. The Company has defined and implemented its risk assumption, measurement and management policies, taking an integrated view of its assets and liabilities in accordance with European Solvency II rules.
With regard to liquidity, underwriting and counterparty risks, ordinary monitoring activities continue to be overseen at all times, in order to ensure the Company's ongoing ability to meet its commitments. Furthermore, with reference to the internal solvency objective referred to in Article 18 of IVASS Regulation No. 38/18, the current assessments do not highlight any critical issues that require specific action.
The Group, also in financial year 2023, was required by the Supervisory Authority to monitor its solvency position on a monthly basis, pursuant to the communication dated 17 March 2020. The results of these monthly assessments showed a high and constant capital solvency level.
In the same period, the Group underwent an organisational enhancement following the merger in November 2022 between Elba Assicurazioni S.p.A. and Revo S.p.A. The Risk Management function was strengthened with new resources (internal and outsourced) and a system of risk oversight tools was created that includes the new risk management policies, Risk Appetite Framework (RAF) and Own Risk and Solvency Assessment (ORSA), as well as a more structured and effective Risk Register.
The Risk Officer's report to the Board of Directors did not highlight any critical issues and noted that the control processes implemented emphasise the Company's timely compliance with the reference provisions and regulations, to safeguard and protect the activity performed.
Based on the risk mapping undertaken, the highest-intensity risk to which the Group is exposed is its underwriting risk. In particular, the following should be noted:
Revo Insurance takes a conservative approach to underwriting risk, in order to avoid underwriting that could undermine the Company's solvency or constitute a serious obstacle to achieving its objectives.
The main techniques used by the Company to mitigate underwriting risk are:
With regard to the assumption of risks in the Suretyship class, which is the Company's core business, policies are written following careful technical investigations to establish the nature and characteristics of the risks to be covered and the soundness in terms of capital, income and cash flow, as well as the reliability, of the obligated entities, depending on the activities they carry out, to which the cover applies.
With regard to reinsurance techniques, specific treaties were entered into for each line of business.

REVO has a portfolio of assets consisting mainly of government and corporate bonds. Liquid assets are managed to ensure that sufficient resources are always available for normal claims payment.
The Company's prudent policy in terms of investments and issuer quality serves to protect it from market risk and liquidity risk, despite the current economic environment.
All investments are denominated in euro and therefore no currency risk exists.
With regard to concentration risk, there is a significant percentage of investment in the Italian Republic (although this has been decreasing steadily since December 2022), amounting to 37.7% of the Group's total portfolio at 31 December 2023 (around 51.8% at 31 December 2022).
The Group is exposed to the risk associated with a deterioration in the creditworthiness of the market counterparties with which it operates and has business and insurance relationships. These exposures mainly derive from reinsurance and co-insurance activities, cash deposits with banks and activities with insurance brokers and policyholders, in respect of which receivables are typically generated according to recurring insurance product underwriting patterns, particularly when the end of each quarter approaches.
At the same time, in its investment activities, the Group is subject to the creditworthiness and default risk of the relevant issuers. In addition to the Italian government, any default on the part of issuers in which the Company has exposure could have a negative impact on its financial position, cash flows and performance, as well as an effect on its Solvency II Ratio.
The default risk management system defined by the Company is assessed on the basis of the material risk factors related to the receivable for which top management ensures the correct and timely application of the same and ensures the consequent establishment of adequate processes for the analysis of overdue receivables and the monitoring and recovery of overdue receivables with respect to the main business counterparties (policyholders, intermediaries and reinsurance partners).
At least once a quarter, as part of its SCR recalculation activities, the Risk Management Function monitors changes in the risk profile and compliance with the risk appetite and risk tolerance limits defined in the Risk Appetite Framework. In addition, the ratings of reinsurance counterparties are monitored every six months, as required by the Reinsurance Policy.
Liquidity risk is the risk of not being able to meet obligations to policyholders and other creditors due to the difficulty of converting investments into cash without suffering losses; this risk is monitored through specific stress scenarios based on short- and medium-term cash flow planning.
Operational risk is the risk of losses due to inefficiencies in human resources, processes and systems, including those used for distance selling, or to external events, such as fraud or the actions of service providers; this definition includes legal risk but not strategic or reputational risk.
In the procedures currently in force, operational risk is also quantified in the context of the solvency requirement through the standard formula.
In addition to this quantitative support, "residual" risk is measured, at least once a year, on the basis of the probability of occurrence of the negative event and the severity of its impact, the scale of which is determined using a qualitative and quantitative methodological approach that helps management in mapping risks in order to adequately identify the most exposed areas and to prioritise when implementing action/mitigation plans.
These assessments enable the Company to ascertain the consistency of the results with the Risk Appetite Framework (RAF), outlined by the Company in its risk appetite policy.
As part of the ORSA assessment, the Group, in accordance with what is indicated in the EIOPA Opinion, carried out qualitative-quantitative assessments relating to climate change and, specifically, in relation to the risk of transition and to

physical risk. The analyzes of these risks are aimed at identifying the possible impacts caused by climate change on the assets and liabilities of the Group. During the quarterly monitoring activity, the Company checks the amount of assets that could be exposed to ESG risk.
Great attention is given to ESG issues, for which an ESG driven pricing project is underway. The Company, in product development, has identified the following emerging risks:
Compliance risk is the risk of incurring legal or administrative penalties or suffering losses or reputational damage as a result of failure to comply with laws, regulations or provisions of the Supervisory Authorities or self-regulation rules, such as articles of association, codes of conduct or governance codes.
The Compliance Risk Management System has been defined, in accordance with the provisions in force. Responsibility for this lies with the Compliance Manager, who is supported by the heads of the corporate functions in performing operating activities.
The compliance mission and operating procedures are defined in directives on the Company's internal control system and operating activities are governed by a specific company procedure.
As part of the activities envisaged in the compliance process, the Compliance Manager monitors on an ongoing basis and shares the relevant impact analyses with the relevant process manager. In the event of critical issues that could entail the risk of legal challenges and penalties, the Board of Directors becomes involved.
A report is produced each year describing all the ongoing and non-ongoing Compliance activities carried out during the year, as provided for in Regulation No. 38/18.
Reputational risk (or image risk) is the risk of losses that the Company may suffer as a result of events that degrade its image among the various types of stakeholders (policyholders, shareholders, counterparties, investors and Supervisory Authorities).
The Company manages reputational risk by means of appropriate mitigation measures and via appropriate organisational and control structures.
In this area, correctness and professionalism are of the utmost importance, particularly regarding:
To this end, the Company has adopted a Code of Ethics in order to promote a culture of ethics and fair behaviour at all levels of the Company. As part of the activities envisaged in the compliance process, the Compliance Manager monitors on an ongoing basis and shares the relevant impact analyses with the process manager.
In the event of critical issues that could entail significant reputational risks, the Board of Directors becomes involved. A report is produced each year describing all the ongoing and non-ongoing Compliance activities carried out during the year, as provided for in Regulation No. 38/18.
Strategic risk is defined as the current or prospective risk arising from a decline in profits or capital and the sustainability of the business model, including the risk of not being able to generate an adequate return on capital based on the risk

appetite defined by the company, arising from changes in the operating environment or poor corporate decisions, inadequate implementation of decisions, incorrect management of the risk of belonging to the group or insufficient responsiveness to changes in the competitive environment.
As part of the ORSA, the Company checks that the analysis of changes in profits resulting from strategic planning and the adequacy of the own funds held to cover the capital requirement, including in major stress scenarios, does not highlight any particular critical situations.
Strategic risk management is based on the Company's ability to identify and measure this form of risk and to adopt management practices that allow it to be mitigated in accordance with the appetite defined by the Board of Directors in the Risk Appetite Framework.
Strategic risk is monitored by the CFO in a qualitative and quantitative manner, taking into account any changes in the corporate and organisational structure, including through quarterly analysis of the performance of the main management KPIs compared with those provided for in the Strategic Plan, and verifying the adequacy of own funds held to cover the capital requirement.
There are no disputes pending, except for claims-related insurance disputes and disputes relating to recourse or recovery of receivables actions.
With regard to insurance disputes, it should be noted that in 2022, the Company received a payment order for approximately €250,000, relating to a counterfeit suretyship policy. At December 31, 2023, the expert reports arranged by the judge accepted the argument that the signatures on the surety policy were not authentic. For this reason, the company decided to release the portion set aside, on a prudential basis, in 2022.
Twenty complaints were received in 2023, one of which was settled, three were accepted and 16 were rejected. As a result of the above, as of the date of preparation of this Report, there is only one complaint in the investigation phase. Internal Audit reports on the above claims were issued and the relevant assessments were carried out by the Board of Statutory Auditors and the Board of Directors and, according to the procedures in force, were notified to the Supervisory Authority.
Pursuant to Article 2497 et seq. of the Italian Civil Code, REVO Insurance S.p.A. exercises management and coordination activities over REVO Underwriting S.r.l.
At 31 December 2023, we report the following transactions between REVO Underwriting S.r.l. and REVO Insurance S.p.A.:
The Related Party Transactions Procedure (the "RPT Procedure"), approved by the Company's Board of Directors on 26 0D\IROORZLQJDSRVLWLYHRSLQLRQIURPWKHLQGHSHQGHQWGLUHFWRUVLQRIĆFHDWWKDWGDWHLVGHVLJQHGWRLUHJXODWH procedures for idenWLI\LQJ UHODWHG SDUWLHV GHĆQLQJ SURFHGXUHVDQG WLPH VFDOHV IRU SUHSDULQJ DQG XSGDWLQJ WKH OLVW RI
related parties and identifying the corporate functions competent for this purpose; (ii) establish rules for identifying transactions with related parties before they are entered into; (iii) regulate procedures for the carrying out of related party transactions by the Company, including through subsidiaries pursuant to Article 93 of the TUF or in any case FRPSDQLHVVXEMHFWWRPDQDJHPHQWDQGFRRUGLQDWLRQDQGLYHVWDEOLVKSURFHGXUHVDQGWLPHVFDOHVIRUWKHIXOĆOPHQWRI reporting obligations to the corporate bodies and to the market.
The Procedure is published in the "corporate-governance/corporate-documents/related party transactions" section of the REVO Insurance website (www.revoinsurance.com).
During the year, only one transaction with a related party was undertaken, with the counterparty being subsidiary REVO Underwriting S.r.l. The transaction was for a modest amount and was by its nature exempt from the application of the Company's related party transactions procedure.
At 31 December 2023, no natural person or legal entity held, directly or indirectly, a number of shares such as to have a controlling interest in REVO Insurance S.p.A. Similarly, no material shareholder agreements were noted or notified to the Company pursuant to Article 122 of the TUF that might result in de facto control.
It follows that the Company is not subject to the management and coordination of any entity or company.
No other significant events occurred during the year, other than those reported in the initial introductory section.
Following the analyses conducted, at its meeting on 8 February 2024, the Board of Directors resolved to commence the process of opening a secondary office in Spain. The project was implemented by Fernando Lara, a manager with proven experience who has already held senior roles in large international insurance groups present in Spain. The operation to establish the secondary office, which is subject to IVASS authorisations, will be concluded by the end of 2024. In the meantime, REVO will both activate functional safeguards to enable the rapid growth of the business following the authorisation process, and continue underwriting activities in 2024 under the freedom to provide services.
No other significant events occurred after the end of the year.
As part of project development, REVO will continue to implement its business plan in accordance with the strategy outlined, aiming to further develop its existing business and to expand its offering with the consolidation of new business lines focused on specialty and parametric risks.
In this regard, the Board of Directors of REVO Insurance S.p.A., at its meeting of 8 February 2024, approved the 2024- 2027 rolling plan, which confirms the main areas of development of the project along the following strategic guidelines:

x Continuation of ESG development projects
In addition, at that meeting, the Board of Directors resolved to begin the process of opening a secondary office in Spain. The specialty line market in Spain has recorded attractive growth rates in recent years, particularly in the market niches already dominated by REVO in Italy. The aim of the "REVO Iberia" project is not only to exploit the commercial relations already in place with the large international brokers with which the Company operates in Italy, but to open its distribution model to local intermediaries, including small ones. At the same time, the project will make it possible to optimise the investments already made for the development of OverX and to identify potential development opportunities in the parametric field, benefiting from the skills acquired by the Italian team.
The business activity in Spain will initially focus on certain strategic lines, such as Financial Lines and Suretyship, a class in which the Company is a leader in Italy, with a progressive extension that aims to provide a complete offering to the Iberian market that is similar to the national one.
This operation allows the Group to add another key strategic element for the development of REVO Insurance, pursuing an approach of greater business diversification at an international level.
With regard to the information required by Article 2428, paragraph 3(3) and (4) of the Italian Civil Code, it should be noted that:
The share buy-back programme implemented during 2023 was implemented pursuant to the resolution adopted by the Ordinary Shareholders' Meeting of 3 May 2023, with the aim of making REVO shares available for any external growth transactions effected through an exchange of shares and for incentive plans reserved for the corporate population.
Pursuant to the regulatory provisions on the transparency of relations with public authorities introduced by Law No. 124/2017, it should be noted that in 2023 REVO Insurance S.p.A. received payments of €113,000 relating to employee training costs. The companies have not received any further subsidies, contributions or economic benefits of any kind from public authorities or from other entities indicated in Article 1, paragraph 125 of the cited law, with the exception of the above.
For the purposes of full disclosure, although these contributions are excluded from the transparency obligations established in the aforementioned legislation, it should be noted that the National Register of State Aid, publicly available in the section on transparency on the relevant website, publishes the aid measures and the relevant individual aid granted and recorded in the system by the granting authorities for the direct or indirect benefit of each of the Group companies.

The information required by Article 123-bis of Legislative Decree No. 58 of 24 February 1998 as amended is contained in the Report on Corporate Governance and Ownership Structure, approved by the Board of Directors and published jointly with the Report on Operations. The Report on Corporate Governance and Ownership Structure is available on the Company's website (www.revoinsurance.com), in the "Corporate Governance/Report on Corporate Governance and Ownership Structure" section.
In order to facilitate an assessment of the quality and sustainability of the Group's financial performance over time, the Report on Operations presents the following alternative performance indicators.
The gross premiums written in this report differ from insurance revenues arising from insurance contracts written in the income statement. They represent the Group's insurance turnover and include premium income from direct and indirect business insurance contracts.
The operating result is not a substitute for profit for the year before tax, determined in accordance with the International Financial Reporting Standards, but should be read in conjunction with the other income statement information and explanatory notes presented in these consolidated financial statements and subject to audit.
This indicator is prepared by reclassifying the profit components for the year before tax, taking into account the recurring nature of revenue and expenses.
In particular, the operating profit measures ordinary profitability which, on the basis of the insurance services result:
Adjusted operating profit corresponds to the operating result, neutralised by those items considered non-recurring, such as:
The adjusted profit corresponds to the profit for the year with neutralisation of the same items, non-recurring, considered for the calculation of the adjusted operating profit as well as the share of net gains on disposal and net impaiment losses on investments.
This alternative performance indicator is calculated as the ratio of:

This alternative performance indicator is obtained from the ratio of:
Verona, 13 March 2024 REVO Insurance S.p.A
Chief Executive Officer (Alberto Minali) humid.

39 TABLE OF CONTENTS | Consolidated financial statements


| Asset items | 31.12.2023 | 31.12.2022 | |
|---|---|---|---|
| 1. | INTANGIBLE ASSETS | 88,415 | 83,071 |
| o/w: Goodwill | 74,323 | 74,323 | |
| 2. | PROPERTY, PLANT AND EQUIPMENT | 13,926 | 14,448 |
| 3. | INSURANCE ASSETS | 68,771 | 45,805 |
| 3.1 | Insurance contracts written classified as assets | - | - |
| 3.2 | Cessions to reinsurance classified as assets | 68,771 | 45,805 |
| 4. | INVESTMENTS | 223,677 | 188,531 |
| 4.1 | Investment property | - | - |
| 4.2 | Investments in associates and joint ventures | 3 | - |
| Investments in subsidiaries | - | - | |
| Investments in associates | 3 | - | |
| Investments in joint ventures | - | - | |
| 4.3 | Financial assets measured at amortised cost | 3,088 | 4,016 |
| 4.4 | Financial assets measured at fair value through OCI | 217,811 | 181,895 |
| 4.5 | Financial assets measured at fair value through profit or loss | 2,775 | 2,620 |
| a) Financial assets held for trading | |||
| b) Financial assets designated at fair value | - | - | |
| c) Other financial assets compulsorily measured at fair value | 2,775 | 2,620 | |
| 5. | OTHER FINANCIAL ASSETS | 4,224 | 3,835 |
| OTHER FINANCIAL ASSETS | 4,224 | 3,835 | |
| 6. | OTHER ASSETS | 19,698 | 19,049 |
| 6.1 | Non-current assets held for sale or disposal groups | - | - |
| 6.2 | Tax assets | 3,539 | 5,402 |
| a) Current | 493 | 5,394 | |
| b) Deferred | 3,046 | 7 | |
| 6.3 | Sundry assets | 16,159 | 13,647 |
| 7. | CASH AND CASH EQUIVALENTS | 6,402 | 4,652 |
| TOTAL ASSETS | 425,113 | 359,391 |

| Shareholders' equity and liability items | 31.12.2023 | 31.12.2022 | |
|---|---|---|---|
| 1. | EQUITY | 225,625 | 216,495 |
| 1.1 | Share capital | 6,680 | 6,680 |
| 1.2 | Other equity instruments | - | - |
| 1.3 | Equity-related reserves | 170 | 170 |
| 1.4 | Income-related reserves and other reserves | 221,049 | 214.854 |
| 1.5 | Treasury shares (-) | -7,803 | - 1,247 |
| 1.6 | Valuation reserves | -5,037 | - 10,154 |
| 1.7 | Assets attributable to non-FRQWUROOLQJLQWHUHVWV-) | - | - |
| 1.8 | 3URILWIRUWKH\HDU-) | 10,566 | 6,193 |
| 1.9 | Profit (loss) for the year attributable to non-FRQWUROOLQJLQWHUHVWV-) | - | - |
| 2. | PROVISIONS FOR RISKS AND CHARGES | 2,988 | 3,243 |
| 3. | INSURANCE LIABILITIES | 156,329 | 101,365 |
| 3.1 | Insurance contract liabilities | 156,329 | 101,365 |
| 3.2 | Reinsurance contract liabilities | - | - |
| 4. | FINANCIAL LIABILITIES | 14,503 | 14,448 |
| 4.1 | Financial liabilities measured at fair value through profit or loss | - | - |
| a) Financial liabilities held for trading | - | - | |
| b) Financial liabilities designated at fair value | - | - | |
| 4.2 | Financial liabilities measured at amortised cost | 14,503 | 14,448 |
| 5. | PAYABLES | 14,760 | 18,167 |
| 6. | OTHER LIABILITIES | 10,908 | 5,673 |
| 6.1 | Liabilities of disposal groups | - | - |
| 6.2 | Tax liabilities | 2,012 | 275 |
| a) Current | 2,012 | - | |
| b) Deferred | - | 275 | |
| 6.3 | Sundry liabilities | 8,896 | 5,398 |
| TOTAL EQUITY AND LIABILITIES | 425,113 | 359,391 |

| ITEMS | 31.12.2023 | 31.12.2022 | |
|---|---|---|---|
| 1. | Insurance revenues deriving from insurance contracts written | 148,949 | 68,732 |
| 2. | Costs of insurance services deriving from insurance contracts written | -118,678 | -45,252 |
| 3. | Insurance revenues deriving from cessions to reinsurance | 69,749 | 24,210 |
| 4. | Costs of insurance services deriving from cessions to reinsurance | -81,087 | -33,967 |
| 5. | Result of insurance services | 18,933 | 13,723 |
| 6. | Net fair value gains (losses) on financial assets and liabilities measured at FVTPL | 179 | -172 |
| 7. | Gains (losses) on investments in associates and joint ventures | - | - |
| 8. | Income/expenses from other financial assets and liabilities and from investment property | 3,073 | 1,928 |
| 8.1 | - Interest income calculated according to the effective interest method | 4,140 | 2,097 |
| 8.2 | - Interest expense | -520 | -198 |
| 8.3 | - Other income/expenses | - | - |
| 8.4 | - Realised gains/losses | -471 | 66 |
| 8.5 | - Unrealised gains/losses | -76 | -37 |
| o/w: Related to non-performing financial assets | 0 | - | |
| 9. | Investment result | 3,252 | 1,756 |
| 10. | Net financial expenses/income from insurance contracts | -393 | 2,311 |
| 11. | Net financial income/expenses from reinsurance contracts | 119 | -979 |
| 12. | Net financial result | 2,978 | 3,088 |
| 13. | Other costs, net | -1,521 | -51 |
| 14. | Operating expenses: | -6,715 | -8,856 |
| 14.1 | - Investment management service expenses | -25 | -201 |
| 14.2 | - Other administrative expenses | -6,690 | -8,655 |
| 15. | Net accruals to provisions for risks and charges | - | -320 |
| 16. | Depreciation and net impaiment losses on property, plant and equipment | -1,767 | -917 |
| 17. | Amortisation and net impaiment losses on intangible assets | -149 | -3 |
| o/w: Impaiment losses on goodwill | - | - | |
| 18. | Other operating expenses, net | -1,618 | -184 |
| 19. | Profit for the year before tax | 10,141 | 6,480 |
| 20. | Taxes | 424 | -287 |
| 21. | Profit for the year after tax | 10,565 | 6,193 |
| 22. | Profit (loss) on discontinued operations | 0 | 0 |
| 23. | Profit for the year | 10,565 | 6,193 |
| o/w: attributable to the owners of the parent | 10,565 | 6,193 |

| ITEMS | 31.12.2023 | 31.12.2022 | |
|---|---|---|---|
| 1. | Profit for the year | 10,565 | 6,193 |
| 2. | Other items, net of tax not, reclassified to profit or loss | 1,439 | 305 |
| 2.1 | Share of valuation reserves of equity-accounted investees | - | - |
| 2.2 | Change in valuation reserve for intangible assets | - | - |
| 2.3 | Change in valuation reserve for property, plant and equipment | - | - |
| 2.4 | Financial income or expense relating to insurance contracts | - | - |
| 2.5 | Profit (loss) from discontinued operations or disposal groups | - | - |
| 2.6 | Actuarial gains and losses and adjustments to defined benefit plans | 1,824 | 690 |
| 2.7 | Gains/losses on equity securities designated at FVOCI | -385 | -385 |
| 2.8 | Change in creditworthiness on financial liabilities designated at FVTPL | - | - |
| 2.9 | Other items | - | - |
| 3. | Other item, net of tax, reclassified to profit or loss | -2,316 | -6,300 |
| 3.1 | Change in translation reserve | - | - |
| 3.2 | Gains/losses on financial assets measured at FVOCI | -2,316 | -6,300 |
| 3.3 | Gains/losses on cash flow hedging instruments | - | - |
| 3.4 | Gains/losses on instruments hedging a net investment in a foreign operation | - | - |
| 3.5 | Share of valuation reserves of equity-accounted investees | - | - |
| 3.6 | Financial income and expenses from insurance contracts | - | - |
| 3.7 | Financial income or expenses from reinsurance contracts | - | - |
| 3.8 | Profit (loss) from discontinued operations or disposal groups | - | - |
| 3.9 | Other items | - | - |
| 4. | TOTAL OTHER COMPREHENSIVE EXPENSE | -877 | -5,995 |
| 5. | COMPREHENSIVE INCOME (Items | 9,688 | 198 |
| 5.1 | o/w: attributable to the owners of the parent | 9,688 | 198 |
| 5.2 | o/w: attributable to non-controlling interests | - | - |

| Share capital | Other equity | Equity-related reserves |
Income-related and other reserves |
Treasury shares | Valuation reserves |
Profit | Equity attributable to the |
Totale | ||
|---|---|---|---|---|---|---|---|---|---|---|
| instruments | for the year | owners of the parent |
equity | |||||||
| Balances at 1.1.2022 | 23,205 | - | 207,045 | 6,462 | - | -4,242 | -13,842 | 218,478 | 218,478 | |
| o/w: Change in opening balances | - | - | - | - | - | - | - | - | - | |
| Allocation of profit for the year | - | - | - | - | - | - | - | - | ||
| Reserves | - | - | - | -13,842 | - | - | 13,842 | - | - | |
| Dividends and other allocations | - | - | - | - | - | - | - | - | - | |
| Changes during the year | - | - | - | - | - | - | - | - | ||
| Issue of new shares | - | - | - | - | - | - | - | - | - | |
| Repurchase of treasury shares | - | - | - | - | - | - | ||||
| Changes in equity investments | - | - | - | - | - | - | - | - | - | |
| Comprehensive income | - | - | - | - | - | -6 | 6,193 | 6,187 | 6,187 | |
| Other FKDQJHV-) | -16,525 | - | -206,875 | 222,234 | - | -5,907 | - | -6,923 | -6,923 | |
| Balances at 31.12.2022 | 6,680 | - | 170 | 214.854 | -10,154 | 6,193 | 216,495 | 216,495 | ||
| Change in opening balances | - | - | - | - | - | - | - | - | - | |
| Allocation of profit for the year | - | - | - | - | - | - | - | - | ||
| Reserves | - | - | - | 6,193 | - | - | -6,193 | - | - | |
| Dividends and other allocations | - | - | - | - | - | - | - | - | - | |
| Changes during the year | - | - | - | - | - | - | - | - | ||
| Issue of new shares | - | - | - | - | - | - | - | - | - | |
| Repurchase of treasury shares | - | - | - | - | -6,555 | - | - | -6,555 | -6,555 | |
| Changes in equity investments | - | - | - | - | - | - | - | - | - | |
| Comprehensive income | - | - | - | 2 | - | 3,983 | 10,566 | 14,551 | 14,551 | |
| 2WKHUFKDQJHV-) | - | - | - | - | - | 1,134 | - | 1,134 | 1,134 | |
| Balances at 31.12.2023 | 6,680 | - | 170 | 221,049 | -7,802 | -5,037 | 10,566 | 225,625 | 225,625 |

| 31.12.2023 | 31.12.2022 | |
|---|---|---|
| Net cash flows generated/utilised by: | ||
| - 3URILWIRUWKH\HDU-) | 10,565 | 6,193 |
| - net income and expenses of insurance contracts and reinsurance contracts (- | 15,758 | 25,960 |
| - Capital losses/gains on financial assets measured at fair value through profit or loss (- | -155 | |
| - Other non-monetary income and expenses deriving from financial instruments, investment | -977 | |
| SURSHUW\DQGHTXLW\LQYHVWPHQWV-) | - | |
| - Net accruals to SURYLVLRQVIRUULVNVDQGFKDUJHV-) | -188 | -1,525 |
| - ,QWHUHVWLQFRPHGLYLGHQGVLQWHUHVWH[SHQVHWD[HV-) | 2,721 | |
| - 2WKHUDGMXVWPHQWV-) | 830 | -775 |
| - LQWHUHVWLQFRPHUHFHLYHG | 3,474 | 3,447 |
| - GLYLGHQGVUHFHLYHG | - | |
| - interest expense paid (-) | -70 | |
| - taxes paid (-) | - | -7,092 |
| Net cash flows generated/utilised by other monetary items related to operating activities | - | |
| - ,QVXUDQFHFRQWUDFWVOLDELOLWLHVDVVHWV-) | -9,008 | -27,477 |
| - Reinsurance contracts DVVHWVOLDELOLWLHV-) | 16,167 | 7,388 |
| - /LDELOLWLHVIURPILQDQFLDOFRQWUDFWVZULWWHQE\LQVXUDQFHFRPSDQLHV-) | - | |
| - Financial assets RIEDQNLQJVXEVLGLDULHV-) | - | |
| - Liabilities of banking VXEVLGLDULHV-) | - | |
| - 2WKHUILQDQFLDODVVHWVDQGOLDELOLWLHVPHDVXUHGDWIDLUYDOXHWKURXJKSURILWRUORVV-) | 24 | 35,048 |
| - 2WKHUILQDQFLDODVVHWVDQGOLDELOLWLHV-) | 4,283 | -4,324 |
| Total net cash flows generated by operating activities | 44,401 | 35,866 |
| Net cash flows generated/utilised by: | ||
| - 6DOHSXUFKDVHRILQYHVWPHQWSURSHUW-) | -3 | - |
| - 6DOHSXUFKDVHRILQYHVWPHQWVLQDVVRFLDWHVDQGMRLQWYHQWXUHV-) | - | 1 |
| - 'LYLGHQGVUHFHLYHGRQLQYHVWPHQWV | - | - |
| - 6DOHSXUFKDVHRIILQDQFLDODVVHWVPHDVXUHGDWDPRUWLVHGFRVW-) | 928 | 3,984 |
| - 6DOHSXUFKDVHRIILQDQFLDODVVHWVPHDVXUHGDW)9WKURXJK2&,-) | -35,916 | -44,217 |
| - Sale/purchase of property,plant and equipment DQGLQWDQJLEOHDVVHWV-) | -2,228 | -15,611 |
| - 6DOHSXUFKDVHRIVXEVLGLDULHVDQGEXVLQHVVXQLWV-) | - | |
| - Other net cash flows from investing DFWLYLWLHV-) | - | |
| Total net cash flows utilised by investing activities | -37,219 | -55,843 |
| Net cash flows generated/utilised by: | ||
| - ,VVXHVSXUFKDVHVRIHTXLW\LQVWUXPHQWV-) | - | - |
| - Issues/reSXUFKDVHVRIWUHDVXU\VKDUHV-) | -6,555 | |
| - Distribution of dividends and other allocations (-) | - | - |
| - Sale/purchase of control of non-FRQWUROOLQJLQWHUHVWV-) | - | - |
| - ,VVXHVSXUFKDVHVRIVXERUGLQDWHGOLDELOLWLHVDQGSDUWLFLSDWLQJILQDQFLDOLQVWUXPHQWV-) | - | - |
| - ,VVXHVSXUFKDVHVRIOLDELOLWLHVPHDVXUHGDWDPRUWLVHGFRVW-) | 1,123 | 13,480 |
| Total net cash flows generated/utilised by financing activities | -5,432 | 12,233 |
| NET CASH FLOWS GENERATED/UTILISED DURING THE YEAR | 1,750 | -7,744 |
| Cash at 31/12/n-1 | 4,652 | 12,396. |
| Cash flows generated/utilised | 1,750 | -7,744 |
| Cash at 31/12/n | 6,402 | 4,652 |
| Items/business segments | Non-life operations | Life operations | Intra-sectoral eliminations |
Total | |||||
|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | ||
| 1 | INTANGIBLE ASSETS | 88,415 | 83,071 | - | - | - | - | 88,415 | 83,071 |
| 2 | PROPERTY, PLANT AND EQUIPMENT | 13,926 | 14,448 | - | - | - | - | 13,926 | 14,448 |
| 3 | INSURANCE ASSETS | 68,750 | 45,805 | - | - | - | - | 68,750 | 45,805 |
| 3.1 | Insurance contracts written classified as assets | -21 | - | - | - | - | - | -21 | - |
| 3.2 | Cessions to reinsurance classified as assets | 68,771 | 45,805 | - | - | - | - | 68,771 | 45,805 |
| 4 | INVESTMENTS | 223,677 | 188,530 | - | - | - | - | 223,677 | 188,530 |
| 4.1 | Investment property | - | - | - | - | - | - | - | - |
| 4.2 | Investments in associates and joint ventures | 3 | - | - | - | - | - | 3 | - |
| 4.3 | Financial assets measured at amortised cost | 3,088 | 4,016 | - | - | - | - | 3,088 | 4,016 |
| 4.4 | Financial assets measured at fair value through OCI | 217,811 | 181,895 | - | - | - | - | 217,811 | 181,895 |
| 4.5 | Financial assets measured at fair value through profit or loss | 2,775 | 2,620 | - | - | - | - | 2,775 | 2,620 |
| 5 | OTHER FINANCIAL ASSETS | 4,224 | 3,835 | - | - | - | - | 4,224 | 3,835 |
| 6 | OTHER ASSETS | 19,699 | 19,049 | - | - | - | - | 19,699 | 19,049 |
| 7 | CASH AND CASH EQUIVALENTS | 6,402 | 4,652 | - | - | - | - | 6,402 | 4,652 |
| TOTAL ASSETS | 425,093 | 359,391 | - | - | - | - | 425,093 | 359,391 | |
| 1 | EQUITY | 225,625 | 216,494 | - | - | - | - | 225,625 | 216,494 |
| 2 | PROVISIONS FOR RISKS AND CHARGES | 2,988 | 3,243 | - | - | - | - | 2,988 | 3,243 |
| 3 | INSURANCE LIABILITIES | 156,308 | 101,365 | - | - | - | - | 156,308 | 101,365 |
| 3.1 | Insurance contracts written classified as liabilities | 156,308 | 101,365 | - | - | - | - | 156,308 | 101,365 |
| 3.2 | Cessions to reinsurance classified as liabilities | - | - | - | - | - | - | - | - |
| 4 | FINANCIAL LIABILITIES | 14,503 | 14,448 | - | - | - | - | 14,503 | 14,448 |
| 4.1 | Financial liabilities measured at FVTPL | - | - | - | - | - | - | - | - |
| 4.2 | Financial liabilities measured at amortised cost | 14,503 | 14,448 | - | - | - | - | 14,503 | 14,448 |
| 5 | LIABILITIES | 14,760 | 18,166 | - | - | - | - | 14,760 | 18,166 |
| 6 | OTHER LIABILITIES | 10,909 | 5,673 | - | - | - | - | 10,909 | 5,673 |
| TOTAL EQUITY AND LIABILITIES | 425,093 | 359,391 | - | - | - | - | 425,093 | 359,391 |

| Non-life operations | Life operations | Intra-sectoral eliminations |
Total | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Items/business segments | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | |
| 1 | Insurance revenues deriving from insurance contracts written | 148,949 | 68,732 | - | - | - | - | 148,949 | 68,732 |
| 2 | Costs of insurance services deriving from ins. contracts written | -118,678 | -45,252 | - | - | - | - | -118,678 | -45,252 |
| 3 Insurance revenues deriving from cessions to reinsurance | 69,749 | 24,210 | - | - | - | - | 69,749 | 24,210 | |
| 4 | Costs of insurance services deriving from cessions to reinsurance | -81,087 | -33,967 | - | - | - | - | -81,087 | -33,967 |
| 5 | Result of insurance services | 18,933 | 13,723 | - | - | - | - | 18,933 | 13,723 |
| 6 Income/expenses from financial assets and liabilities measured at FVTPL | 179 | -172 | - | - | - | - | 179 | -172 | |
| Income/expenses from investments in subsidiaries, associates and joint | |||||||||
| 7 ventures |
- | - | - | - | - | - | - | - | |
| Income/expenses from other financial assets and liabilities and from | |||||||||
| 8 | investment property | 3,073 | 1,928 | - | - | - | - | 3,073 | 1,928 |
| 9 | Investment result | 3,252 | 1,756 | - | - | - | - | 3,252 | 1,756 |
| 10 | Financial expense/income relating to ins. contracts |
-393 | 2,311 | - | - | - | - | -393 | 2,311 |
| 11 | Financial income/expense relating to reinsurance contracts |
119 | -979 | - | - | - | - | 119 | -979 |
| 12 | Net financial income | 2,978 | 3,087 | - | - | - | - | 2,978 | 3,087 |
| 13 | Other revenues/costs | -1,520 | -51 | - | - | - | - | -1,520 | -51 |
| 14 | Operating expenses: | -6,715 | -8,856 | - | - | - | - | -6,715 | -8,856 |
| 15 | Other operating income/expenses | -3,534 | -1,424 | - | - | - | - | -3,534 | -1,424 |
| Profit for the year before tax | 10,141 | 6,480 | - | - | - | - | 10,141 | 6,480 |

49 TABLE OF CONTENTS | Notes to the financial statements

REVO Insurance S.p.A. is a newly incorporated joint stock insurance company created by the reverse merger between REVO S.p.A. (SPAC – special purpose acquisition company) and Elba Assicurazioni S.p.A., having its registered office at Via dell'Agricoltura 7, Verona, VAT No. 05850710962 and entered in the Verona Companies Register.
REVO was created by the reverse merger on 21 November 2022 of REVO SPAC and Elba Assicurazioni S.p.A., an insurance company operating in the insurance market since 2008.
Since that date, the Company has been listed on the Euronext STAR market organised and managed by Borsa Italiana S.p.A. In May 2022, REVO Underwriting S.p.A. was established as an agency authorised to write, issue and manage insurance policies, under licences and authorisations held by the insurance company, as well as its risk capital.
The Company, together with the subsidiary, REVO Underwriting S.r.l., forms the REVO Insurance Group, entered in the IVASS register under No. 059.
These consolidated financial statements have been prepared pursuant to ISVAP Regulation No. 7 of 13 July 2007 and have been prepared in accordance with applicable legal provisions, according to the measurement criteria and international reporting standards referred to below, and corresponding to the accounting records that reflect the transactions carried out by the REVO Insurance Group (hereinafter also the "Group") at 31 December 2023, supplemented by internal management data not directly identifiable in the accounts.
They have been prepared on a going concern basis and in accordance with the reporting standards applied in the previous year, to ensure the comparability of the data.
The figures at 31 December 2023 of the REVO Insurance Group are compared, for the comparison with the previous year, with the consolidated figures appropriately adjusted for the entry into force of the new IFRS 17 on 1 January 2023.
Amounts are shown in thousands of euro, unless expressly specified.

Pursuant to Legislative Decree No. 38/2005, REVO Insurance S.p.A. prepared the consolidated financial statements at 31 December 2023 in accordance with Legislative Decree No. 209 of 7 September 2005 (Private Insurance Code) in force at the reporting date and ISVAP Regulation No. 7 of 13 July 2007, as amended, and thy comply with the International Financial Reporting Standards (IFRS) issued by the IASB and endorsed by the European Union in accordance with Regulation (EC) No. 1606 of 19 July 2002, Legislative Decree No. 38/2005 and Legislative Decree No. 209/2005. These consolidated financial statements include the financial statements of REVO Insurance S.p.A. and REVO
in order to provide a true and fair view of the financial position, cash flows and financial performance.
The going concern requirement is considered to be confirmed with reasonable certainty, as it is believed that the companies belonging to the REVO Insurance Group have adequate resources to ensure the continuity of operations in the foreseeable future.
The unit of account used is the euro. All amounts shown in the notes are expressed in thousands of euro, unless otherwise indicated, for a better representation of the data.
The Group's consolidated financial statements have been audited by the Indipendent Auditor, KPMG S.p.A., charged with auditing the consolidated financial statements for financial years 2017-2025.
These consolidated financial statements have been prepared in accordance with ISVAP Regulation No. 7/2007 and consist of:
They are accompanied by the Directors' Report on Operations, drawn up in accordance with Article 100 and Legislative Decree No. 209/05 and Article 2428 of the Italian Civil Code.
The reporting date of the consolidated financial statements is 31 December 2023, which is the closing date of the financial statements of the Parent Company, REVO S.p.A. All of the companies included in the scope of consolidation close their financial statements on 31 December.
No significant events occurred after the end of the financial year that could affect the figures in the consolidated financial statements.
The scope of consolidation includes the annual financial statements of the Parent Company, REVO S.p.A., and those of its direct or indirect subsidiaries.
At 31 December 2023, the scope of consolidation exclusively included REVO Underwriting S.r.l., which is wholly owned by REVO Insurance S.p.A. Details of the equity investment included in the scope of consolidation are provided below:

| Progres sive |
Name | Country of register ed office |
Country of operational headquarters (1) |
Method (2) |
Activity (3) |
Relations hip type (4) |
% Direct investme nt |
Total investme nt (5) |
% Availabi lity of votes (6) |
% consolidat ion |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Revo Underwriting S.r.l | Italy | F | 11 | 1 | 100.0% | 100.0% | 100% |
The consolidation method for subsidiaries provides for the line-by-line consolidation, from the date of acquisition, of the assets, liabilities, income and expenses of the consolidated companies. By contrast, the carrying amount of the investment is eliminated with the corresponding share of the equity of each subsidiary, and, in the case of equity investments of less than 100%, the share of equity and profit or loss for the year pertaining to non-controlling interests is shown.
The differences resulting from this operation, if positive, are recognised – after allocation to the assets or liabilities of the Subsidiary, including intangible assets – as goodwill under intangible assets.
Any negative differences are recognised in the income statement.
With regard to intragroup transactions, when preparing the consolidated financial statements, receivables and payables between the companies included in the scope of consolidation are de-recognised, as are income and expenses relating to transactions between the companies themselves, and gains and losses arising from transactions between such companies and not yet realised with third parties.
The international reporting standard that governs share-based payments is IFRS 2. This standard defines a share-based payment transaction as a transaction in which the company receives goods or services from a supplier (including employees and financial advisors) under a share-based payment agreement.
This agreement confers the right to receive cash or other assets of the company in amounts based on the price (or value) of the equity instruments of the entity or another Group entity, or to receive equity instruments of the entity or another Group entity, provided that the specified vesting conditions, if they exist, are met.
In view of the difficulty in reliably assessing the fair value of services received based on the value of shares, reference is made to the fair value of the financial instrument, with the expense recognised over the vesting period. The obligation assumed by the company may be settled by delivery of own financial instruments ("equity-settled") or by delivery of cash and/or financial instruments of other entities ("cash-settled").
The Group settles the obligation through the former configuration, with a contra-entry in equity for the expense, thus without generating either a decrease in equity or monetary effects in the income statement.
In accordance with IAS 33, basic earnings per share are calculated by dividing the profit attributed to shareholders holding ordinary shares of REVO Insurance S.p.A. by the weighted average number of ordinary shares outstanding during the year. Diluted earnings per share are calculated by dividing the profit attributed to shareholders holding ordinary shares by the weighted average number of any additional ordinary shares that would be outstanding in the event of the conversion of all potential ordinary shares with dilutive effect. In the event of a loss for the year, a loss (basic and diluted) per share is calculated.
In accordance with IAS 21, items denominated in foreign currencies are managed according to multi-currency accounting principles.

Monetary items in foreign currencies (currency units held and assets or liabilities to be collected or paid out as a number of fixed or determinable currency units) are converted using the exchange rate prevailing at the reporting date. Foreign exchange differences deriving from the settlement or valuation of monetary items are recognised in the income statement. At 31 December 2023, the Group did not hold any non-monetary assets denominated in foreign currencies.
IFRS 17 for the recognition, measurement, presentation and disclosure of insurance contracts entered into force on 1 January 2023. The standard requires entities to measure insurance contracts using current estimates of cash flows associated with the fulfilment of insurance contracts, both incoming and outgoing, using one of the three measurement models envisaged.
REVO uses the simplified Premium Allocation Approach as a measurement model, after verifying compliance with the conditions that have to be met in order to apply it, with a year-to-date approach regarding the accounting estimates used, or with a measurement and change of the estimates on a year-to-year basis.
The effects for the Company of the effects of the choices made since the adoption of the new standard in the various areas are presented below:
The standard defines as an insurance contract a contract under which one party (the issuer) accepts significant insurance risk from another party (the policyholder) by agreeing to compensate the policyholderif a specified uncertain future event (the insured event) adversely affects the policyholder.
Reinsurance contracts do not exempt the Company from its liability associated with the underlying insurance contracts, but are designed to compensate the Company against claims arising from one or more insurance contracts issued by the latter (underlying contracts). Assets deriving from reinsurance contracts held are presented separately in the statement of financial position to indicate the extent of the credit risk and the Company's obligations to its policyholders.
The Group did not identify any significant impact arising from the introduction of the new IFRS 17 with regard to the classification of contracts as insurance contracts.
Insurance contracts and reinsurance contract assets held are aggregated into insurance contract portfolios according to the underlying risk and the management of such risks, further subdivided into groups according to expected profitability and the year in which the contract was signed, and they are then broken down into annual cohorts.
The Group has divided the business into 20 different groups of contracts, with an approach that reflects the lines currently marketed and is consistent with the segmentation already used for other business valuations. These groups are in turn divided into 11 portfolios of contracts with similar risks, which are managed jointly.
The table below sets out the classification of business within the above contract groups and portfolios:
| IFRS 17 portfolio | Contract group - REVO LoB | ||
|---|---|---|---|
| Engineering | |||
| Property | Property | ||
| FI | |||
| Indirect Property | Property Cat | ||
| Parametric Cat | |||
| Parametric | Parametric Agro | ||
| Parametric Financial Loss | |||
| Accident & Health | PA | ||
| Other Motor | Land Vehicles | ||
| Aviation | |||
| MAT Specialty Lines | FA&S | ||
| Marine | |||
| Liability | |||
| General Liability | PI | ||
| D&O |

| Cyber | |
|---|---|
| Credit | Credit |
| Agro | Agro |
| Suretyship | Bond |
| Legal | Legal |
With regard to the breakdown of portfolios into the three buckets, provided for by the standard, on the basis of expected profitability, an appropriate onerousness test (Onerous Contract Test or OCT) was defined. This test is carried out on the date of initial recognition of a new group of contracts as well as annually when the financial statements measurements are performed and consists in determining a combined ratio including the non-financial risk component (risk adjustment). The IFRS 17 combined ratio (also indicated below as CoRכ (is calculated as follows:
CoRכ <39(&(&ODLPV\$FTXLVLWLRQFRVWV2SHUDWLQJH[SHQVHV5\$@39)&)3UHPLXPVZULWWHQ
The CoRכ is obtained from the ratio of the sum of discounted cash flows relating to claims, acquisition costs, operating expenses and the risk adjustment component to the discounted premiums issued.
The ratio numerator is the sum of the following cash flows appropriately discounted on the basis of the discount rate curve shown below in this section of the report:
The breakdown is obtained by comparing CoRכ with the values of the thresholds selected by the Company and set out below:
At 31 December 2023, as at 31 December 2022, no group of contracts was found to be onerous. For this reason, no loss component and loss recovery were determined.
The Group measures its insurance contracts and the assets of the reinsurance contracts held primarily using the Premium Allocation Approach (PAA).
The option of applying the PAA for businesses with a duration of more than one year derives from a quantitative analysis (eligibility test), which concluded that the results of applying the PAA do not present significant deviations from the application of the General Model.
The elements necessary for measurement are:

There are two types of costs directly attributable and included in the contract boundaries:
The PVFCF value takes into account the effects of the acquisition of the insurance portfolio of Elba Assicurazioni S.p.A. completed in November 2021 (ex. VoBA).
x Risk adjustment (RA) - the compensation required in order to withstand the uncertainty of cash flows (in terms of amount and time) due to non-financial risk. The Group calculates this figure using the Percentile Approach, which is an appropriate approximation for estimating the risk adjustment. The amount is therefore calculated using the Value at Risk method with a 75% confidence level. 12
This component is calculated on two dimensions:
The valuation is performed by using the Solvency II LoBs as an aggregation and adopting as the sigma and average of the normal distribution, respectively: the expected sigmas 13 for the premium risk, for the purposes of calculating the RA for the LFRC, and the reserve risk, for the purposes of calculating the RA for the LIC, appropriately adjusted to be used in a log-normal distribution and multiplied by the square root of the duration, both taken from the Solvency II valuations (premiums best estimate duration and claims best estimate) as well as the averages obtained from the natural logarithm of the volume measures and the claims best estimates appropriately adjusted by reducing the sigma raised to the second power.
The risk adjustment in terms of absolute value is obtained by subtracting from the result of the normal distribution, with a confidence level at the 75th percentile, the amount of the volume measures and the claims best estimates at the date divided by Solvency LOB.
12 The risk adjustment uses the method with a run-off view for measurements at 31 December 2023. For this reason, the value of the presented sigma of the standard formula is adjusted for duration. For transition measurements and at 31 December 2022, a method with a one-year view was used. Therefore, the value of the sigma presented in the standard formula is not affected by the adjustment of duration, and is less than 75%.
The minimum duration value was set at 1.
13 The Group uses a different sigma from that of the standard formula in the presence of historically significant data that is supported by appropriate analysis, calibrating its value on its portfolio. At 31 December 2023, the sigma calibrated on the portfolio was used for the Suretyship portfolio only.

The amounts thus determined for each individual LOB are adjusted on the basis of the correlation indices established by Solvency II and, subsequently, taken from the Solvency II LOB to the REVO LOB based on the Solvency II LOB weight matrices obtained:
The Group uses the PAA to measure insurance and reinsurance contracts held that are found to be eligible for a simplified methodology. The simplified methodology is permitted when the coverage period of each contract is one year or less or when the Company reasonably expects that the valuation of the liability for remaining coverage (LRC) will not differ materially from that deriving from the application of the General Model (based on a materiality threshold identified by the Company).
In the PAA model for insurance contracts, at the time of initial recognition of each group, the carrying amount of the LRC is calculated on the basis of premiums written less any acquisition costs attributed to the group. The LRC is recognised in the income statement on the basis of the contractual coverage period, in particular for the Group using the pro-rata temporis method.
Unless there are onerous contracts, the adjustment for non-financial risks is estimated only to determine liabilities for incurred claims (LIC).
If there are indications that a group of insurance contracts is onerous, the Company recognises a loss in costs for insurance services in the income statement and consequently increases the value of the LRC. This excess amount is recognised as a loss component within the LRC, which is recognised in liabilities deriving from insurance contracts in the statement of financial position.
In conclusion, the carrying amount of a group of insurance contracts at each reporting date is obtained from the sum of the LRC and the LIC. Upon subsequent measurement, the carrying amount of the LRC is increased by any new premiums written and the amortisation of acquisition costs, less the amount recognised as insurance revenues for services provided and any additional insurance acquisition costs allocated after initial recognition.
The LIC includes cash flows relating to claims and expenses that have not yet been paid, including claims incurred but not reported. Its value reflects both an adjustment for non-financial risk and an adjustment for the time value of money, to take account of the time between the reporting and the settlement of the claim.
In each reporting period, the Company measures any loss component using the same calculation as that used at initial recognition and reflects any changes by adjusting the loss component as required until it is reduced to zero. If a loss component did not exist at the time of initial recognition but there are indications that a group of contracts has become onerous during a subsequent measurement, then the loss component is determined using the same methodology as that used at initial recognition.
For reinsurance contracts, the carrying amount at initial recognition of the ARC (assets for remaining coverage) is measured as the premiums ceded adjusted for cession fees.
When a group of onerous underlying contracts exists, a loss recovery component is created to adjust the value of the ARC. In measurements following initial recognition, the carrying amount ofreinsurance contracts held is the sum of the ARC and the AIC (assets for incurred claims). In particular, the carrying amount of the ARC is increased by any new premiums ceded and reduced by the amount recognised as reinsurance cost for the services received.
For contracts measured according to the PAA, the AIC reflects an adjustment for non-financial risk and the time value of money.
If a loss recovery component exists, at the time of subsequent assessments, it is adjusted to reflect the changes in the loss component of the group of underlying onerous contracts and cannot exceed the portion of the loss component that the Company expects to recover from the reinsurance contracts held.

The measurement of the LIC includes estimates of future cash flows, appropriately adjusted to take into account the time value of money and the non-financial risk (uncertainty of flows in terms of amount and timing). These estimates reflect a range of possible scenarios and results, in which the cash flows for each scenario are discounted and weighted according to the estimated probability of occurrence in order to determine the expected present value.
The estimates reflect the Group's view of current expectations at the measurement date, which include both internal and external historical data updated to reflect current expectations that could affect the amount of cash flows.
The calculation of cash flows may include some measurements and professional judgements in circumstances where the existing inputs, assumptions or techniques do not capture all the relevant risks.
Some consideration is also given regarding the allocation of expenses. In particular, acquisition costs are allocated to contracts on the basis of total premiums, while claims management costs are allocated on the basis of the amount paid. General expenses are allocated based on the nature and cost centre of the expense and on the basis of earned premiums. These costs are recognised in the income statement when they are incurred.
The liability for incurred claims (LFIC) is determined using the following input data:
The liability for incurred claims is calculated as the sum of the discounted claims UBEL and the discounted risk adjustment reserve risk component.
The claims UBEL is taken from the groupings of Solvency II contracts to the REVO LOB based on the weight matrix obtained from the claims provision for compensation and direct settlement costs (used in the valuation of the Company's local financial statements).
The discounting process 14 of the claims UBEL takes place via these steps:
A bottom-up approach is used. In order to be consistent with what has been done at the Solvency II level, the Group decided to use the EIOPA risk free curve, appropriately adjusted for the volatility adjustment component, as an estimate of the illiquidity premium established by IFRS 17.
The table below shows the discount rates used at the various measurement dates (transition, 31 December 2022 and 2023). It should be noted that the Group has decided to include all financial costs and income arising from the discounting of insurance liabilities in the income statement for the year:
$$rf_{t_{Q_l}} = rf_{t-1} * \left(\frac{4-i}{4}\right) + rf_t * \left(\frac{i}{4}\right), \qquad i = 1, \ldots, 4$$
where ݎ݂௧ is the rate provided by EIOPA for the year ݐ and ݅ the reference quarter.
14 The curve provided by EIOPA, as it is annual, has to be made quarterly in order to be consistent with the cash flow valuation step. This process is based on a linear interpolation approach in order to derive the rates for each quarter. The quarterly rates are calculated as follows:

| IFRS 17 discount curve | Group | |||
|---|---|---|---|---|
| Currency | EUR | |||
| Maturity (years) | YE2023 | YE2022 | ||
| 1 | 3.18% | 3.56% | ||
| 2 | 3.30% | 2.89% | ||
| 3 | 3.20% | 2.64% | ||
| 4 | 3.15% | 2.55% | ||
| 5 | 3.13% | 2.52% | ||
| 6 | 3.11% | 2.52% | ||
| 7 | 3.09% | 2.53% | ||
| 8 | 3.09% | 2.55% | ||
| 9 | 3.09% | 2.57% | ||
| 10 | 3.09% | 2.59% | ||
| 11 | 3.10% | 2.62% | ||
| 12 | 3.09% | 2.64% | ||
| 13 | 3.07% | 2.66% | ||
| 14 | 3.05% | 2.67% | ||
| 15 | 3.02% | 2.67% | ||
| 16 | 2.97% | 2.66% | ||
| 17 | 2.92% | 2.65% | ||
| 18 | 2.86% | 2.63% | ||
| 19 | 2.81% | 2.61% | ||
| 20 | 2.77% | 2.61% | ||
| 21 | 2.74% | 2.60% | ||
| 22 | 2.72% | 2.61% | ||
| 23 | 2.70% | 2.61% | ||
| 24 | 2.70% | 2.62% | ||
| 25 | 2.70% | 2.63% | ||
| 26 | 2.70% | 2.64% | ||
| 27 | 2.70% | 2.66% | ||
| 28 | 2.71% | 2.67% | ||
| 29 | 2.72% | 2.69% | ||
| 30 | 2.73% | 2.70% |
With regard to the date of occurrence of the claims used, it should be noted that this is exclusively the year of occurrence and that for all years the reference discount curve will be that of 31 December of each year.
For the purposes of determining the settlement date, the settlement speed established by the Solvency II process is used. For the latter, the transition from an assessment made for grouping contracts under Solvency II to an assessment for REVO LOB is also carried out using the claims UBEL as a driver.
The total claims UBEL for REVO LOB at the various settlement dates is aggregated to obtain the UBEL by IFRS 17 portfolio based on the convergence table reported in the "aggregations" section of this chapter. For each IFRS 17 portfolio and for each settlement date, the settlement speed is obtained as the ratio of the claims UBEL at the date and the total claims UBEL.
The risk adjustment is calculated on the two components of claims UBEL and the discounted amount by multiplying for each IFRS 17 portfolio the RA percentage for the respective components of claims UBEL and the discounting factor.
The Transition date (1 January 2022) is the date of commencement of the annual period immediately preceding the effective date of the standard. The purpose of the Transition period is to carry out measurements, under IFRS 17, of the periods prior to the entry into force of the standard, to allow for a comparison of the results.
Following the eligibility test, the Group measured the entire business using the simplified PAA method on 1 January 2022. The following is a restated statement of financial position for the year beginning on 1 January 2022 (start date of the Transition period):

| STATEMENT OF FINANCIAL POSITION - ASSETS | 01.01.2022 | |
|---|---|---|
| 1. | INTANGIBLE ASSETS | 76,380 |
| o/w: goodwill | 74,323 | |
| 2. | PROPERTY, PLANT AND EQUIPMENT | 1,630 |
| 3. | INSURANCE ASSETS | 39,038 |
| 3.1 | Insurance contracts written classified as assets | - |
| 3.2 | Cessions to reinsurance classified as assets | 39,038 |
| 4. | INVESTMENTS | 186,794 |
| 4.1 | Investment property | - |
| 4.2 | Investments in associates and joint ventures | 1 |
| 4.3 | Financial assets measured at amortised cost | 8,000 |
| 4.4 | Financial assets measured at fair value through OCI | 141,126 |
| 4.5 | Financial assets measured at fair value through profit or loss | 37,668 |
| a) financial assets held for trading | 37,668 | |
| b) financial assets designated at fair value | - | |
| c) Other financial assets compulsorily measured at fair value | - | |
| 5. | OTHER FINANCIAL ASSETS | 4,876 |
| 6. | OTHER ASSETS | 11,475 |
| 6.1 | Non-current assets or disposal groups held for sale | - |
| 6.2 | Tax assets | - |
| a) current | - | |
| b) deferred | - | |
| 6.3 | Sundry assets | 11,475 |
| 7 | CASH AND CASH EQUIVALENTS | 12,396 |
| TOTAL ASSETS | 332,590 |
| STATEMENT OF FINANCIAL POSITION – SHAREHOLDERS' EQUITY AND LIABILITIES | 01.01.2022 | |
|---|---|---|
| 1. | EQUITY | 217,464 |
| 1.1 | Share capital | 6,680 |
| 1.2 | Other equity instruments | - |
| 1.3 | Equity-related reserves | 170 |
| 1.4 | Income-related reserves and other reserves | 214,856 |
| 1.5 | Treasury shares (-) | 0 |
| 1.6 | Valuation reserves | -4,242 |
| 1.7 | Equity attributable to non-FRQWUROOLQJLQWHUHVWV-) | - |
| 1.8 | Profit (loss) for the year attributable to the parent -) | - |
| 1.9 | Profit (loss) for the year attributable to non-FRQWUROOLQJLQWHUHVWV-) | - |
| 2. | PROVISIONS FOR RISKS AND CHARGES | 4,701 |
| 3. | INSURANCE LIABILITIES | 80,375 |
| 3.1 | Insurance contracts issued that are liabilities | 80,375 |
| 3.2 | Reinsurnce contracts held that are liabilities | 0 |
| 4. | FINANCIAL LIABILITIES | 1,316 |
| 4.1 | Financial liabilities measured at fair value through profit or loss | 0 |
| a) financial liabilities held for trading | 0 | |
| b) financial liabilities designated at fair value | 0 | |
| 4.2 | Financial liabilities measured at amortised cost | 1,316 |
| 5. | LIABILITIES | 21,525 |
| 6. | OTHER LIABILITIES | 7,208 |
| 6.1 | Liabilities of disposal groups | - |
| 6.2 | Tax liabilities | 4,367 |
| a) current | 888 | |
| b) deferred | 3,479 | |
| 6.3 | Sundry liabilities | 2,841 |
| TOTAL EQUITY AND LIABILITIES | 332,590 |
The following table shows the impact on equity of the application of IFRS 17 at 1 January 2022:
| Equity | 01.01.2022 |
|---|---|
| Equity IFRS 4 | 218,477 |
| IFRS 17 effects: | |
| - PVFCF measurement | -141 |
| - inclusion of non-financial risk | -1,254 |
| - discounting of reserves and credit risk | -70 |
| - loss component net of loss recovery | - |
| - deferred taxes | 452 |
| Equity | 217,464 |
The effects of the application of IFRS 17 on 1 January 2022 were:
Since the adoption of IFRS 17 on 1 January 2023, the Company has revised certain internal controls on financial reporting. These changes were necessitated by the implementation of new information systems, new actuarial processes, and the reconciliation of financial data between IFRS 4 and IFRS 17.
The Group's insurance contracts, measured using the PAA method, resulted in minimisation of the impact of the transition from IFRS 4 to IFRS 17.
The supplementary schedules for the consolidated financial statements as at 31 December 2022 are provided below, distinguishing between adjustments due to measurement changes following the adoption of the new standard and adjustments due to mere reclassification of amounts:
| ASSETS | IFRS 9 and 4 | Reclassifications | Adjustments | IFRS 9 and 17 |
|---|---|---|---|---|
| INTANGIBLE ASSETS | x | 83,071 | - | 83,071 |
| INTANGIBLE ASSETS | 92,128 | -92,128 | x | x |
| Goodwill | 74,323 | -74,323 | x | x |
| Other intangible assets | 17,805 | -17,805 | x | x |
| PROPERTY, PLANT AND EQUIPMENT | x | 14,448 | - | 14,448 |
| PROPERTY, PLANT AND EQUIPMENT | 14,448 | -14,448 | x | x |
| Property | 13,973 | -13,973 | x | x |
| Other items of property, plant and equipment | 475 | -475 | x | x |
| REINSURERS' SHARE OF TECHNICAL PROVISIONS | 55,737 | -55,737 | x | x |
| INSURANCE ASSETS | x | 46,045 | -240 | 45,805 |
| INVESTMENTS | 188,531 | - | - | 188,531 |
| OTHER FINANCIAL ASSETS | x | 3,835 | - | 3,835 |
| MISCELLANEOUS RECEIVABLES | 52,856 | -52,856 | x | x |
| Receivables deriving from direct insurance operations | 40,303 | -40,303 | x | x |
| Receivables deriving from reinsurance operations | 969 | -969 | x | x |
| Other receivables | 11,584 | -11,583 | x | x |
| OTHER ASSETS | 7,528 | 11,519 | - | 19,049 |
| Non-current assets held for sale or disposal groups | - | - | - | - |
| Deferred acquisition costs | - | - | x | x |

| Deferred tax assets | - | 7 | - | 7 |
|---|---|---|---|---|
| Current tax assets | 5,394 | - | - | 5,394 |
| Other assets | 2,134 | 11,511 | - | 13,647 |
| CASH AND CASH EQUIVALENTS | 4,654 | 0 | - | 4,652 |
| TOTAL ASSETS | 415,882 | -56,250 | -240 | 359,391 |
| LIABILITIES | IFRS 9 and 4 |
Reclassifications | Adjustments | IFRS 9 and 17 |
|---|---|---|---|---|
| EQUITY | 216,632 | - | -137 | 216,495 |
| Share capital | 6,680 | - | - | 6,680 |
| Equity-related reserves | 170 | - | - | 170 |
| Income-related reserves and other reserves | 215,870 | -3 | -1,014 | 214.854 |
| (Treasury shares) | - | - | ||
| Gains/losses on financial assets measured at FVOCI | -6,687 | 6,687 | x | x |
| Valuation reserves | x | -10,154 | - | -10,154 |
| Other gains or losses recognised directly in equity | -3,470 | 3,470 | x | x |
| Profit for the year | 5,316 | 877 | 6,193 | |
| PROVISIONS | 3,176 | -3,176 | x | x |
| PROVISIONS FOR RISKS AND CHARGES | 0 | 3,243 | 0 | 3,243 |
| TECHNICAL PROVISIONS | 140,074 | -140,074 | x | x |
| INSURANCE LIABILITIES | x | 101,405 | -40 | 101,365 |
| FINANCIAL LIABILITIES | 16,048 | -1,600 | 0 | 14,448 |
| LIABILITIES | x | 18,167 | - | 18,167 |
| PAYABLES | 31,613 | -31,613 | - | - |
| Payables deriving from direct insurance operations | - | - | x | x |
| Payables deriving from reinsurance operations | 9,061 | -9,061 | x | x |
| Sundry payables | 22,553 | -22,553 | x | x |
| OTHER LIABILITIES | 8,340 | -2,606 | -61 | 5,673 |
| Liabilities of disposal groups | - | - | - | - |
| Deferred tax liabilities | 336 | - | -61 | 275 |
| Current tax liabilities | - | - | - | |
| Other liability items | 8,004 | -2,606 | - | 5,398 |
| TOTAL EQUITY AND LIABILITIES | 415,882 | -56,250 | 639 | 359,391 |
The main effects are reported below, taking the figures presented in the statement of financial position at 31 December 2022 shown above as a reference:
The effect, on 1 January 2023, of the entry into force of IFRS 17, was a reduction in equity of €137,000, as shown in the table below, recognised in the valuation reserve and mainly attributable to the determination of the PVFCF of the liability for incurred claims (LIC), as well as the inclusion of non-financial risk, which, at that date, had an overall impact on the total LIC reserves net of the AIC of approximately 7%.

| Equity | 01.01.2023 |
|---|---|
| Equity IFRS 4 | 216,632 |
| IFRS 17 effects: | - |
| - inclusion of non-financial risk | -1,428 |
| - discounting of reserves and credit risk | 1,231 |
| - loss component net of loss recovery | - |
| - deferred taxes | 61 |
| Equity | 216,495 |
The table below shows a breakdown of equity items at 1 January 2023 and a breakdown of equity items at 31 December 2022 in the official financial statements:
| Items | Equity at 31.12.2022 | Equity at 1.1.2023 |
|---|---|---|
| Share capital and equity-related, net of treasury shares | 5,603 | 5,603 |
| Other equity instruments | - | - |
| Income-related reserves and other reserves | 215,870 | 215,870 |
| Valuation reserves | -10,154 | -10,154 |
| Equity attributable to non-controlling interests | - | - |
| Profit for the year | 5,316 | 5,316 |
| First-WLPHDGRSWLRQUHVHUYHXQGHU,)56-) | X | - 1,015 |
| Determination of first-time adoption reserve under IFRS 17: | X | X |
| Technical provisions before discontinued operations - IFRS 4 | 97,004 | X |
| Deferred acquisition costs - IFRS 4 | - | X |
| Other IFRS 4 assets | 12,954 | X |
| Insurance contracts written that are recognised as liabilities - IFRS 17 | X | 86,613 |
| Of which PAA: Insurance contracts written - Adjustment relating to the | ||
| component without loss | X | 86,613 |
| Of which PAA: Insurance contracts written - Adjustment relating to the loss | ||
| component | X | - |
| Technical provisions ceded - IFRS 4 | 39,895 | X |
| Cessions to reinsurance classified as assets - IFRS 17 | X | 40,993 |
| Of which PAA: Cessions to reinsurance - Adjustment relating to component | ||
| without loss recovery | X | 40,993 |
| Of which PAA: Cessions to reinsurance - Adjustment relating to the loss | ||
| recovery component | X | - |
| Other adjustments | - | 877 |
| First-WLPHDGRSWLRQUHVHUYHXQGHU,)56-): | X | - |
| o/w: Financial assets: classification in accounting portfolios - business model | X | - |
| o/w: Financial assets: classification in accounting portfolios - SPPI test | X | - |
| o/w: Financial assets: impairment | X | - |
| o/w: Financial liabilities: own credit risk | X | - |
| o/w: Other adjustments, if any (detail if material) | X | - |
| TOTAL | 216,635 | 216,495 |
In January 2020, the IASB issued amendments to IAS 1 to clarify how to classify debt and other financial liabilities as current or non-current, and in particular how to classify liabilities with an uncertain settlement date and liabilities that can be settled through conversion to equity. These amendments are effective as of 1 January 2023. The Group has not recorded any material impact due to the adoption of these amendments.
In February 2021, the IASB issued amendments to IAS 1, requiring entities to provide information on their material accounting policies, rather than significant accounting policies, and providing guidance on how to apply the concept of

materiality to the disclosure of accounting policies. These amendments in effect from 1 January 2023 did not have material impacts on the Group.
In February 2021, the IASB issued amendments to IAS 8, clarifying that entities are to distinguish changes in accounting policies from changes in accounting estimates. These amendments are effective as of 1 January 2023. The Group has not recorded any material impact due to the adoption of these amendments.
In May 2021, the IASB issued amendments to IAS 12 to clarify how entities should account for deferred tax liabilities on transactions such as leases and decommissioning obligations, transactions for which entities recognise both an asset and a liability. In particular, it was clarified that the exemption does not apply and that entities are required to recognise deferred taxation on such transactions. These amendments, effective as of 1 January 2023, have not resulted in any material impact for the Group.
In May 2023, the IASB issued amendments to IAS 12 - "Income Taxes" that allow companies to temporarily suspend the recognition of deferred taxes deriving from the international tax reform aimed at implementing the Pillar Two Model Rules of the Organisation for Economic Cooperation and Development (OECD), according to which large multinationals with turnover of over €750 million must pay a global minimum tax rate of 15% in each jurisdiction in which they operate. The amendments introduced:
Companies may immediately benefit from the temporary exception, but are required to provide disclosure to investors for annual reporting periods starting on or after 1 January 2023.
These amendments did not have any impact on the Group, as it does not fall within the scope of the amendment.
The following new standards, amendments and interpretations have been issued by the International Accounting Standards Board (IASB) and adopted by the European Union, and will become mandatory from 2024 or in subsequent years:
In September 2022, the IASB issued amendments to IFRS 16 with the aim of clarifying how the vendor and lessee may measure the sale and leaseback transaction in order to comply with the requirements of IFRS 15 to account for the sale. The amendment will enter into force on 1 January 2024. The Group does not expect the adoption of these amendments to have any material impact.

The above amendments issued by the IASB on 31 October 2022 aims to clarify the conditions under which an entity may record a short-term or long-term liability. The amendment will enter into force on 1 January 2024. The Group does not expect the adoption of these amendments to have any material impact.
In May 2023, the IASB published amendments to IAS 7 and IFRS 7 following a request from IFRIC concerning the requirements for the presentation of liabilities and related cash flows arising from supplier finance arrangements (reverse factoring) and related additional disclosures.
Entities will be required to provide certain specific information (qualitative and quantitative) regarding supplier finance arrangements. The amendments also provide guidance on the characteristics of supplier finance arrangements.
The amendment will enter into force on 1 January 2024. The Group does not expect the adoption of these amendments to have any material impact.
With regard to sustainability reporting, on 26 June 2023 the International Sustainability Standards Board (ISSB) published the first two standards:
The two standards came into effect on 1 January 2024: the information will therefore be available from 2025. The Company and the Group will be required to apply these standards jointly and are exploring the issues related to the
application of these new rules.

In accordance with IAS 38, an intangible asset is only recognised if it is identifiable, controllable, is expected to generate future economic benefits and its cost can be reliably determined, but it does not include deferred acquisition costs, which must be included in the relevant item 6.2 "Other assets".
This category includes goodwill and other intangible assets, including application software for long-term use.
Goodwill represents the excess of the purchase cost over the acquirer's share of the fair value of the acquiree's identifiable net assets and liabilities. The purchase cost includes costs directly associated with the transaction.
After initial recognition, goodwill is measured at cost less any cumulative impairment losses. Goodwill is subjected to impairment testing, in order to avoid any impairment. In compliance with IAS 36, goodwill is not amortised.
The purpose of goodwill impairment testing is to identify the existence of any impairment of the value recorded as an intangible asset. To this end, cash generating units (CGUs), to which the goodwill is to be allocated, are first identified. Any impairment is equal to any negative difference between the carrying amount previously recognised and its recoverable amount. The latter is determined as the higher of the fair value of the cash-generating unit and its value in use, which is equal to the discounted future cash flows of the unit. If the reason for a previous impairment no longer pertains, in no case can the carrying amount be reinstated.
Intangible fixed assets with a finite useful life are measured at purchase cost or development cost net of amortisation and impairment. Amortisation must be calculated on the basis of useful life, starting from the time when the asset is available for use.
Meanwhile, other intangible fixed assets with an indefinite life are not subject to amortisation but are periodically tested for impairment.
The account also includes intangible assets under development and advances paid for the acquisition of intangible assets, although they cannot be amortised.
This item includes operating properties, plant, other machinery and equipment and other assets.
In accordance with IAS 16, land and buildings destined for use by the Company are recorded in this category. Property is recognised at purchase cost net of depreciation and impairment. Directly attributable costs incurred to get the asset into the condition necessary for its operation according to business requirements are included.
Ordinary maintenance costs are charged directly to the income statement. Costs incurred after purchase are capitalised only if they can be reliably determined and if they increase the future economic benefits of the assets to which they relate; other costs are recognised in the income statement.
Depreciation, using the straight-line method, is charged over the estimated useful life of properties, ranging from 30 to 50 years.
Maintenance costs that are not ordinary in nature, improvements and transformations that result in an increase in the value, functionality or useful life of the assets, are directly capitalised, allocated to the assets to which they refer and depreciated. Ordinary maintenance and repair costs are charged to the income statement.
Property is tested for impairment by comparing its carrying amount with its estimated fair value, determined according to specific appraisals. Impaired property assets are written down as required.
This item includes movable property, furnishings and office machinery.
These are recorded, as established by IAS 16, at purchase cost and subsequently recognised net of depreciation and any impairment. Included in the determination of cost are ancillary charges and directly attributable costs incurred to get the asset to the location and into the condition necessary for its operation according to business requirements. They are systematically depreciated on the basis of economic/technical rates determined in relation to their remaining useful life. Depreciation rates are reduced for purchases during the financial year by 50% compared with the rates indicated below, which apply from the year after the first year:
| Rate | |
|---|---|
| Furniture and fixtures | 12% |
| Plant | 15% |
| Other equipment | 20% |
| Electronic machinery | 20% |
| Movable property entered in public registers | 25% |
Repair and ordinary maintenance costs are charged to the income statement for the year in which they are incurred. Subsequent costs, which can be reliably determined and which increase the future economic benefits of the asset are capitalised and depreciated according to the remaining useful life of the asset to which they relate.
Pursuant to IAS 36, these assets are subject, at least once a year, to impairment testing (recognising as a loss the negative difference between the carrying amount and the recoverable amount) and to a residual useful life test.
If the recoverable amount is lower than the carrying amount, an impairment loss is recognised. If, subsequently, the loss no longer exists or is reduced, the carrying amount of the asset or cash-generating unit would be increased up to the new recoverable amount. However, this new amount may not exceed the amount determined prior to recognition of the loss.
As required by paragraph 78 of IFRS 17 and referred to in IVASS Regulation No. 7/2007, this item includes insurance contracts, including reinsurance contracts, issued and investment contracts with discretionary participation features (DPFs), issued, defined and governed by IFRS 17, belonging to portfolios of insurance contracts written that are classified as assets, as the closing balance is positive.
This item includes reinsurance cession contracts defined and governed by IFRS 17, belonging to portfolios of reinsurance cession contracts that are classified as assets, as the closing balance is positive.
This item includes receivables and payables vis-a-vis reinsurance companies or insurance companies relating to reinsurance relationships. They are recognised at their nominal value and subsequently measured at each reporting date at their estimated realisable value.
In accordance with IAS 40, the Group considers investment property to be property assets held for the purpose of earning rental income or capital appreciation purposes, or both.

Investments intended for use by the Company or for sale in the ordinary course of its business are classified under "Property, plant and equipment".
Investment property is recorded at cost, less depreciation and any impairment. Also included in the determination of cost are ancillary costs and directly attributable costs incurred to get the asset into the condition necessary for its operation according to business requirements.
Depreciation is charged on a straight-line basis over the estimated useful life of the assets.
Land, which is assumed to have an unlimited useful life, is not included in the depreciation process. For the purposes of the different accounting treatment, land and buildings are recorded separately, even if they were purchased together.
Repair costs and ordinary maintenance costs are charged to the income statement for the year in which they are incurred. Subsequent costs, which can be reliably determined and which increase the future economic benefits of the asset, are capitalised and depreciated according to the remaining useful life of the asset to which they relate.
Pursuant to IAS 36 -Impairment of Assets, investment property is tested for impairment by comparing the carrying amount with the estimated fair value, determined through specific appraisals. Any negative difference is recognised in the income statement.
The Group does not have any investment property.
This item includes equity investments in subsidiaries, associates and joint ventures, regulated by IFRS 10, IAS 28 and IFRS 11, that are not classified as held for sale in accordance with IFRS 5.
A company is defined as an associate when the investor exercises significant influence, having the power to participate in determining the investee's operational and financial decisions, without holding control or joint control. A significant influence is presumed to exist if the investor possesses, directly or indirectly, at least 20% of the votes exercisable at the shareholders' meeting.
Joint ventures are equity investments in jointly controlled arrangements in which the parties have rights to the assets and assume obligations for the liabilities relating to the arrangement; they differ from joint operations, which exist when joint control of an economic activity is contractually agreed, i.e. when decisions on the relevant activities require the unanimous consent of the parties that share control.
Regardless of the legal form of the investee, the assessment of control takes into account the actual power over the investee and the actual ability to influence the relevant activities, regardless of the number of voting rights.
The measurement criterion adopted by the Group is the 'equity method', i.e. the accounting method by which the equity investment is initially measured at cost and subsequently adjusted as a result of changes in the investor's share of the investee's equity. The profit or loss of the investor reflects its share of the profit or loss for the year of the investee, as per the last approved financial statements.
The list of investments that make up this item is attached to these consolidated financial statements.
This category includes financial assets that meet both of the following conditions:
Initial recognition of the financial asset occurs at the settlement date for debt securities and at the disbursement date for loans. On initial recognition, assets are recorded at fair value, including transaction costs or income directly attributable to the instrument.
After initial recognition, loans and receivables are measured at amortised cost, which is equal to their initial value increased or decreased by principal repayments, impairment losses and gains and amortisation - calculated using the effective interest rate method - of the difference between the amount disbursed and the amount to be repaid at maturity, typically related to the costs and income directly attributable to the individual loan or receivable.

The amortised cost method is not used for loans or receivables, whose short duration makes the effect of applying the discounting logic negligible. Such loans or receivables are measured at their historical cost.
The accounting treatment is closely connected to the inclusion of the instruments in question in one of the three stages (stages of credit risk) provided for in IFRS 9, the last of which (Stage 3) includes non-performing financial assets and the remaining performing financial assets (Stages 1 and 2).
If the grounds for impairment cease to apply as a result of an event that occurs after an impairment loss has been recognised, impairment gain is made in the income statement. The gainmay not exceed the amortised cost that the financial instrument would have had in the absence of previous adjustments.
This category includes financial assets that meet both of the following conditions:
This item also includes equity instruments not held for trading, for which the option of designation at fair value through other comprehensive income was exercised on initial recognition.
In particular, this item includes:
On initial recognition, assets are recorded at fair value, including transaction costs or income directly attributable to the instrument.
After initial recognition, assets classified at fair value through other comprehensive income, other than equity securities, are measured at fair value, with the impact of the application of amortised cost, impairment and any foreign exchange effect recognised in the income statement, while other gains or losses deriving from a change in fair value are recognised in a specific equity reserve until the financial asset is de-recognised. At the time of full or partial disposal, the gain or loss accumulated in the valuation reserve is reversed in the income statement.
Equity securities classified at fair value through other comprehensive income are measured at fair value, with the recognition of fair value gains of losses in equity and the recognition of dividend income in the income statement.
Financial assets are de-recognised only when the contractual rights to the associated cash flows expire or when the financial asset is sold with the substantial transfer of all the risks and rewards associated with the assets.
This item includes financial assets not classified as financial assets measured at amortised cost or at fair value through other comprehensive income, in particular:
This item includes trade receivables from insurance intermediaries and financial assets. Sundry financial assets are recognised at their nominal amount and are subsequently measured at their estimated realisable value. Amortised cost was not applied as the application of this criterion would be practically the same as the historical cost and,
when determining the recoverable amount, no cash flows were discounted, which would yield completely negligible results.

Other sundry receivables that are not related to insurance. They are recognised at their nominal value and subsequently measured at their estimated realisable value and discounted where appropriate.
This item includes non-current assets held for sale or disposal groups, current and deferred tax assets and other assets.
Non-current assets held for sale or disposal groups are recognised under this item in accordance with IFRS 5. Non-current assets and disposal groups are classified as held for sale if their carrying amount will be recovered mainly through a sale transaction rather than through their continuous use. This condition is considered fulfilled only when a sale is highly probable and the discontinued asset or disposal group is available for immediate sale in its current condition. Assets are recognised at the lower of their carrying amount and their fair value, net of estimated costs to sell. The resulting profit or loss, after tax, is presented separately in the statement of comprehensive income.
These items include assets relating to current and deferred taxes, as defined and regulated by IAS 12. These assets are recognised in accordance with current tax legislation on an accruals basis. For tax assets recognised as deferred taxes, a check is periodically carried out on each reporting date for any changes in the relevant tax legislation that might determine a different valuation.
Sundry assets include accrued income and prepaid expenses, tax assets other than those recognised under "Tax assets", such as assets associated with withholding agent activity and residual assets not included in the above items, in particular claims in course of payment.
This item includes cash, cash equivalents and deposits that are available on demand. These are recognised at nominal value.

Ordinary shares and preference shares are recorded as share capital and their value corresponds to the nominal value actually paid.
This item includes equity instruments not included in the share capital, consisting of special classes of shares, as well as equity components included in complex financial instruments.
This item includes, in particular, the share premium reserve of the company that prepares the consolidated financial statements.
In particular, this item includes:
Any gains or losses due to fundamental errors and changes in accounting standards or the estimates used are included (IAS 8).
This item includes sums paid out as interim dividends to shareholders. Its amount is to be reported as a reduction of the item "Equity".
As specified by IAS 32, this item includes the equity instruments of the company that prepares the consolidated financial statements held by the company itself and by the consolidated companies. The item is negative. Gains or losses deriving from their subsequent sale are recognised as changes in equity.
This item includes valuation reserves relating to:

The macro-item comprises equity instruments and components and the relevant reserves attributable to non-controlling interests.
The Group does not have any equity attributable to non-controlling interests.
This item shows the profit or loss for the year.
In accordance with IAS 37, provisions are liabilities of uncertain amounts or maturities that are recognised under the following conditions:
Measurement of the values representing the obligation is reviewed periodically. Any change in the estimate is recognised in the income statement in the period in which it occurs.
As required by paragraph 78 of IFRS 17 and referred to in IVASS Regulation No. 7/2007, this item includes insurance contracts, including reinsurance contracts, issued and investment contracts with discretionary participation features (DPFs), issued, defined and governed by IFRS 17, belonging to portfolios of insurance contracts issued that are liabilities, as the closing balance is negative.
This item also includes receivables from policyholder for premiums not yet collected and payables for commissions on premiums still to be collected. They are recognised at their nominal value and subsequently measured at each reporting date at their estimated realisable value.
This item includes reinsurance cession contracts defined and governed by IFRS 17, belonging to portfolios of reinsurance cession contracts that are classified as liabilities on the basis of the sign of the closing balance.
This item includes financial liabilities regulated by IFRS 9 other than payables.
This item includes financial liabilities at fair value through profit or loss, and specifically:
This item includes financial liabilities, including investment contracts written by insurance companies, other than indexand unit-linked contracts, which do not fall within the scope of IFRS 17 and reinsurance deposits.

Liabilities include liabilities to policyholders and insurance intermediaries, as well as other payables, such as trade liabilities, recognised at nominal value.
This item specifically includes provisions for payables to employees for post-employment benefits, recognised in accordance with IAS 19.
In addition, there are other liabilities of a definite nature and certain existence that are not allocated to the previous sections of the consolidated financial statements.
In accordance with IFRS 5, liabilities relating to disposal groups held for sale are recognised under this item.
These items include liabilities relating to current and deferred taxes, as defined and regulated by IAS 12. These liabilities are recognised in accordance with current tax legislation and are recognised on an accruals basis. For liabilities recognised as deferred taxes, a check is periodically carried out on each reporting date for any changes in the relevant tax legislation that might determine a different valuation.
This item includes accrued expenses and deferred income, determined on an accrual basis, taxes payable by policyholders, liabilities for sundry tax charges and to social security and pension institutions and, in general, credit tax liabilities other than those included in the item "Tax liabilities", such as those associated with withholding agent activity, as well as production bonuses to be paid to staff in the following year.
IFRS 13 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the valuation date.
Allocation to one of the three fair value levels envisaged by IFRS 13 meets the following criteria:
Observable market variables and assumptions are favoured in the definition of fair value and measurement techniques are only used in the absence of such inputs.
These valuation methods must be applied in hierarchical order: if, in particular, an active market price is available, no other valuation approach can be used.
In summary, first the prices quoted on active markets for the same or identical financial instruments were examined, then the inputs for the asset or liability, observable both directly and indirectly, and finally the inputs relating to the asset or liability that are not based on observable market data.
If available, the fair value of bonds traded in an active and liquid market is defined by the market price. Otherwise, bonds, both Italian and foreign, that are not listed on active markets, are valued by referring respectively to:

The same valuation methods are also applicable to asset-backed securities and securities issued by special purpose vehicles that are bonds or similar.
This category includes shares, exchange traded funds (ETFs), rights, warrants and covered warrants.
If an active market is available, the fair value of an Italian or foreign equity security is identified by reference to the price expressed by the reference market.
In the absence of any indications of value (i.e. in the absence of an active market), the valuation criterion followed varies according to the sector to which it belongs, in line with the valuation practices in use.
The methods applied are as follows:
In the case of listed investment funds, fair value is represented by the market price based on quotations in the active market.
Otherwise, the fair value is represented by the net asset value (NAV) communicated by the asset management company ("SGR") or by the fund administrator, or derived from the information provider.
With regard to derivatives (as defined by Legislative Decree No. 58 of 24 February 1998 (Consolidated Law on Finance), if listed on an active market, the fair value is determined by referring to the reference stock exchange price ("close" or "last price" of Bloomberg or alternative information providers).
The fair value of over the counter (OTC) derivatives is determined by referring to:
At the reporting date, the Group is not making use of derivatives.
A contract contains a lease if, in exchange for a consideration, it confers the right to control the use of a specified asset for a period of time.

For contracts in this category the right-of-use asset and the relevant financial liabilities are recognised, except in the following cases: short-term contracts (i.e. leases with a term of 12 months or less) or low-value assets (less than €5,000 when new).
The right-of-use asset and the relevant lease liability are recognised on the contract inception date
Financial liabilities are initially determined at the present value of future payments at the contract inception date, discounted at the implicit rate of the lease or, if this is not readily determinable, at the lessee's incremental borrowing rate. In subsequent entries, the amortised cost method is applied, i.e. the carrying amount of the liability is increased by the interest thereon and decreased to take account of payments made under the lease.
The value of the financial liability is recalculated (with a corresponding adjustment to the value of the right-of-use asset) in the following cases: a change in the term of the lease; a change in the exercise price of the purchase option; a change in the value of lease payments following changes in indices or rates; or amounts expected to be payable under residual value guarantees. The value of the liability is redetermined by discounting the new lease payments at the initial discount rate (unless the lease payments change as a result of a fluctuation in variable interest rates, in which case a revised discount rate is used).
The right-of-use asset is initially measured at cost, which includes: the initial value of the liability deriving from the lease; and lease payments made before or on the inception date of the contract. In subsequent entries, the right-of-use asset is recognised in the financial statements net of depreciation and any impairment. Depreciation is on a straight-line basis over the period between the inception date of the contract and the shorter of the lease term and the residual useful life of the underlying asset.

The macro-item includes revenues associated with insurance contracts written that reflect the portion of the consideration received from the policyholderfor services provided during the year on the basis of IFRS 17.
IFRS 17 defines an insurance contract as a contract in which one party accepts a significant insurance risk from another, agreeing to compensate the policyholderif a specific uncertain future event adversely affects the other party.
The following are accounted for in this item, in accordance with IFRS 17 and IVASS Regulation No. 7 of 2007: costs for insurance services, presenting separately;
This item includes the positive or negative balance of other technical expenses and other technical income not included in fulfilment cash flows relating to insurance contracts written.
The item includes:
In accordance with paragraph 86 of IFRS 17, the following are accounted for in this item:
This item includes the positive or negative balance of other technical expenses and other technical income not included in the fulfilment cash flows connected to cessions to reinsurance.
The item includes realised gains and losses and increases or decreases in the fair value of financial assets and liabilities measured at fair value through profit or loss.
The item includes:
x gain from equity investments in subsidiaries, associates and joint ventures recognised under the corresponding asset item. Specifically, it includes the portion of the profoit for the year relating to Group companies, accounted for using the equity method;

x losses arising from equity investments in subsidiaries, associates and joint ventures recognised under the corresponding asset item. Specifically, it includes the share of the profit for the year relating to Group companies, accounted for using the equity method.
The macro-item includes income and expenses deriving from financial instruments not measured at fair value through profit or loss.
Specifically, income includes interest income recognised on financial instruments measured using the effective interest method, other investment income and gains realised following the sale of a financial asset or liability.
Expenses include interest expenses recognised using the effective interest method, and in particular losses realised due to the derecognition of a financial asset or liability, impairment losses and other real estate expenses, capital losses on the sale of securities, and lastly the impaiment of bonds of issuers in technical default.
This item includes interest income recognised using the effective interest method.
This item includes interest expenses recognised using the effective interest criterion on financial liabilities.
The Group recognises under this item:
This item includes, inter alia, costs relating to investment properties, particularly service charges and maintenance and repair costs that are not added to the value of investment property.
This item includes the balance of gains and losses realised on the sale of financial instruments not measured at fair value through profit or loss or on the occasion of a repurchase of its financial liabilities measured at amortised cost.
This item includes the balance, positive or negative, between:
This item includes the balance, positive or negative, of changes in the carrying amount of insurance contracts issued in connection with the effects of changes in the time value of money.
This item includes the balance, positive or negative, of changes in the carrying amount of reinsurance contracts connected with the effects of changes in the time value of money.
The macro-item includes:

The macro-item includes administrative expenses not included in the calculation of insurance assets and liabilities, as well as investment management expenses. It also includes payroll expenses of companies engaged in activities other than insurance and general and payroll expenses relating to investment operations.
This item includes general and payroll expenses relating to the management of financial instruments, investment property and equity investments.
This item includes general and payroll expenses not included in the calculation of insurance assets and liabilities and not allocated to expenses for acquiring insurance contracts and investment management expenses.
The item includes accruals to and any releases to the income statement of the item "Provisions for risks and charges" in statement of financial position liabilities.
This item includes impairment losses, reversals of impairment losses and depreciation of property, plant and equipment and right-of-use assets acquired through leasing transactions involving the use of items of property, plant and equipment.
This item includes impairment, reversals of impairment losses amortisation of intangible assets and rights-of-use assets acquired through leasing transactions involving the use of intangible assets.
The item includes amounts that cannot be attributed to the other income statement items indicated above.
This item includes current taxes for the year and deferred taxes.
The schedule includes income components other than those that make up the income statement, recognised directly in equity for transactions other than those carried out with owners.
Revenue and cost items, in accordance with the provisions of ISVAP Regulation No. 7 of 13 July 2007, are shown net of related tax effects and are broken down into items that can or cannot be reclassified to the income statement. The comprehensive income is presented in the statement of changes in equity.
The prospectus, as regulated by ISVAP Regulation No. 7 of 13 July 2007, shows all the changes in shareholders' equity. In particular:
x the item "Change in opening balances" shows the changes made to the closing balances of the previous year in order to correct any errors or to recognise the effects of changes in accounting policies and changes arising due to first-time adoption of IFRS;

The prospectus was prepared using the indirect method and in accordance with ISVAP Regulation No. 7 of 13 July 2007, distinguishing between operating, investing and financing activities.
In accordance with the IFRS, the preparation of financial statements requires the use of estimates that affect the carrying amounts of assets, liabilities, costs and revenues, as well as the disclosure of contingent assets and liabilities.
For the 2023 consolidated financial statements, the assumptions made are believed to be congruous and appropriate and the consolidated financial statements are believed to be prepared clearly, providing a true and fair view of the financial position, cash flows and financial performance for the year.
In order to make reliable estimates, reference was made to historical experience and other reasonable factors. In particular, estimates were used in:
These estimates are reviewed periodically and the effects of changes are reflected in the income statement. However, due to the uncertainty inherent in these financial statement items, their actual values may differ from estimates due to the occurrence of unexpected events or changes in operating conditions.
In the following sections, the disclosures and analyses as required in Paragraph 93 et seq. of IFRS 17 are provided, specifically:
This is qualitative and quantitative information on exposure to insurance, market, credit and liquidity risk deriving from the use of financial instruments, as well as sensitivity analyses, which highlight the impact of changes in the main financial and insurance variables.

Item 1. Intangible assets
(in thousands of
| Total | ||||
|---|---|---|---|---|
| 2022 | ||||
| Finite life | Indefinite life | Finite life | Indefinite life | |
| X | 74,323 | X | 74,323 | |
| X | 74,323 | X | 74,323 | |
| X | - | X | - | |
| 14,092 | 74,323 | 8,748 | 74,323 | |
| - | - | - | - | |
| - | - | - | - | |
| 14,092 | - | 8,748 | - | |
| - | - | - | - | |
| - | - | - | - | |
| - | - | - | - | |
| 14,092 | 74,323 | 8,748 | 74,323 | |
| Total 2023 |
Intangible assets include start-up costs and other directly attributable deferred costs, and are recognised in the consolidated financial statements at purchase cost. They are amortised over five years on a straight-line basis according to their expected useful life, deemed appropriate to represent the residual useful life of the assets. No impairment losses have been recognised.
Goodwill, recognised following the acquisition by REVO SPAC of Elba Assicurazioni S.p.A. in November 2021, amounted to €74,323,000 and was unchanged compared with the end of the previous year.
During the year, no potential indicators of impairment were observed and, in particular, no indicators of a failure to achieve the objectives set out in the Plan or material changes with negative effects for the Group from a technological, market, economic and regulatory viewpoint.
IAS 36 requires that goodwill be tested for impairment at least once a year to determine whether there is evidence that the carrying amounts of assets may not be fully recoverable.
The impairment testing process involves ascertaining whether there are any indicators that the assets may have become impaired and then determining the amount of any such losses. Impairment indicators can essentially be divided into two categories:
The portion of the purchase price of Elba Assicurazioni's equity investment, that is higher than the portion at current value (net fair value) of assets and liabilities, was accounted for as goodwill and represents a payment made in anticipation of

future economic benefits deriving from assets that cannot be identified individually and recognised separately. The ancillary costs incurred during the acquisition were charged to the income statement during the year.
In light of the current structure of the REVO Group and future corporate developments, focused, from the point of view of business development, on traditional and parametric insurance, mainly relating to the SME segment, the CGU was identified as the operating business itself, as there are no individual organisational/functional units capable of autonomously producing cash flows independently of each other.
With regard to the determination of value in use, parameters, methodologies and criteria commonly used by operators for this type of assessment have been adopted, such as the methodology of excess capital distributable beyond a certain Solvency Ratio threshold identified within the Company's risk appetite system, the cost of capital and the perpetual growth rate "g", determined on the basis of methodologies commonly used for valuation and forward-looking results based on the latest available economic and financial projections with a time horizon of at least four years.
On the basis of these methodologies, the impairment tests performed at 31 December 2023 were successful and did not entail any need to make write-downs.
Specifically, the cost of capital was determined on the basis of the CAPM (Capital Asset Pricing Model), with particular reference to a beta coefficient attributable to European insurance companies operating in the non-life segment and an equity risk premium attributable to the Italian market. On the basis of these parameters, and taking into account the fact that the Company is still limited in size and the project is still in the development phase, a cost of capital of 8.82% was identified, in addition to a nominal long-term growth rate "g" of 0.5%. For the purposes of quantifying potentially distributable capital, a Solvency Ratio threshold of 130% was identified.
A sensitivity analysis was also conducted, using broader values for the parameters described, including the cost of capital DQGWKHJURZWKUDWHêJë-0.5%) and the Solvency Ratio threshold (range of 120%-160%). This analysis did not indicate any need to recognise any goodwill impairment.
Other intangible assets totalled €14,092,000 (€8,748,000 at 31 December 2022).
The item includes multi-year costs of €14,026,000 incurred for the preparation and implementation of software relating to corporate information systems (€7,655,000 at 31 December 2022), advances on intangible fixed assets of €46,000 (€42,000 at 31 December 2022), trademarks, patents and similar rights of €11,000 and start-up and expansion costs of €9,000;
The increase in the item relating to information systems was specifically due to the implementation of the strategic development plan that envisaged substantial IT investments to support and sustain the Group during the business development phase (in particular the change in the accounting management system and the development of the OverX platform, designed, inter alia, to simplify and facilitate underwriting processes).
| Intangible assets | Gross carrying amount at 31.12.2022 |
Accumulated amortisation at 31.12.2022 |
Change | Amortis ation |
Accumulated amortisation at 31.12.2023 |
Net carrying amount at 31.12.2023 |
|---|---|---|---|---|---|---|
| Other | 15,005 | -6,253 | 8,280 | -2,940 | -9,193 | 14,092 |
| Total | 15,005 | -6,253 | 8,280 | -2,940 | -9,193 | 14,092 |

| (in thousands of euro) | ||||||
|---|---|---|---|---|---|---|
| Goodwill | Other intangible assets: internally generated |
Other intangible assets: other | Total | |||
| DEF | INDEF | DEF | INDEF | |||
| A. Opening balances | 74,323 | - - |
8,752 | - | 83,075 | |
| A.1 Total amortisation and net impairment losses |
- | - - |
- | - | - | |
| A.2 Net opening balances | 74,323 | - - |
8,752 | - | 83,075 | |
| A.2.a Adjustment of opening balances | - | - - |
- | - | - | |
| B. Increases | - | - - |
8,280 | - | 8,280 | |
| B.1 Purchases | - | - - |
8,280 | - | 8,280 | |
| - Business combinations |
- | - - |
- | - | - | |
| - Other purchases |
- | - - |
- | - | - | |
| B.2 Increases in internal intangible assets | X | - - |
- | - | - | |
| B.3 Reversals of impairment losses | X | - - |
- | - | - | |
| B.4 Positive changes in restated value | - | - - |
- | - | - | |
| - to statement of comprehensive income | X | - - |
- | - | - | |
| - to income statement | X | - - |
- | - | - | |
| B.5 Positive foreign exchange differences | - | - - |
- | - | - | |
| B.6 Other changes | - | - - |
- | - | - | |
| 2WKHUFKDQJHV | - | - - |
8,280 | 8,280 | ||
| C. Decreases | - | - - |
-2,940 | -2,940 | ||
| C.1 Sales | - | - - |
- | - | - | |
| - Business combinations |
- | - - |
- | - | - | |
| - Other sales |
- | - - |
- | - | - | |
| C.2 Amortisation and impairment losses | - | - - |
-2,940 | -2,940 | ||
| - Amortisation | X | - - |
-2,940 | -2,940 | ||
| - Impairment losses | - | - - |
- | - | - | |
| VWDWHPHQWRIFRPSUHKHQVLYHLQFRPH | X | - - |
- | - | - | |
| LQFRPHVWDWHPHQW | - | - - |
- | - | - | |
| C.3 Negative changes in restated value | - | - - |
- | - | - | |
| - to statement of comprehensive income |
X | - - |
- | - | - | |
| - to income statement |
X | - - |
- | - | - | |
| C.4 Transfers to non-current assets held for sale | - | - - |
- | - | - | |
| C.5 Negative foreign exchange differences | - | - - |
- | - | - | |
| C.6 Other changes | - | - - |
- | - | - | |
| D. Net closing balances | 74,323 | - - |
14,092 | 88,415 | ||
| D.1 Total amortisation and net impairment losses |
- | - - |
-9,193 | - | -9,193 | |
| E. Gross closing balances | 74,323 | - - |
23,286 | 97,608 | ||
F. Measurement at cost

| (in thousands of euro) | ||||||
|---|---|---|---|---|---|---|
| Assets/values | Assets for own use | Balances pursuant to IAS 2 | ||||
| At cost | At restated value | |||||
| 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | |
| 1. Own assets | 495 | 475 | - | - | - | - |
| a) land | - | - | - | - | - | - |
| b) buildings | - | - | - | - | - | - |
| c) office furniture and machinery | 495 | 454 | - | - | - | - |
| d) plant and equipment | - | - | - | - | - | - |
| e) other assets | - | 21 | - | - | - | - |
| 2. Right-of-use assets | 13,431 | 13,973 | - | - | - | - |
| a) land | - | - | - | - | - | - |
| -b) buildings | 13,198 | 13,727 | - | - | - | - |
| c) office furniture and machinery | - | - | - | - | - | - |
| d) plant and equipment | - | - | - | - | - | - |
| e) other assets | 233 | 246 | - | - | - | - |
| Total | 13,926 | 14,448 | - | - | - | - |
At 31 December 2023, property, plant and equipment net of related accumulated depreciation, amounted to €13,926,000. The item includes:
For details on lease agreements, please refer to the dedicated paragraph in Section F – Other information in these notes.
Property, plant and equipment are recognised at purchase cost and depreciated according to the rates below, which are considered appropriate to reflect the remaining useful life of the assets, in line with the Ministerial Decree of 1988. Depreciation rates are reduced for purchases during the financial year by 50% compared with the rates indicated below, which apply from the year after the first year:
| Rate | |
|---|---|
| Furniture and fixtures | 12% |
| Plant | 15% |
| Other equipment | 20% |
| Electronic machinery | 20% |
| Movable property entered in public registers | 25% |
The following table shows a breakdown of changes in property, plant and equipment during the year.

| (in thousands of euro) | ||||||
|---|---|---|---|---|---|---|
| Land | Buildings | Office furniture and machinery |
Plant and equipment | Other tangible assets |
Total | |
| A. Gross opening balances | - | 13,726 | 454 | - | 267 | 14,447 |
| A.1 Accumulated depreciation and net impairment losses |
- | - | - | - | - | - |
| A.2 Net opening balances | - | 13,726 | 454 | - | 267 | 14,447 |
| A.2.a Adjustment of opening balances | - | - | - | - | - | |
| B. Increases | - | 1,114 | 158 | - | 112 | 1,384 |
| B.1 Purchases | - | - | - | - | - | - |
| - Business combinations |
- | - | - | - | - | - |
| Business combinations – mergers |
- | - | - | - | - | - |
| - Other purchases |
- | 1,114 | 158 | - | 112 | 1,384 |
| B.2 Capitalised improvement costs | - | - | - | - | - | - |
| B.3 Reversals of impairment losses | - | - | - | - | - | - |
| B.4 Positive change in restated value allocated to | - | - | - | - | - | - |
| a) statement of comprehensive income | - | - | - | - | - | - |
| b) income statement | - | - | - | - | - | - |
| B.5 Positive foreign exchange differences | - | - | - | - | - | - |
| )RUHLJQH[FKDQJHGLIIHUHQFHLQSXW | - | - | - | - | - | - |
| \$XWRPDWLFIRUHLJQH[FKDQJHGLIIHUHQFHV | - | - | - | - | - | - |
| B.6 Transfers from investment property | - | - | - | - | - | - |
| B.7 Other changes | - | - | - | - | - | - |
| C. Decreases | - | -1,642 | -117 | -146 | -1,905 | |
| C.1 Sales | - | - | - | - | - | - |
| C.2 Depreciation | - | -1,642 | -117 | -125 | -1,884 | |
| C.3 Impairment losses recognised in | - | - | - | - | - | - |
| a) statement of comprehensive income | - | - | - | - | - | - |
| b) income statement | - | - | - | - | - | - |
| C.4 Negative changes in the restated value | - | - | - | - | - | - |
| a) statement of comprehensive income | - | - | - | - | - | - |
| b) income statement | - | - | - | - | - | - |
| C.5 Negative foreign exchange differences | - | - | - | - | - | - |
| Foreign exchange difference input (-) | - | - | - | - | - | - |
| Automatic foreign exchange differences (-) | - | - | - | - | - | - |
| C.6 Transfers to: | - | - | - | - | - | - |
| a) investment property | - | - | - | - | - | - |
| b) non-current assets or disposal groups held for sale | - | - | - | - | - | - |
| C.7 Other changes | - | - | - | - | -21 | -21 |
| D. Net closing balances | - | 13,198 | 495 | - | 233 | 13,926 |
| D.1 Accumulated depreciation and net impairment losses | - | -2,280 | -849 | - | -244 | -3,373 |
| D.2 Gross closing balances | - | 15,478 | 1,344 | - | 477 | 17,299 |
E. Measurement at cost

| Insurance assets | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Cessions to reinsurance classified as assets | 68,771 | 45,805 | 22,966 |
| Total | 68,771 | 45,805 | 22,966 |
Cessions to reinsurance classified as assets, measured according to the simplified PAA method, are detailed below:
| 31.12.2023 | 31.12.2022 | |
|---|---|---|
| Assets for remaining coverage | 52,150 | 43,110 |
| Assets for incurred claims | 44,880 | 15,043 |
| Reinsurance payables | -28,259 | -12,348 |
| Total | 68,771 | 45,805 |
The change in the "Assets for remaining coverage" item is in line with the evolution of the portfolio and with the reinsurance plan implemented by the Company.
The "Assets for incurred claims" item includes the risk adjustment amount of €2,192,000 for non-insurance risks and the counterparty credit risk totalling €3,000.
The table below shows changes in the carrying amounts of cessions to reinsurance.

| (in thousands of euro) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Asset for remaining coverage 2023 |
Assets for claims incurred 2023 | Asset for remaining coverage 2022 |
Assets for claims incurred 2022 |
|||||||
| Items/Breakdown of carrying amount | Net of loss recovery component |
Loss recovery component |
Present value of cash flows |
Adjustment for non-financial risks |
Total 2023 |
Net of loss recovery component |
Loss recovery component |
Present value of cash flows |
Adjustment for non-financial risks |
Total 2022 |
| A. Initial carrying amount | ||||||||||
| 1. Cessions to reinsurance classified as assets | 33,418 | - | 11,360 | 1,027 | 45,805 | - | - | - | - | - |
| 2. Cessions to reinsurance classified as liabilities | - | - | - | - | - | - | ||||
| 3. Net carrying amount as at 1 January | 33,418 | - | 11,360 | 1,027 | 45,805 | 28,412 | - | 9,574 | 1,052 | 39,038 |
| B. Economic effects related to reinsurance cessions | - | |||||||||
| 1. Cost of reinsurance | -81,087 | - | - | - -81,087 | -33,967 | - | - | - | -33,967 | |
| 2. Claims and other costs recovered | - | - | 38,707 | 38,707 | - | 20,666 | 317 | 20,982 | ||
| 3. Change in the asset for incurred claims | - | - | 28,553 | 1,165 | -29,718 | - | 3,570 | -341 | 3,229 | |
| 4. Reinsurance cessions covering onerous contracts | - | - | - | - | - | - | - | - | - | - |
| 4.1 Revenues related to the recognition of onerous underlying ins. | - | - | - | - | - | - | - | - | - | - |
| contracts | ||||||||||
| 4.2 Releases of the loss recovery component other than changes in cash | - | - | - | - | - | - | - | - | - | - |
| flows of reinsurance cession contracts | ||||||||||
| 4.3 Changes in cash flows of reinsurance ceded from onerous underlying | - | - | - | - | - | - | - | - | - | - |
| insurance contracts | ||||||||||
| 5. Effects of change in the risk of default by reinsurers | - | - | ||||||||
| 6. Total | -81,087 | - | 67,260 | 1,165 -12,662 | -33,967 | - | 24,236 | -24 | -9,755 | |
| C. Result of insurance services (Total B) | -81,087 | - | 67,260 | 1,165 -12,662 | -33,967 | - | 24,236 | -24 | -9,755 | |
| D. Financial income/expense | - | - | - | - | ||||||
| 1. Relating to reinsurance cessions | - | - | 119 | 119 | - | - | -979 | - | -979 | |
| 1.1. Recognised in profit or loss | - | - | 119 | 119 | - | - | -979 | - | -979 | |
| 1.2. Recognised in statement of comprehensive income | - | - | - | - | - | - | - | - | - | |
| 2. Effects related to exchange rate fluctuations | - | - | - | - | - | - | - | - | - | |
| 3. Total | - | - | 119 | 119 | - | - | -979 | -979 | ||
| E. Investment components | - | - | ||||||||
| F. Total amount recognised in profit or loss and other comprehensive LQFRPH&'( |
-81,087 | - | 67,379 | 1,165 -12,584 | -33,967 | - | 23,257 | -24 | -10,734 | |
| G. Other changes | - | - | - | - | - | - | - | - | - | |
| Increases | - | - | - | - | - | - | - | - | - | |
| Decreases | - | - | - | - | - | - | - | |||
| Other changes (-) | - | - | - | - | - | - | - | |||
| H. Cash movements | - | - | - | - | - | - | - | |||
| 1. Premiums paid net of amounts not related to claims recov. from reins. | 72,892 | - | - | 72,892 | 38,974 | - | - | - | 38,974 | |
| 2. Amounts recovered from reinsurers | - | 37,382 | 37,382 | - | 21,471 | - | 21,471 | |||
| 3. Total | 72,892 | - | 37,382 | 35,510 | 38,974 | - | 21,471 | - | 21,471 | |
| ,1HWFDUU\LQJDPRXQWDW'HFHPEHU\$)*+ | 25,223 | - | 41,356 | 2,192 | 68,771 | 33,418 | - | 11,360 | 1,028 | 45,807 |
| L. Final carrying amount | - | - | ||||||||
| 1. Cessions to reinsurance classified as assets | 25,223 | - | 41,356 | 2,192 | 68,771 | 33,418 | - | 11,360 | 1,028 | 45,807 |
| 2. Cessions to reinsurance classified as liabilities | - | - | ||||||||
| 3. Net carrying amount at 31 December | 25,223 | - | 41,356 | 2,192 | 68,771 | 33,418 | - | 11,360 | 1,028 | 45,807 |

| Investments | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Investment property | - | - | |
| Investments in subsidiaries, associates and joint ventures | 3 | - | 3 |
| Financial assets measured at amortised cost | 3,088 | 4,016 | -928 |
| Financial assets measured at fair value through OCI | 217,811 | 181,895 | 35,916 |
| Financial assets measured at fair value through profit or loss | 2,775 | 2,620 | 154 |
| Total | 223,677 | 188,531 | 35,146 |
The following tables set out the Group's exposures solely to debt securities at 31 December 2023, with a breakdown by geographical area and maturity band. In particular, government bonds are broken down into maturities ranging from 0 to 2 years and 2 to 5 years, while corporate bonds fall mainly within the 2 to 5-year range.
In terms of geographical exposure, government debt securities are mainly Italian government bonds, followed by issues by France, Spain, Germany and supranational entities. The bond issuers in the portfolio are well-diversified geographically between the United States, the United Kingdom, Germany, Spain and elsewhere.
| Description | 0-2 | 2-5 | > 5 | Total |
|---|---|---|---|---|
| Non-Italian corporate bonds | 8,889 | 20,077 | - | 28,966 |
| Italian corporate bonds | 497 | 6,243 | - | 6,740 |
| Non-Italian government bonds | 43,739 | 39,340 | 12,988 | 96,067 |
| Italian government bonds | 41,610 | 40,401 | 3,470 | 85,481 |
| Total | 94,735 | 106,062 | 16,458 | 217,255 |
| Years to maturity | 0-2 | 2-5 | >5 | Total |
| Non-Italian government bonds | 43,739 | 39,340 | 12,988 | 96,067 |
| FR | 13,945 | 5,867 | 4,712 | 24,525 |
| ES | 8,546 | 9,055 | 5,262 | 22,863 |
| DE | 8,966 | 7,477 | 1,537 | 17,980 |
| SNAT | 2,438 | 12,608 | 1,037 | 16,082 |
| BE | 7,838 | - | - | 7,838 |
| NL | 2,006 | 4,333 | - | 6,339 |
| CL | - | - | 440 | 440 |
| Italian government bonds | 41,610 | 40,401 | 3,470 | 85,481 |
| IT | 41,610 | 40,401 | 3,470 | 85,481 |
| Non-Italian corporate bonds | 8,889 | 20,077 | - | 28,966 |
| US | 6,879 | - | - | 6,879 |
| UK | 516 | 3,569 | - | 4,085 |
| DE | 502 | 3,356 | - | 3,858 |
| ES | - | 3,395 | - | 3,395 |
| FR | - | 3,183 | - | 3,183 |
| BE | - | 2,701 | - | 2,701 |
| NL | - | 1,862 | - | 1,862 |
| CA | - | 1,549 | - | 1,549 |
| AT | 992 | - | - | 992 |
| CZ | - | 463 | - | 463 |
| Italian corporate bonds | 497 | 6,243 | - | 6,740 |
| IT | 497 | 6,243 | - | 6,740 |
| Total | 94,735 | 106,062 | 16,458 | 217,255 |

The tables relating to exposure by rating subdivided into government securities and corporate bonds are set out below.
| Government securities | Amount |
|---|---|
| AAA | 37,497 |
| AA | 35,268 |
| A | 23,302 |
| BBB | 85,481 |
| Total | 181,548 |
| Corporate securities | Amount |
|---|---|
| AAA | 3,108 |
| AA | 1,462 |
| A | 13,675 |
| BBB | 17,461 |
| Total | 35,706 |
Item 4.2 Investments in subsidiaries, associates and joint ventures
On 19 December 2023, the insurance company acquired a stake in the insurance brokerage company MedInsure S.r.l., consisting of 33% of its share capital. The remaining 67% of the share capital of MedInsure is held by Holborn Underwriting Ltd, a company incorporated under UK law. The parties agreed on the terms of a call option in favour of REVO which, at the end of the fifth year, will have the right to acquire the remaining 67% stake, subject to authorisation by the Supervisory Authority.
| Progressive Company* |
Name | Country of registered office |
Country of operational headquarte rs (1) |
Activit y (2) |
Relationshi p type (3) |
% Direct investmen t |
% 100% interest (4) |
% Availability of votes at the ordinary shareholder s' meeting (5) |
|---|---|---|---|---|---|---|---|---|
| Associates | ||||||||
| 2 | MedInsure S.r.l Italy | 11 | b | 33 | 33 |
| Name | Relationship type | Carrying amount | Fair value | Dividends received |
|---|---|---|---|---|
| Associates | ||||
| MedInsure S.r.l. | b | 3 | 3 | - |
| Total | 3 | 3 | - |
The mechanism for exercising the above-mentioned call option is representative of practices recognised by the market. At 31 December 2023, this option had a value of zero.
The accounting information and reconciliation of the equity investment valued in these financial statements using the equity method are as follows:

| (in thousands of euro) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Inve stme nts |
Other assets |
Cash and cash equivalent s |
Insurance liabilities |
Financial liabilities |
Total revenue |
Impairment losses/reversals of impairment losses of PP&E and intangible assets |
Loss from continuing operations before tax |
Loss from continuing operations after tax |
Profit (Loss) from discontinu ed operations after tax |
Loss for the year (1) |
Other comprehensi ve income after tax (2) |
Comprehensiv e expense (3) = (1) + (2) |
| B. Associates | |||||||||||||
| MedInsure S.r.l. | - | 211 | X | - | 152 | 30 | X | (143) | (143) | - | (143) | - | (143) |
| Name | Carrying amount of the investment at the beginning |
2023 Comprehensive expense att. to the owners of the |
Dividends received during the |
Carrying amount of the equity investment at the end of the year |
Carrying amount of the equity investment at the beginning of the year (T-1) |
2022 Comprehensive income att. to the owners of the parent (+/-) (T-1) |
Dividends received during the year (-) (T-1) |
Carrying amount of the equity investment at the end of the year (T-1) |
|---|---|---|---|---|---|---|---|---|
| B. Associates | of the year | parent (+/-) |
year (-) | |||||
| MedInsure S.r.l. | - | (143) | - | 3 | - | - | - | - |
(in thousands of euro)

| (in | thousands of |
||||||
|---|---|---|---|---|---|---|---|
| euro) | |||||||
| Carrying amount 2023 | Carrying amount 2022 | ||||||
| Stage 1 | Stage 2 | Stage 3 | Stage 1 | Stage 2 | Stage 3 | ||
| Government securities | - | - | - | - | - | - | |
| Other debt securities | - | - | - | - | - | - | |
| Loans and receivables: | - | - | - | - | - | - | |
| a) from banks | - | - | - | - | - | - | |
| b) from customers | - | - | - | - | - | - | |
| - mortgage loans | - | - | - | - | - | - | |
| - loans on policies | - | - | - | - | - | - | |
| - other loans and receivables | 3,088 | - | - | 4,016 | - | - | |
| Total 2023 | 3,088 | - | - | - | - | - | |
| Total 2022 | 4,016 |
| 2023 | 2022 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Items/Values | Carrying amount |
Comp % |
L1 | L2 | L3 | Total fair value |
Carrying amount |
Comp % |
L1 | L2 | L3 | Total fair value |
| 1) Debt securities | - | - | - | - | - | - | - | - | - | - | - | - |
| Government securities |
- | - | X | X | X | X | - | - | X | X | X | X |
| a) listed | - | - | X | X | X | X | - | - | X | X | X | X |
| b) unlisted | - | - | X | X | X | X | - | - | X | X | X | X |
| Other debt securities |
- | - | X | X | X | X | - | - | X | X | X | X |
| a) listed | - | - | X | X | X | X | - | - | X | X | X | X |
| b) unlisted | - | - | X | X | X | X | - | - | X | X | X | X |
| 2) Loans and receivables |
3,088 | 100% | 3,088 | - | - | 3,088 | 4,016 | 100% | - | - | 4,016 | 4,016 |
| Total | 3,088 | 100% 3,088 | - | - | 3,088 | 4,016 | 100% | - | - | 4,016 | 4,016 |
| Stage 1 | Gross value o/w: Assets with low credit risk |
Stage 2 | Stage 3 |
Stage 1 |
Impairment losses o/w: Assets with low credit risk |
Stage 2 | Stage 3 |
Total 31.12.2023 |
Total 31.12.2022 |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Government securities | - | - | - | - | - | - | - | - | ||
| Other debt securities | - | - | - | - | - | - | - | - | ||
| Loans and receivables: | 3,088 | - | - | - | - | - | 3,088 | 4,016 | ||
| a) with banks | - | - | - | - | - | - | - | - | ||
| b) with customers | 3088 | - | - | - | - | - | 3,088 | 4,016 | ||
| Total 2023 | 3,088 | - | - | - | - | - | 3,088 | |||
| Total 2022 | 4,016 | - | - | - | - | - | - | 4,016 |
This category includes financial assets held to collect contractual cash flows, the terms of which give rise to cash flows on specified dates that are solely payments of principal and interest on the principal amount outstanding.

The amount of €3,088,000 refers to deposits in escrow accounts designed to secure the obligations assumed by the sellers of Elba Assicurazioni S.p.A. shares to pay indemnities other than those of a tax nature as specified in the share purchase agreement signed on 19 July 2021. The amount deposited is expected to be released by 30 December 2026, as per the escrow agreement of 30 November 2021.
The change recorded in the escrow deposits with respect to 31 December 2022, amounting to approximately €1,000, is due to the release that took place in December 2023 in relation to tax guarantees provided for in the purchase agreement.
| (in thousands of |
||||
|---|---|---|---|---|
| euro) | ||||
| 2023 | 2022 | |||
| Carrying amount | Comp % | Carrying amount | Comp % | |
| Equity securities | 556 | 0.2% | 556 | 0.3% |
| a) listed | - | - | - | - |
| b) unlisted | 556 | 0.2% | 556 | 0.3% |
| Debt securities | 217,254 | 99.8% | 181,339 | 99.7% |
| Government securities | 181,548 | 83.4% | 153,997 | 84.7% |
| a) listed | 181,548 | 83.4% | 153,997 | 84.7% |
| b) unlisted | - | - | - | - |
| Other debt securities | 35,706 | 16.4% | 27,342 | 15.0% |
| a) listed | 35,706 | 16.4% | 27,342 | 15.0% |
| b) unlisted | - | - | - | - |
| Other financial instruments | - | - | - | - |
| Total | 217,811 | 100% | 181,895 | 100% |
Financial assets measured at fair value through other comprehensive income totalled €217,811,000 (€181,895,000 at 31 December 2022), showing an increase of €35,916,000, essentially attributable to growth in equity compared with the closing date of the previous year.
This item mainly includes Italian and foreign government bonds, Italian and foreign corporate bonds and other listed fixedincome securities that have passed the SPPI test, amounting to €217,255,000. The bonds in the portfolio are all investment grade securities and therefore all allocated to Stage 1 for the purposes of determining the ECL (expected credit loss); the statement of financial position ECL component relating to these instruments amounts to a total of €149,000.
The item also includes a 9.5% 15 equity investment in Mangrovia Blockchain Solutions S.r.l., acquired in the first half of 2022 and recognised in the financial statements at €556,000. As it is strategic, the Group has decided to designate this investment at fair value through other comprehensive income. Qualitative and quantitative measurements have confirmed the valuation of the equity investment at the amount recognised in the 2022 annual financial statements.
| Stage 1 | Gross value o/w: Assets with low credit risk |
Stage 2 |
Stage 3 | Stage 1 |
Total impairment losses o/w: Assets with low credit risk |
Stage 2 |
Stage 3 | Total 2023 | Total 2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Government securities | 181,697 | - | - | - | -149 | - | - | - | 181,548 | 153,997 | |
| Other debt securities | 35,706 | - | - | - | - | - | - | - | 37,706 | 27,342 | |
| Other financial instruments | 556 | - | - | - | - | - | - | 556 | 556 |
15 The equity investment decreased from 10% on 31 December 2022 to 9.5% as a result of the increase in the company's share capital subscribed by the majority shareholder.

| Total 2023 | 217,96 | -149 | 217,811 | 181,895 |
|---|---|---|---|---|
| Total 2022 | 181,443 | -104 | 181,895 | 181,895 |
| Financial assets measured at fair value through profit or loss | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Listed shares - |
- | - | - |
| Debt securities held for trading - |
- | - | - |
| - Equity investments | - | - | - |
| Total financial assets held for trading | - | - | - |
| - Investment property | - | - | - |
| - Listed debt securities held - regulated markets | - | - | - |
| - Time deposits | - | - | - |
| - Unlisted equity securities measured at fair value | - | - | - |
| Total financial assets measured at fair value | - | - | - |
| - Units of UCIs | 2,775 | 2,620 | 155 |
| Total other financial assets compulsorily measured at fair value | 2,775 | 2,620 | 155 |
| Total | 2,775 | 2,620 | 155 |
At 31 December 2023, the amount of €2,775,000 (€2,620,000 at 31 December 2022) is exclusively attributable to "Financial assets compulsorily measured at fair value", which exclusively comprises mutual fund units held by the Group. There are no "Financial assets designated at fair value" or "Financial assets held for trading" in the portfolio. This item shows a slight increase of €155,000, due exclusively to the recovery in the value of the UCI in the portfolio recorded during the year.
At 31 December 2023, there were no Group financial investment exposures to Russia and Ukraine. The table below shows the product breakdown by type and percentage.

(in thousands of
| euro) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial assets held for trading | Financial assets designated at fair value | Financial assets compulsorily measured at fair value |
||||||||||
| Items/Values | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | ||||||
| Carrying amount |
Comp % |
Carrying amount |
Comp % |
Carrying amount |
Comp % |
Carrying amount |
Comp % |
Carrying amount |
Comp % |
Carrying amount |
Comp % |
|
| Equity securities | - | - | - | - | - | - | ||||||
| a) listed | - | - | - | - | - | - | - | - | - | - | - | - |
| b) unlisted | - | - | - | - | - | - | - | - | - | - | - | - |
| Treasury shares | - | - | - | - | - | - | - | - | - | - | - | - |
| Own financial liabilities | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt securities | - | - | - | - | - | - | - | - | - | - | - | - |
| a) listed | - | - | - | - | - | - | - | - | - | - | - | - |
| b) unlisted | - | - | - | - | - | - | - | - | - | - | - | - |
| Units of UCIs | - | - | - | - | - | - | - | - | 2,775 | 100% | 2,620 | 100% |
| Non-hedging derivatives | - | - | - | - | - | - | - | - | - | - | - | - |
| Hedging derivatives | - | - | - | - | - | - | - | - | - | - | - | - |
| Other financial | - | - | - | - | - | - | - | - | - | - | - | - |
| instruments | ||||||||||||
| Total | - | - | - | - | - | - | - | - | 2,775 | 100% | 2,620 | 100% |

| Other financial assets | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Receivables from agents and brokers | 3,904 | 3,795 | 109 |
| Other receivables | 320 | 40 | 280 |
| Total | 4,224 | 3,835 | 388 |
At 31 December 2023, miscellaneous receivables amounted to €4,224,000 (€3,835,000 at 31 December 2022), representing an increase of €388,000.
Receivables from intermediaries are essentially in line with the amount present at 31 December 2022.
The nature of the receivables, their amount and the collection of a large portion limit the relative credit risk for the Group.
| Other assets | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Non-current assets held for sale or disposal groups | - | - | - |
| Deferred tax assets | 3,046 | 7 | 3,039 |
| Current tax assets | 493 | 5,395 | -4,902 |
| Sundry assets | 16,159 | 13,647 | 2,512 |
| Total | 19,698 | 19,049 | 649 |
Other assets refer to:
| Cash and cash equivalents | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Cash and cash equivalents | 6,402 | 4,652 | 1,750 |
| Total | 6,402 | 4,652 | 1,750 |
Cash and cash equivalents showed a balance of €6,402,000 at 31 December 2023 (€4,652,000 at 31 December 2022). This item consists exclusively of bank current accounts and cash.

Item 1. Equity
| Shareholders' equity | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Share capital | 6,680 | 6,680 | - |
| Other equity instruments | - | - | - |
| Equity-related reserves | 170 | 170 | - |
| Income-related reserves and other reserves | 221,049 | 214.854 | 6,195 |
| (Treasury shares) | -7,803 | -6,556 | |
| Valuation reserves | -5,037 | -10,154 | 5,117 |
| Profit for the year attributable to the owners of the parent | 10,566 | 6,193 | 4,373 |
| Total equity attributable to the owner of the parent | 225,625 | 216,495 | 9,129 |
| Share capital and reserves - non-controlling interests | - | - | - |
| Gains or losses recognised directly in equity | - | - | - |
| Profit (loss) for the year attributable to non-controlling interests | - | - | - |
| Total equity attributable to non-controlling interests | - | - | - |
| Total | 225,625 | 216,495 | 9,129 |
At 31 December 2023, €6,680,000 of the share capital was subscribed and paid up, and it consisted of 24,619,985 ordinary shares and 710,000 special shares convertible to ordinary shares subject to the conditions laid down in Article 5.8 of the Articles of Association.
At 30 June 2023, the Group held 850,700 treasury shares, amounting to €7,803,000 (around 3.46% of the share capital, including only ordinary shares). The Group did not sell any own shares during the year.
The "Valuation reserves" item, amounting to -€5,037,000, includes the costs of -€4,160,000 incurred by REVO for the listing, the adjustment pursuant to IAS 19 of the post-employment benefits of -€13,000 and the adjustment of €1,837,000 arising from the application of IFRS 2 relating to the portion of the fair value of the three-year incentive plan described below, as well as the -€2,701,000 change in financial assets measured at fair value through other comprehensive income and relating to the IFRS 9 adjustments.
| (in thousands of euro) | ||
|---|---|---|
| Items/Types | Ordinary | Other |
| A. Existing shares at the beginning of the year | 24,619,985 | - |
| - fully paid up | 24,619,985 | - |
| - not fully paid up | - | - |
| A.1 Treasury shares (-) | -140,953 | - |
| A.2 Shares outstanding: opening balances | 24,479,032 | 710,000 |
| Changes in opening balances | - | - |
| B. Increases | - | - |
| B.1 New issues | - | - |
| - payment | - | - |
| - business combinations | - | - |
| - conversion of bonds | - | - |
| - warrant exercise | - | - |
| - other | - | - |
| - bonus | - | - |
| - to employees | - | - |
| - to directors | - | - |
| - other | - | - |
| B.2 Sale of treasury shares | - | - |
| B.3 Other changes | - | - |
| Business combinations - external | - | - |
| Business combinations - internal | - | - |
| Business combinations - mergers | - | - |
| - Other FKDQJHV | - | - |
| )RUHLJQH[FKDQJHGLIIHUHQFHLQSXW | - | - |
|---|---|---|
| \$XWRPDWLFIRUHLJQH[FKDQJHGLIIHUHQFHV | - | - |
| &KDQJHLQVFRSHRIFRQVROLGDWLRQ | - | - |
| &KDQJHLQPHWKRGDQGRIFRQVROLGDWLRQ | - | - |
| C. Decreases | -709,747 | - |
| C.1 Cancellation | - | - |
| C.2 Repurchase of treasury shares | -709,747 | - |
| C.3 Business disposal transactions | - | - |
| C.4 Other changes | - | - |
| Business combinations - external | - | - |
| Business combinations - internal | - | - |
| - Other changes (-) | - | - |
| Foreign exchange difference input (-) | - | - |
| Automatic foreign exchange differences (-) | - | - |
| Change in scope of consolidation (-) | - | - |
| Change in method and % of consolidation (-) | - | - |
| D. Outstanding shares: closing balances | 23,769,285 | 710,000 |
| D.1 Treasury VKDUHV | 850,700 | - |
| D.2 Shares existing at the end of the year | 24,619,985 | 710,000 |
| - fully paid up | 24,619,985 | 710,000 |
| - not fully paid up |
In the first half of 2022, the Company announced a plan to allot bonus ordinary shares, named the "2022-2024 Performance Share Plan" (the "Plan"), reserved for the Chief Executive Officer and employees of the Company who perform significant roles or functions and for which an action is justified that will strengthen their loyalty with a view to creating value.
The Plan was approved by the Company's Shareholders' Meeting of 4 April 2022.
The allotment of shares is subject to verification by the Board of Directors, for the year ending 31 December 2024, of a consolidated Solvency II Ratio higher than 130%, while the number of shares to which each beneficiary is entitled will depend on the number of rights allotted to each beneficiary, the level of performance targets achieved by the Company as defined in the Plan rules and the weighting attributed to individual targets.
Beneficiaries will be required to hold 50% of the shares received in each tranche for at least one year from the allotment date.
The following table sets out the reconciliation of equity:
| Share capital and reserves |
Profit for for the year |
Equity | |
|---|---|---|---|
| Balances of REVO Parent Company – Local GAAP | 211,144 | 5,830 | 216,974 |
| IFRS Parent Company adjustment | - | - | - |
| - 2021 IFRS adjustment | 52 | - | 52 |
| - Treasury shares | -7,803 | - | -7,803 |
| - OCI reserve | -3,861 | - | -3,861 |
| - Local supplementary reversal | 3,249 | 1,862 | 3,249 |
| - Valuation of securities portfolio under IFRS 9 | 6,138 | -2,189 | 6,138 |
| - Retained earnings reserve | 221 | - | 221 |
| - Amortisation of value of acquisition of Elba Ass. portfolio (formerly VoBA) | -6,491 | -2,583 | -6,491 |
| - Valuation of post-employment benefits | -127 | 23 | -127 |
| - Valuation of agency severance indemnity | 678 | -164 | 678 |
| - Property under IFRS 16 | -1,971 | -1,587 | -1,971 |
| - LTI | - | -1,659 | - |
| - Write-off of improvements to third-party assets | 185 | 95 | 185 |
| - Reclassification of Mangrovia impairment loss | - | - | - |
| - IFRS 17 valuations - LIC and AIC discounting | 1,973 | 731 | 1,973 |
| - IFRS 17 valuations - RA | -2,169 | -729 | -2,169 |
| - Reversal of amortisation of calculated intangible value (CIV) of goodwill | 17,808 | 8,904 | 17,808 |

| - Tax effects related to the above consolidation adjustments | 670 | 1,911 | 670 |
|---|---|---|---|
| Balances of Parent Company – IFRS | 219,696 | 10,445 | 225,526 |
| Elimination of carrying amount of consolidated equity investments: | - | - | - |
| - Local GAAP results achieved by investee REVO Underwriting | 99 | 120 | 99 |
| Equity and profit attributable to the owners of the parent | 219,795 | 10,565 | 225,625 |
| Equity and profit attributable to non-controlling interests | - | - | - |
| Equity and profit as per the consolidated financial statements | 219,795 | 10,565 | 225,625 |
Basic earnings per share was calculated by dividing the net profit attributable to the owners of the parent by the weighted average number of ordinary shares outstanding during the period.
| (amounts in euro) | 31.12.2023 |
|---|---|
| Profit for the year | 10,565,625 |
| Weighted average no. of shares | 24,619,985 |
| Average earnings per share | 0.42 |
Diluted earnings per share reflects any dilutive effect of potential ordinary shares.
| (amounts in euro) | 31.12.2023 |
|---|---|
| Profit for the year | 10,565,625 |
| Weighted average no. of shares 16 | 29,305,985 |
| Diluted earnings per share | 0.36 |
No dividends were distributed during 2023.
| Provisions for risks and charges | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Provisions for risks and charges | 2,987 | 3,243 | -256 |
| Total | 2,987 | 3,243 | -256 |
At 31 December 2023, this item includes provisions for future risks amounting to €2,987,000 (€3,243,000 at 31 December 2022) that refer, in accordance with IAS 37, to all future risks arising from potential terminations of agency relationships existing at 31 December 2023 (the "TFM provision", amounting to €2,856,000 at 31 December 2022). It should be noted that in 2023, the allocation of €200,000 recognised at 31 December 2022 was fully utilised following the settlement of a non-insurance dispute, and that with regard to the payment order relating to a counterfeit surety policy, it was decided to release the allocated amount of €120,000, following the expert report ordered by the judge, who accepted the argument that the signatures on the surety policy were not authentic.
The agents' end-of-service provision benefited from the review of mandate agreements with the new agencies, which began in 2022, in order to determine and maintain provisions in the financial statements for the part within the Company's remit not covered by an appropriate indemnity, and was affected by the utilisation of €31,000 to pay some agencies that reached the end of their mandates.
16 The weighted average number of outstanding shares is calculated by adding to the weighted average of outstanding ordinary shares the number of ordinary shares in the event of conversion of special shares at the established conversion rate.

| Insurance liabilities | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Insurance contracts written classified as liabilities | 156,330 | 101,365 | -54,965 |
| Cessions to reinsurance classified as liabilities | - | - | - |
| Total | 156,330 | 101,365 | -54,965 |
Liabilities relating to insurance contracts classified as liabilities, measured according to the simplified PAA method, are detailed below:
| Insurance contracts classified as liabilities | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Liability for remaining coverage | 133,125 | 107,344 |
| - o/w non-distinct investment component | 53 | 34 |
| Loss component | - | - |
| Net flows attributable to the value paid for the acquisition of Elba Assicurazioni (ex. VoBA) | -6,463 | -9,046 |
| Total LRC | 126,662 | 98,298 |
| Liability for incurred claims (PVFCF) | 83,552 | 35,551 |
| Risk adjustment | 4,348 | 2,455 |
| Total LIC | 87,900 | 38,006 |
| Receivables from policyholders | -41,062 | -36,545 |
| Amounts to be recovered | -25,033 | -5,319 |
| Commissions for premiums in the process of collection | 7,863 | 6,925 |
| Total | 156,330 | 101,365 |
The liability for remaining coverage includes the value of business acquired which, following the business combination in November 2022, was allocated to reduce future risk liabilities by €6,463,000 at 31 December 2023.
The liability for incurred claims includes the present value of future cash flows (PVFCF) of €83,552,000 and the risk adjustment for non-insurance risks of €4,348,000 (5.2% of the value of PVFCF).
| Liability for remaining coverage 2023 |
Liability for remaining Liabilities for claims Liabilities for claims incurred 2023 coverage 2022 incurred 2022 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Items/Liabilities | Net of loss | Loss | Present value of cash flows |
Adjustment for non-financial risks |
Total 2023 | Net of loss |
Loss | Present value of cash flows |
Adjustment for non-financial risks |
Total 2022 |
| A. Initial carrying amount | ||||||||||
| 1. Ins. contracts written that are classified as liabilities |
68,676 | - | 30,233 | 2,455 | 101,364 | - | - | - | - | - |
| 2. Ins. contracts written that are classified as assets | - | - | - | - | - | - | - | - | - | - |
| 3. Net carrying amount as at 1 January | 68,676 | - | 30,233 | 2,455 | 101,364 | 55,261 | - | 22,782 | 2,333 | 80,375 |
| B. Insurance revenues | -148,949 | - | -148,949 | -68,732 | - | -68,732 | ||||
| C. Costs of insurance services | ||||||||||
| 1. Incurred claims and other directly att. costs | - | - | 94,210 | - | 94,210 | - | 28,437 | 28,437 | ||
| 2. Change in liability for incurred claims | - | - | 22,574 | 1,893 | 24,467 | - | 11,374 | 122 | 11,496 | |
| 3. Losses and related recoveries on onerous | - | - | - | |||||||
| contracts | ||||||||||
| 4. Amortisation of contract acquisition costs | - | - | - | |||||||
| 5. Total | - | - | 116,784 | 1,893 | 118,677 | - | 39,811 | 122 | 39,933 | |
| '5HVXOWRILQVXUDQFHVHUYLFHV%& | -148,949 | - | 116,784 | 1,893 | -30.272 | -68,732 | - | 39,811 | 122 | -28,799 |
| E. Net financial income/expense | - | - | - | |||||||
| 1. Relating to insurance contracts written | - | - | 393 | - | 393 | - | - | -2,311 | - | -2,311 |
| 1.1 Recognised in profit or loss | - | - | 393 | - | 393 | - | - | -2,311 | - | -2,311 |
| 1.2 Recognised in other comprehensive income | - | - | - | - | - | - | - | - | - | - |
| 2. Effects related to exchange rate fluctuations | - | - | - | - | - | - | - | - | - | - |
| 3. Total | - | - | 393 | 393 | - | -2,311 | -2,311 | |||
| F. Investment components | - | - | - | |||||||
| G. Total amount recognised in profit or loss and RWKHUFRPSUHKHQVLYHLQFRPH'() |
-148,949 | - | 117,178 | 1,893 | -29,878 | -68,732 | - | 37,500 | 122 | -31,110 |
| H. Other changes | - | - | - | - | - | -9 | - | - | - | - |
| I. Cash movements | - | - | - | - | - | - | - | |||
| 1. Premiums received | 209,138 | - | - | - | 209,138 | 102,559 | - | - | - | 102,559 |
| 2. Payment related to acquisition costs of contracts | -35,401 | - | - | - | -35,401 | -20,403 | - | - | - | -20,403 |
| 3. Claims paid and other cash outflows | - | -88,894 | - | -88,894 | - | -35,396 | - | -35,396 | ||
| 4. Total | 173,737 | - | -88,894 | - | 82,989 | 82,156 | - | -35,396 | - | 46,759 |
| L. Net carrying amount at 31 December \$*+, |
93,464 | - | 58,518 | 4,348 | 156,330 | 68,676 | - | 30,233 | 2,455 | 101,364 |
| M. Final carrying amount | - | |||||||||
| 1. Ins. contracts written that are classified as liabilities |
93,464 | - | 58,518 | 4,348 | 156,330 | 68,676 | - | 30,233 | 2,455 | 101,364 |
| 2. Ins. contracts written that are classified as assets | - | - | - | - | - | |||||
| 3. Net carrying amount at 31 December | 93,464 | - | 58,518 | 4,348 | 156,330 | 68,676 | - | 30,233 | 2,455 | 101,364 |

| (in thousands of euro) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Claims/Time bands | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | Total |
| A. Cumulative claims paid and other directly attributable | |||||||||||
| costs paid | |||||||||||
| 1 At the end of the year of occurrence | -4,346 | -6,194 | -8,021 | -7,290 | -7,426 | -8,905 | -6,528 | -6,945 | -7,123 | -28,170 | x |
| 2. One year later | -7,608 | -9,817 | -14,660 | -9,928 | -10,035 | -19,066 | -9,545 | -8,521 | -41,503 | x | x |
| 3. Two years later | -8,313 | -10,426 | -14,984 | -10,521 | -10,311 | -19,689 | -10,353 | -10,006 | x | x | x |
| 4. Three years later | -8,483 | -10,588 | -15,693 | -10,769 | -11,683 | -20,542 | -10,624 | x | x | x | x |
| 5. Four years later | -8,731 | -10,913 | -15,874 | -11,043 | -13,875 | -20,667 | x | x | x | x | x |
| 6. Five years later | -8,184 | -11,858 | -16,073 | -12,354 | -14,007 | x | x | x | x | x | x |
| 7. Six years later | -9,300 | -12,078 | -16,122 | -12,677 | x | x | x | x | x | x | x |
| 8. Seven years later | -9,494 | -13,005 | -16,370 | x | x | x | x | x | x | x | x |
| 9. Eight years later | -9,812 | -13,078 | x | x | x | x | x | x | x | x | x |
| 10. Nine years later | -9,852 | x | x | x | x | x | x | x | x | x | x |
| Total cumulative claims paid and other directly att. costs paid (Tot. A) |
-85,123 | -97,957 | -117,797 | -74,582 | -67,337 | -88,869 | -37,050 | -25,472 | -48,626 | -28,170 | -670,983 |
| B. Estimated final cost of cumulative claims (amount gross | |||||||||||
| of cessions to reinsurance and not discounted) | |||||||||||
| 1 At the end of the year of occurrence | -4,737 | -5,597 | -8,612 | -6,612 | -7,057 | -14,339 | -7,063 | -8,876 | -12,024 | -5,804 | x |
| 2. One year later | -2,013 | -2,074 | -4,283 | -3,720 | -2,932 | -4,837 | -4,092 | -8,092 | -11,110 | x | x |
| 3. Two years later | -1,703 | -1,930 | -4,130 | -2,935 | -2,103 | -3,071 | -4,161 | -7,527 | x | x | x |
| 4. Three years later | -1,199 | -1,662 | -3,261 | -2,675 | -1,952 | -3,376 | -4,650 | x | x | x | x |
| 5. Four years later | -841 | -1,988 | -3,091 | -1,870 | -2,071 | -3,481 | x | x | x | x | x |
| 6. Five years later | -390 | -1,252 | -2,316 | -1,345 | -2,147 | x | x | x | x | x | x |
| 7. Six years later | -331 | -2,469 | -2,307 | -1,386 | x | x | x | x | x | x | x |
| 8. Seven years later | -356 | -1,695 | -1,910 | x | x | x | x | x | x | x | x |
| 9. Eight years later | -288 | -1,740 | x | x | x | x | x | x | x | x | x |
| 10. Nine years later | -297 | x | x | x | x | x | x | x | x | x | x |
| Estimated final cost of gross cumulative claims not discounted at the reporting date (Total B) |
-12,155 | -20,407 | -29,910 | -20,543 | -18,262 | -29,104 | -19,966 | -24,495 | -23,134 | -54,804 | 252,780 |
| C. Liabilities for undiscounted gross claims incurred - year of occurrence from T to T-9 (Total B – Total A) |
72,968 | 77,550 | 87,887 | 54,039 | 49,075 | 59,765 | 17,084 | 977 | 25,492 | -26,634 | 418,203 |
| D. Liabilities for undiscounted gross claims incurred - years prior to T-9 |
x | x | x | x | x | x | x | x | x | x | 440 |
| E. Discounting effect | x | x | x | x | x | x | x | x | x | x | -5,940 |
| F. Effect of adjustment for non-financial risks | x | x | x | x | x | x | x | x | x | x | -4,348 |
| G. Liabilities for claims incurred gross of insurance contracts written |
x | x | x | x | x | x | x | x | x | x | -62,866 |

| (in thousands of euro) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Claims/Time bands | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | Total |
| A. Cumulative claims paid and other directly att. costs paid | |||||||||||
| 1 At the end of the year of occurrence | -2,203 | -3,105 | -4,014 | -3,664 | -3,813 | -4,223 | -3,282 | -3,528 | -4,806 | -24,914 | x |
| 2. One year later | -3,860 | -4,944 | -7,457 | -5,037 | -5,054 | -8,487 | -4,886 | -4,464 | -34,022 | x | x |
| 3. Two years later | -4,248 | -5,284 | -7,642 | -5,350 | -5,218 | -8,873 | -5,308 | -29,096 | x | x | x |
| 4. Three years later | -4,343 | -5,379 | -8,020 | -5,480 | -5,922 | -9,300 | -5,526 | x | x | x | x |
| 5. Four years later | -4,473 | -5,564 | -8,115 | -5,623 | -7,029 | 10,224 | x | x | x | x | x |
| 6. Five years later | -4,702 | -6,062 | -8,249 | -6,281 | -7,113 | x | x | x | x | x | x |
| 7. Six years later | -4,764 | -6,196 | -8,275 | -6,568 | x | x | x | x | x | x | x |
| 8. Seven years later | -4,865 | -6,674 | -8,499 | x | x | x | x | x | x | x | x |
| 9. Eight years later | -5,032 | -6,727 | x | x | x | x | x | x | x | x | x |
| 10. Nine years later | -5,070 | x | x | x | x | x | x | x | x | x | x |
| Total cumulative claims paid and other directly att. costs paid (Total A) | -43,559 | -49,933 | -60,271 | -38,003 | -34,149 | -20,659 | -19,003 | -37,088 | -38,828 | -24,912 | -366,407 |
| B. Estimated final cost of cumulative claims (amount gross of cessions to | |||||||||||
| reinsurance and not discounted) | |||||||||||
| 1 At the end of the year of occurrence | -2,466 | -2,921 | -4.510 | -3,405 | -3,390 | -6,450 | -3,830 | -5,208 | -7,303 | -23,369 | x |
| 2. One year later | -1,174 | -1,153 | -2,464 | -1,958 | -1,546 | -2,562 | -2,253 | -4,722 | -7,327 | x | x |
| 3. Two years later | -1,081 | -1,080 | -2,347 | -1,527 | -1,142 | -1,569 | -2,483 | -4,384 | x | x | x |
| 4. Three years later | -779 | -888 | -1,863 | -1,419 | -1,043 | -1,734 | -2,811 | x | x | x | x |
| 5. Four years later | -466 | -1,037 | -1,797 | -1,015 | -1,135 | -1,730 | x | x | x | x | x |
| 6. Five years later | -221 | -669 | -1,394 | -768 | -1,198 | x | x | x | x | x | x |
| 7. Six years later | -174 | -1,122 | -1,391 | -816 | x | x | x | x | x | x | x |
| 8. Seven years later | -191 | -762 | -1,131 | x | x | x | x | x | x | x | x |
| 9. Eight years later | -167 | -810 | x | x | x | x | x | x | x | x | x |
| 10. Nine years later | -176 | x | x | x | x | x | x | x | x | x | x |
| Estimated final cost of gross cumulative claims not discounted at the | -6,895 | -10,442 | -16,898 | -10,910 | -9,454 | -14,046 | -11,377 | -14,314 | -14,629 | -23,369 | -132,335 |
| reporting date (Total B) | |||||||||||
| C. Liabilities for undiscounted gross claims incurred - year of occurrence from T to T-9 (Total B – Total A) |
36,664 | 39,491 | 43,374 | 27,093 | 24,695 | 6,612 | 7,626 | 22,773 | 24,199 | 1,544 | 234,072 |
| D. Liabilities for undiscounted net claims - years prior to T-9 | x | x | x | x | x | x | x | x | x | x | -267 |
| E. Discounting effect | x | x | x | x | x | x | x | x | x | x | -3,154 |
| F. Effect of adjustment for non-financial risks | x | x | x | x | x | x | x | x | x | x | -2,156 |
| G. Liabilities for claims incurred net of insurance contracts written | x | x | x | x | x | x | x | x | x | x | -19,318 |

| Financial liabilities | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Financial liabilities measured at fair value through profit or | - | - | - |
| loss | |||
| Financial liabilities held for trading | - | - | - |
| Financial liabilities designated at fair value | - | - | - |
| Financial liabilities measured at amortised cost | 14,503 | 14,448 | 55 |
| Total | 14,433 | 14,448 | 55 |
At 31 December 2023, financial liabilities amounted to €14,503,000. This item includes, exclusively, lease liabilities pursuant to IFRS 16, and includes liabilities relating to the rental of:
The amount also includes lease liabilities for company cars amounting to €239,000.
The table below shows the breakdown by type, percentage composition and fair value hierarchy.

| (in thousands of euro) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | |||||||||||
| Items/Values | Carrying amount |
Comp % |
L1 | L2 | L3 | Total fair value |
Carrying amount |
Comp % | L1 | L2 | L3 | Total fair value |
| Participating financial instruments |
||||||||||||
| Subordinated liabilities | ||||||||||||
| Debt securities issued | ||||||||||||
| Other loans obtained | 14,503 | 100% | 14,448 | 100% | ||||||||
| - from banks | x | x | x | x | x | x | x | x | ||||
| - from customers |
14,503 | 100% | x | x | x | x | 14,448 | 100% | x | x | x | x |
| Total | 14,503 | 100% | 14,448 | 100% |

| Payables | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Trade payables | 3,719 | 4,694 | -975 |
| Invoices to be received | 304 | 3,413 | -3,109 |
| Miscellaneous payables | 9,987 | 9,457 | 530 |
| Post-employment benefits | 750 | 602 | 148 |
| Total | 14,760 | 18,166 | -3,406 |
Trade payables include invoices not yet paid at year end.
Invoices to be received show a substantial decrease, mainly due to contracts entered into for activities carried out in 2022, for which an invoice had not yet been received.
Miscellaneous payables include, inter alia:
| Other liabilities | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Liabilities of disposal groups | - | - | - |
| Deferred tax liabilities | - | 275 | -275 |
| Current tax liabilities | 2,012 | - | 2,012 |
| Sundry liabilities | 8,896 | 5,395 | 3,501 |
| Total | 10,908 | 5,670 | 5,238 |
Current tax liabilities, amounting to €2,012,000 (zero at December 2022), include €1,963,000 relating to Parent Company corporation tax payable for 2023, not present at 31 December 2022, and €49,000 in current taxes on the result of subsidiary REVO Underwriting.
Sundry liabilities amounted to €8,896,000 and refer to:

| Insurance revenues deriving from insurance contracts written | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| LFRC release | 148,949 | 68,732 | 80,217 |
| Total | 148,949 | 68,732 | 80,217 |
The following table provides a breakdown of insurance revenues deriving from insurance contracts written:
| Items | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Gross premiums written | 216,241 | 131,388 |
| LRC release for the period | 179,955 | 91,087 |
| LRC change due to premiums for the period | -213,602 | -133,472 |
| Earned premiums | 182,595 | 89,003 |
| Depreciation of value of acquired portfolio (ex. VoBA) | -2,583 | -3,909 |
| Non-distinct investment component | -275. | -63 |
| Earned premiums net of the value of the acquired portfolio (ex. VoBA) and investment component | 179,737 | 85,031 |
| Commissions | -38,673 | -25,827 |
| LRC release - part for commissions | -39,842 | -29,072 |
| Change in LRC due to commissions for the period | 47,727 | 38,601 |
| Commissions for the period | -30,788 | -16,298 |
| Insurance revenue deriving from insurance contracts written | 148,949 | 68,732 |
The item "Insurance revenues deriving from insurance contracts written" amounted to €148,949,000, comprising €179,737,000 in gross premiums earned (€85,031,000 at 31 December 2022) and €30,788,000 in commissions for the period (€16,298,000 at 31 December 2022).
7KHUHZDVDVLJQLILFDQWLQFUHDVHLQJURVVSUHPLXPVHDUQHGFRPSDUHGZLWK'HFHPEHUGXHWR
'XULQJWKHSHULRGWKHUHZDVDQLQFUHDVHQRWRQO\LQ6XUHW\VKLSFRPSDUHGZLWKZKLFKUHPDLQHGWKHPDLQ business class, but also a significant increase in the other portfolios, which more than doubled their premium volumes, mainly due to the impetus provided by the expansion of the product range and the distribution network.
At the end of the year, the insurance portfolio was more diversified, with the Suretyship class representing 39.4% of total earned premiums (55.7% at 31 December 2022), due to greater exposure to the other portfolios, the percentage of which increased from 44.3% at 31 December 2022 to 60.6% at 31 December 2023.
For further comments on business performance in 2023, please see the relevant section of the Report on Operations.
| Costs of insurance services deriving from insurance contracts written | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Costs of insurance services deriving from insurance contracts written | 118,678 | 45,252 | 73,426 |
| Total | 118,678 | 45,252 | 73,426 |
The following table provides a breakdown of costs of insurance services deriving from insurance contracts written:
| Items | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Amounts paid | 67,288 | 15,985 |
| Change in LIC - PVFCF | 47,607 | 11,376 |

| Change in risk adjustment | 1,893 | 122 |
|---|---|---|
| Loss component | - | - |
| Non-distinct investment component | -256 | -29 |
| Amounts recovered | -16,858 | -5,915 |
| Amounts to be recovered | -19,714 | -1,615 |
| Insurance costs excluding operating expenses and other technical expenses | 79,962 | 19,925 |
| Expenses directly attributable to insurance contracts | 34,593 | 24,231 |
| Balance of other technical expenses/income | 4,123 | 1,096 |
| Insurance costs deriving from insurance contracts written | 118,677 | 45,252 |
Costs of insurance services increased by a total of €73,426,000.
The overall performance of claims-related expenses at 31 December, measured in terms of loss ratio was, although increasing, appropriate in view of the development and diversification of other lines of production, standing at 42.0% 17, compared with 20.3% in 2022.
In absolute terms, the costs of insurance services provided by insurance contracts written increased, mainly due to the effect of the Property portfolio (€26,164,000), the MAT Specialty lines portfolio which although negligible in 2022, recorded an increase of €24,760,000 caused by the reporting of six large claims for a claims-related expense net of reinsurance of approximately €2,790,000, and the Agro portfolio, which recorded an increase of €12,751,000, linked both to the development of the business underwritten and to the weather events that occurred during 2023, causing substantial damage to crops.
The technical performance of the Suretyship portfolio was, once again, particularly profitable, with an increase of €375,000 in insurance costs compared with 2022 and a ratio of claims for the year to insurance revenue net of reinsurance unchanged compared with 2022 at 12.5%.
With regard to the largest claims 18, the following should be noted:
The claims provision was strengthened by setting aside a higher IBNR, net of reinsurance, of €2,916,000, and €1,628,000 net of reinsurance, the result of a normal increase in overall business.
17 The loss ratio is obtained by comparing claims from direct and indirect business with insurance revenue before commissions and the value of the portfolio acquired (ex. VoBA).
18 With an impact net of reinsurance of more than €200,000.

| (in thousands of euro) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Items/Bases of aggregation | Base A1 2023 |
Basis A2 2023 |
Basis A5 2023 |
Total 2023 |
BASE A1 2022 |
BASIS A2 2022 |
BASIS A5 2022 |
Total 2022 |
| A. Ins. revenues der. from ins. con. written measured on the basis of the GMM and the VFA |
- | - | - | - | - | - | - | - |
| A.1 Amounts related to changes in assets for remaining coverage | - | - | - | - | - | - | - | - |
| 1. Incurred claims and other expected costs for ins. services | - | - | - | - | - | - | - | - |
| 2. Changes in the adjustment for non-financial risks | - | - | - | - | - | - | - | - |
| 3. Contractual service margin recorded in profit or loss for services provided | - | - | - | - | - | - | - | - |
| 4. Other amounts | - | - | - | - | - | - | - | - |
| A.2 Acquisition costs of ins. con. recovered | - | - | - | - | - | - | - | - |
| A.3 Total insurance revenues deriving from insurance contracts written measured on the basis of the GMM or VFA |
- | - | - | - | - | - | - | - |
| A.4 Total insurance revenue deriving from insurance contracts written measured on the basis of the PAA |
- | - | - | 148,949 | - | - | 68,666 | |
| - Life segment |
X | X | X | X | X | X | ||
| 19 - Non-Life segment – Motor |
X | X | X | 856 | X | X | X | |
| - Non-Life segment – Non-Motor |
X | X | X | 148,093 | X | X | X | 68,666 |
| A.5 Total insurance revenues deriving from insurance contracts written | - | - | - | 148,949 | - | - | - | 68,666 |
| B. Costs of insurance services deriving from insurance contracts written – GMM or VFA |
- | - | - | - | - | - | - | - |
| 1. Incurred claims and other directly attributable costs | - | - | - | - | - | - | - | - |
| 2. Change in liability for incurred claims | - | - | - | - | - | - | - | - |
| 3. Losses on onerous contracts and recovery of such losses | - | - | - | - | - | - | - | - |
| 4. Amortisation of the acquisition expenses of ins. contracts | - | - | - | - | - | - | - | - |
| 5. Other amounts | - | - | - | - | - | - | - | - |
| B.6 Total costs of insurance services deriving from insurance contracts written – GMM or VFA |
- | - | - | - | - | - | - | - |
| B.7 Total costs of insurance services deriving from insurance contracts written measured on the basis of the PAA |
- | - | - | -118,678 | - | - | - | -45,252 |
| - Life segment |
X | X | X | X | X | X | ||
| - Non-Life segment – Motor | X | X | X | -1,003 | X | X | X | |
| - Non-Life segment – Non-Motor |
X | X | X | -117,675 | X | X | X | -45,252 |
| C. Total net costs/revenue deriving from insurance contracts written \$%% |
30,271 | 23,414 |
19 In the non-life segment, only the Land Vehicles LOB is included.

| Insurance revenue from cessions to reinsurance | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Insurance revenue from cessions to reinsurance | 69,749 | 24,211 | 45,538 |
| Total | 69,749 | 24,211 | 45,538 |
The following table provides a breakdown of the item for 2023 compared with 2022:
| Insurance revenues from cessions to reinsurance | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Amounts paid ceded net of recoveries | 11,611 | 3,286 |
| Amounts recovered | 1,324 | -807 |
| Change in AIC | 28,553 | 3,570 |
| Change in risk adjustment | 1,165 | -25 |
| Reinsurers' share of commissions payable | 39,075 | 26,197 |
| Non-distinct investment component | -11,980 | -8,011 |
| Total | 69,749 | 24,211 |
| Costs of insurance services deriving from cessions to reinsurance | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Costs of insurance services deriving from cessions to reinsurance | 81,087 | 33,967 | 47,120 |
| Total | 81,087 | 33,967 | 47,120 |
The following table provides a breakdown of the item for 2023 compared with 2022:
| Insurance costs from cessions to reinsurance | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Premiums ceded to reinsurance | 99,954 | 53,823 |
| ARC release | 40,883 | 7,150 |
| Change in ARC reserve for the year | -48,315 | -17,805 |
| Change in non-distinct investment component | -13,588 | -10,099 |
| Other technical income/expenses ceded | 2,153 | 898 |
| Total | 81,087 | 33,967 |
Costs of insurance services from cessions to reinsurance, which amounted to €81,087,000 (€33,967,000 for 2022) increased due to new business and the new proportional, non-proportional and optional treaties entered into, primarily from the second half of 2022 and in 2023.

| (in thousands of euro) | ||||||
|---|---|---|---|---|---|---|
| Items/Bases of aggregation | Basis of aggregation 1 2023 |
Basis of aggregation 2 2023 |
Total 2023 | Basis of aggregation 1 2022 |
Basis of aggregation 2 2022 |
Total 2022 |
| A. Allocation of premiums paid relating to cessions to reinsurance measured on the basis of the GMM |
- | - | - | - | - | - |
| A.1 Amounts related to changes in assets for remaining coverage | - | - | - | - | - | - |
| 1. Amount of claims and other recoverable costs expected | - | - | - | - | - | - |
| 2. Change in the adjustment for non-financial risks | - | - | - | - | - | - |
| 3. Margin on contract services registered in P&L for services | - | - | - | - | - | - |
| received | ||||||
| 4. Other amounts | - | -663 | -663 | - | -454 | -454 |
| 5. Total | - | -663 | -663 | - | -454 | -454 |
| A.2 Other costs directly attributable to cess. to reins. | - | - | - | - | - | - |
| A.3 Allocation of premiums paid relating to cess. to reins. measured on the basis of the PAA |
- | -80,424 | -80,424 | - | -33,513 | -33,513 |
| %7RWDOFRVWVGHULYLQJIURPFHVVLRQVWRUHLQVXUDQFH\$\$\$ | - | -81,087 | -81,087 | - | -33,967 | -33,967 |
| C. Effects of the change in the risk of default by reins. | - | - | - | - | - | - |
| D. Amount of claims and other expenses recovered | - | 12,935 | 12,935 | - | 2,480 | 2,480 |
| E. Changes in the ass. for incurred claims | - | 29,718 | 29,718 | - | 3,545 | 3,545 |
| F. Other recoveries | - | 27,095 | 27,095 | - | 18,186 | 18,186 |
| G. Total net costs/revenue deriving from cessions to reinsurance %&'() |
- | -11,338 | -11,338 | - | -9,756 | -9,756 |

| (in thousands of euro) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aggregation costs/bases | Basis A1 - with DPF 2023 |
Basis A2 - without DPF 2023 |
Basis A1 + Basis A2 2023 |
Basis A3 2023 |
Basis A4 2023 |
Basis A3 + Basis A4 2023 |
Other 2023 |
Basis A1 - with DPF 2022 |
Basis A2 - without DPF 2022 |
Basis A1 + Basis A2 2022 |
Basis A3 2022 |
Basis A4 2022 |
Basis A3 + Basis A4 2022 |
Other 2022 |
| Costs attributed to acquisition of insurance contracts |
- | - | - | - | - | - | X | - | - | - | - | - | - | X |
| Other directly attributable costs | - | - | - | - | -2 | -2 | X | - | - | - | - | - | - | X |
| Investment management expenses | X | X | - | X | X | - | -95 | X | X | - | X | X | - | -201 |
| Other costs | X | X | - | X | X | -34,591 | -6,810 | X | X | - | X | X | -24,231 | -8,717 |
| Total | - | - | - | X | X | -34,593 | -6,905 | - | - | - | X | X | -24,231 | -8,918 |
Item 6. Net fair value gains (losses) on financial instruments measured at fair value through profit or loss
| Net fair value gains (losses) on financial instruments measured at fair value through profit or loss |
31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Net fair value gains (losses) on financial instruments measured at fair value through profit or loss |
178 | -172 | 350 |
| Total | 178 | -172 | 350 |
Net fair value gains on financial instruments measured at fair value through profit or loss amount to €178,000 due to unrealised gains on instruments in the Group's portfolio (€155,000) and capital gains on disposals (€23,000).
The Group holds an equity investment in the associate, MedInsure S.r.l., acquired in December 2023. No gains or losses were recognised on this investment at 31 December 2023.
| Income deriving from other financial instruments and investment property | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Interest income net of discounts | 4,140 | 2,097 | 2,043 |
| Interest expenses | -520 | -198 | -322 |
| Other income and expenses | - | - | - |
| Realised gains and losses | -471 | 66 | -537 |
| Unrealised gains and losses | -76 | -38 | -38 |
| Total | 3,073 | 1,927 | 1,146 |
The item "Income deriving from other financial instruments and investment property" amounts to €3,073,000 and comprises interest income totalling €4,140,000, interest expense of €520,000 (including €434,000 in interest linked to leases on buildings, €16,000 to leases on company cars and €70,000 in interest expense on loans), realised losses of €471,000 and unrealised losses of €76,000.
The following tables show the breakdown of economic and financial items.
| (in thousands of euro) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Impairment losses o/w: Assets |
Impairment gains o/w: Assets |
|||||||||
| Stage 1 | with low credit risk |
Stage 2 | Stage 3 | Stage 1 | with low credit risk |
Stage 2 | Stage 3 | |||
| Government securities | -82 | - | - | - | - | - | - | - | ||
| Other debt securities | - | - | - | - | 6 | - | - | - | ||
| Loans and receivables: | - | - | - | - | - | - | - | - | ||
| - with banks | - | - | - | - | - | - | - | - | ||
| - with customers | - | - | - | - | - | - | - | - | ||
| Total 2023 | -82 | - | - | - | 6 | - | - | - | ||
| Government securities | -38 | - | - | - | - | - | - | - | ||
| Other debt securities | - | - | - | - | - | - | - | - | ||
| Loans and receivables: | - | - | - | - | - | - | - | - | ||
| - with banks | - | - | - | - | - | - | - | - | ||
| - with customers | - | - | - | - | - | - | - | - | ||
| Total 2022 | -38 | - | - | - | - | - | - | - |

The following table shows the breakdown of financial expenses and income relating to the discounting of direct and indirect insurance cash flows.
| (in thousands of euro) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Items/Bases of aggregation | Base A1 2023 |
Basis A2 2023 |
Basis A3 2023 |
Total 2023 |
Base A1 2022 |
Basis A2 2022 |
Basis A3 2022 |
Total 2022 |
| 1. Accrued interest | - | - | -227 | -227 | - | - | 155 | 155 |
| 2. Effects of changes in interest rates and other financial assumptions |
- | - | -166 | -166 | - | - | 2,156 | 2,156 |
| 3. Change in the fair value of the assets underlying contracts measured on the basis of the VFA |
- | - | - | - | - | - | - | - |
| 4. Effects of exchange rate changes | - | - | - | - | - | - | - | - |
| 5. Other | - | - | - | - | - | - | - | - |
| 6. Total net financial income/expenses relating to insurance contracts written recorded in the income statement |
- | - | -393 | -393 | - | - | 2,311 | 2,311 |
The following table shows a breakdown of financial costs and revenues associated with the discounting of cash flows relating to reinsurance contracts.
| (in thousands of euro) | ||||||
|---|---|---|---|---|---|---|
| Items/Bases of aggregation | Base A1 2023 |
Basis A2 2023 |
Total 2023 |
Base A1 2022 |
Basis A2 2022 |
Total 2022 |
| 1. Accrued interest | - | 79 | 79 | - | -67 | -67 |
| 2. Effects of changes in interest rates and other financial assumptions |
- | 40 | 40 | - | -912 | -912 |
| 3. Effects of exchange rate changes | - | - | - | - | - | - |
| 4. Other | - | - | - | - | - | - |
| 5. Total net financial income/expenses from reinsurance contracts |
- | 119 | 119 | - | -979 | -979 |
| Items/Bases of aggregation | Life segment 2023 |
o/w: DPF | Non-life segment 2023 |
Total 2023 |
Life segment 2022 |
o/w: DPF |
Non-life segment 2022 |
Total 2022 |
|---|---|---|---|---|---|---|---|---|
| A. NET FINANCIAL RESULT OF INVESTMENTS | - | - | 8,969 | 8,969 | - | - | -7,905 | -7,905 |
| A.1 Interest income from financial assets measured at amortised cost and at fair value through OCI |
- | - | 4,140 | 4,140 | - | - | 1,899 | 1,899 |
| A.2 Net gains/losses on assets measured at fair value through profit or loss |
- | - | 178 | 148 | - | - | -171 | -171 |
| A.3 Net impairment losses for credit risk |
- | - | -76 | -76 | - | - | -38 | -38 |
| A.4 Other net income/expenses | - | - | -990 | -920 | - | - | 66 | 66 |
| A.5 Net capital gains/losses on financial assets measured at fair value through OCI |
- | - | 5,717 | 5,717 | - | - | -9,660 | -9,660 |
| B. NET CHANGE IN INVESTMENT CONTRACTS WRITTEN IFRS 9 | - | - | - | - | ||||
| C. TOTAL NET FINANCIAL RESULT OF INVESTMENTS | - | - | 8,969 | 8,969 | - | - | -7,904 | -7,904 |
| of which: recorded in the income statement | - | - | 3,252 | 3,252 | - | - | 1,756 | 1,756 |
| of which: recorded in the statement of comprehensive income | - | - | 5,717 | 5,717 | - | - | -9,660 | -9,660 |
| (in thousands of euro) | |||||||
|---|---|---|---|---|---|---|---|
| 2023 | 2022 | ||||||
| Results summary/Basis of aggregation | Life segment | Non-Life segment | Total | Life segment | Non-Life segment | Total | |
| A. Financial results | - | 8,696 | 8,696 | - | -6,573 | -6,573 | |
| A.1 Amounts recorded in the income statement | - | - | |||||
| 1. Total net financial result of investments | - | 3,252 | 3,252 | - | 1,755 | 1,755 | |
| 2. Net financial income/expenses from insurance contracts | - | -274 | -274 | - | 1,332 | 1,332 | |
| 3. Total | - | 2,978 | 2,978 | - | 3,087 | 3,087 | |
| A2. Amounts recorded in the statement of comprehensive | - | - | |||||
| income | |||||||
| 1. Total net financial result of investments | - | 5,717 | 5,717 | - | -9,660 | -9,660 | |
| 2. Net financial income/expenses from of insurance contracts |
- | - | - | - | - | - | |
| 3. Total | - | 5,717 | 5,717 | - | -9,660 | -9,660 | |
| B. Insurance and net financial result | - | - | |||||
| 1. Net result of insurance services | - | 18,933 | 18,933 | - | 13,657 | 13,657 | |
| 2. Total net financial result of investments | - | 8,969 | 8,969 | - | -7,905 | -7,905 | |
| 3. Net financial result of insurance contracts | - | -274 | -274 | - | 1,332 | 1,332 | |
| 4. Total | 27,628 | 27,628 | - | 7,084 | 7,084 |

| Other costs, net | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Other revenue | 70 | 0 | 70 |
| Other costs | -1,590 | -51 | -1,539 |
| Total | -1,521 | -51 | -1,469 |
Other revenue included €28,000 at 31 December 2023 relating to revenues from the sale of property, plant and equipment and interest of €42 on current accounts, while Other costs included the fees paid to intermediaries by the subsidiary, Revo Underwriting S.r.l. (€51,000 at 31 December 2022).
| Operating expenses | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Investment management service expenses | 25 | 201 | -176 |
| Other administrative expenses | 6,690 | 8,655 | -1,964 |
| Total | 6,715 | 8,856 | -2,141 |
Other administrative expenses of €6,690,000 (€8,655,000 for 2022) represent the portion of the Company's management costs that are not attributable to insurance contracts. This value was determined by an analysis carried out on the basis of the nature of the cost and the cost centres and mainly consists of payroll costs of €2,640,000, one-off costs of €1,288,000, consultancy costs and legal and notarial expenses of €1,197,000 and fees to corporate officers and the independent auditors of €1,111,000.
| Depreciation/amortisation and net impairment losses on property, plant and equipment and | 31.12.20 | 31.12.20 | Chang |
|---|---|---|---|
| intangible assets | 23 | 22 | e |
| Depreciation and net impairment losses on property, plant and equipment | -1,767 | -917 | -945 |
| Amortistaion and net impairment losses on intangible assets | -149 | -3 | 14 |
| Total | -1,916 | -920 | -931 |
Depreciation/amortisation and net impairment losses on property, plant and equipment and intangible assets include depreciation of property, plant and equipment of €1,767,000 resulting from the adoption of IFRS 16 relating to leased assets, and amortisation of intangible assets of €149,000.
| Other operating expenses, net | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Other operating expenses | -1,938 | -186 | -1,752 |
| Other operating income | 320 | 2 | 318 |
| Total | -1,618 | -184 | -1,434 |
Other operating income includes the use of the provision of €200,000 recognised at 31 December 2022, following the settlement of a non-insurance dispute and the release of the portion of €120,000 set aside in 2022, arising from a court payment order concerning a counterfeit surety policy.

Other operating expenses include €164,000 for the adjustment of the actuarial valuation of the agents' severance indemnity, an allocation of €1,659,000 for the LTI plan, €101,000 in costs deriving from exchange rate differences on bank current accounts, and €14,000 for contingent liabilities.
| Taxes | 31.12.2023 | 31.12.2022 | Change |
|---|---|---|---|
| Taxes | 424 | -287 | 711 |
| Total | 424 | -287 | 711 |
Taxes have been accounted for in accordance with current tax provisions on an accruals basis.
Deferred tax assets are duly adjusted taking into account the temporary differences between the carrying amounts of assets and liabilities and the corresponding values recognised for tax purposes.
The balance at 31 December 2023 of €424,000 was affected by the following factors:
x current taxes: the calculation of current regional business tax and corporation tax benefited from €2,863,000 in a tax relief for the New Patent Box (hereinafter "NPB"), linked to the OverX software, as it is particularly innovative and potentially worthy of legal protection.
Decree-Law No. 146 of 21 October 2021, "Urgent measures on economic and fiscal matters, to protect employment and for requirements that cannot be deferred", published in the Official Journal of 21 October 2021 No. 252, which came into force on 22 October 2021, made radical changes to the "patent box" system for tax relief on income from the direct or indirect use of certain intangible assets, which was introduced in 2015. The government amendment to the 2022 Budget Law, approved on 28 December 2021, confirmed the repeal of the Patent Box (old scheme), but corrected the start date indicated in the Decree-Law. The scheme has been cancelled based on the options starting from the 2021 financial year (five-year period 2021-2025), while the options for the five-year period 2020-2024 remain valid, including if they are exercised after 22 October 2021, although effectively they are weaker.
The option is valid for five tax periods and is irrevocable and renewable.
Relief may be obtained on costs incurred directly or indirectly in the conduct of business activities, for the research and development of copyrighted software, industrial patents, designs and models. Research and development activities may be carried out inside the undertaking or externally by means of research agreements with universities, research organisations or companies not directly or indirectly linked to the party requesting the relief.
The costs incurred for eligible intangible assets benefit from a specific incremental deduction of 110% for corporate income tax purposes. The option exercised is valid for both regional business tax (IRAP) and corporation tax (IRES) purposes.
x DTA/DTL on IFRS adjustments: at 31 December 2023, the adjustment of amortisation of statutory goodwill of €8,904,000 is present: this does not generate corresponding deferred tax assets as statutory goodwill is not relevant for tax purposes.
The following table sets out the reconciliation between the tax rate and the effective rate:
| Effect of increases or (decreases) compared with the ordinary rate | REVO INSURANCE 31.12.2023 |
REVO UNDERWRITING 31.12.2023 |
|
|---|---|---|---|
| IRES | |||
| a | Profit before tax | 7,260 | 177 |
| a' | IRES rate | 24% | 24% |
| Expected corporation tax (IRES) for the current year | 1,742 | 42 | |
| Expected tax increase | |||
| Multi-year commissions | 23,249 | - | |
| Change in net claims provision | 14,998 | - | |
| Allocation to productivity bonuses | 2,059 | - | |
| Amortisation of goodwill | 8,904 | - | |
| Other increases | 598 | 20 | |

| b | Total increase | 49,808 | 20 | ||
|---|---|---|---|---|---|
| c | Total expected tax increase | 11,954 | 5 | ||
| Expected tax decrease | |||||
| Multi-year commissions | 13,798 | - | |||
| Change in net claims provision | 5,056 | - | |||
| NPB deduction | 9,288 | - | |||
| Other decreases | 2,084 | - | |||
| d | Total decrease | 30,225 | 0 | ||
| e | Total expected tax decrease | 7,254 | 0 | ||
| Tax losses | 5,168 | 29 | |||
| ACE (Support for Economic Growth scheme) | 2,709 | 3 | |||
| Total other decreases | 7,877 | 32 | |||
| Total other expected tax decreases | 1,891 | 8 | |||
| I DEG | IRES taxable base | 18,966 | 165 | ||
| g=f x a' | IRES for the current year | 4,552 | 39 | ||
| h= g/a | Effective IRES rate | 62.70% | 22.31% | ||
| IRAP | |||||
| i | Technical result | 15,421 | 186 | ||
| i' | IRAP rate | 6.82% | 3.90% | ||
| Expected IRAP for the current year | 1,052 | 7 | |||
| Expected tax increase | |||||
| Non-deductible payroll costs | 15,362 | - | |||
| Other administrative expenses | 1,934 | - | |||
| other increases | 185 | 64 | |||
| l | Total increase | 17,481 | 64 | ||
| m | Total expected tax increase | 1,192 | 2 | ||
| Expected tax decrease | |||||
| Deduction for certain employees (employee tax wedge) | 14,356 | - | |||
| Amortisation of intangible operating assets | 2,708 | - | |||
| Other decreases | 136 | - | |||
| NPB deduction | 9,288 | - | |||
| n | Total decrease | 26,488 | 0 | ||
| o | Total expected tax decrease | 0 | 0 | ||
| S LOQ | IRAP tax base | 6,414 | 250 | ||
| q=p x i' | IRAP for the current year | 437 | 10 | ||
| r= q/i | Effective IRAP rate | 2.84% | 5.24% | ||
| Summary | |||||
| a | Profit before tax | 7,260 | 177 | ||
| V JT | IRES and IRAP for the current year | 4,989 | 49 | ||
| t=s/a | 7RWDOWD[UDWHIRUWKH\HDUFXUUHQW,5(6,5\$3 | 68.72% | 27.82% | ||
| X D L |
WKHRUHWLFDOUDWH,5(6,5\$3 | 30.82% | 30.82% | ||
| v | Deferred tax assets 2023 | -9,117 | |||
| v' | Deferred tax assets 2022 | 5,557 | 7 | ||
| v'' (v-v') | Balance of deferred tax assets for temporary differences | -3,559 | 7 | ||
| \ VY | Taxes for the year including effect of deferred tax assets | 1,430 | 56 | ||
| z=y/a | Effective tax rate for the year (including previous prepaid tax effect) | 19.70% | 31.77% | ||
| Total consolidated taxes | |||||
| ̃ | Total changes adj. IAS/IFRS | -6,202 | |||
| ɴ | Tax rate applied on adj. IAS/IFRS | 30.82% | |||
| ȼ=ɲΎɴ | Total taxes on changes adj. IAS/IFRS | -1,912 | |||

| ɸ \̐ | Total consolidated taxes | -425 |
|---|---|---|
| ̛ | Profit before consolidated taxes | 10,142 |
| ɸ/ʘ | Effective tax rate for the year (including previous prepaid tax effect) | 4.19% |
The following table summarises the data relating to the deferred tax assets and liabilities recognised in the financial statements, based on the nature of the temporary differences that generated them:
| 31.12.2023 | ||||
|---|---|---|---|---|
| Deferred tax assets | Temporary differences | Tax effect | ||
| IRES | Multi-year commissions | 18,849 | 4,524 | |
| IRES | Change in net claims provision | 16,487 | 3,957 | |
| IRES | Directors' remuneration and impairment losses | 293 | 70 | |
| IRES | Non-deductible portion of receivables impairment losses | 2,059 | 494 | |
| IRES | Productivity bonuses | 353 | 85 | |
| IRES | REVO 2021 tax loss | 500 | 120 | |
| IRES | Measurement of securities under IFRS 9 | -2,340 | - 562 | |
| IRES | Measurement of IFRS 17 reserves | -19,735 | -4,736 | |
| IRES | Measurement of leases under IFRS 16 | 2,063 | 495 | |
| IRES | Valuation of post-employment benefits and agency severance indemnity | 423 | 101 | |
| IRES | Leasehold improvements | 280 | 67 | |
| IRES | Total deferred tax assets - IRES | 19,037 | 4,616 | |
| IRAP | Non-deductible portion of receivables impairment losses | 277 | 19 | |
| IRAP | Measurement of securities under IFRS 9 | -2,340 | -160 | |
| IRAP | IFRS 17 measurement | -19,735 | -1,346 | |
| IRAP | Measurement of leases under IFRS 16 | 2,063 | 141 | |
| IRAP | Measurement of post-employment benefits and agency severance indemnity | 423 | 29 | |
| IRAP | Leasehold improvements | 280 | 19 | |
| IRAP | Total deferred tax assets - IRAP | -19,227 | -1,298 | |
| Total deferred IRES and IRAP tax liabilities/assets | -190 | 3,318 | ||
| Deferred tax assets on merger securities | -878 | -271 | ||
| Total deferred IRES and IRAP tax liabilities/assets | -1,068 | 3,047 |
The temporary differences that generated deferred tax assets, as shown in the above table, are the same as those recorded in previous years.
Following the reverse merger between REVO and ELBA, which had retroactive effect as of 1 January 2022, the latter's financial investments were revalued at market value on that date, generating a positive difference of €878,000 (higher values deriving from the allocation of goodwill arising on the merger). To avoid any difference between accounting and tax values, the Company has opted to apply the substitute tax for corporation tax (IRES) and regional business tax (IRAP), obtaining tax recognition of the higher values recognised in the financial statements. Accordingly, to all intents and purposes, this is a substitute tax payable in January 2024.
The tax loss of REVO generated during 2021 has been fully utilised.
IFRS 13 regulates the measurement of fair value and the related disclosure.
A breakdown of the measurement at fair value and the amount of investments and financial liabilities recorded in the consolidated financial statements is provided below.
| 31.12.2023 | 31.12.2022 | ||||
|---|---|---|---|---|---|
| Carrying amounts and fair values | Carrying amount | Fair value | Carrying amount | Fair value | |
| Investment property | - | - | - | - | |
| Investments in subsidiaries, associates and joint ventures | 3 | 3 | - | - | |
| Financial assets measured at amortised cost | 3,088 | 3,088 | 4,016 | 4,016 |

| Financial assets measured at FV through OCI | 217,811 | 217,811 | 181,895 | 181,895 |
|---|---|---|---|---|
| Financial assets measured at FVTPL | 2,775 | 2,775 | 2,620 | 2,620 |
| Cash and cash equivalents | - | - | - | - |
| Total investments | 223,677 | 223,677 | 188,531 | 188,531 |
| Financial liabilities measured at fair value through profit or loss | - | - | - | - |
| Financial liabilities measured at amortised cost | 14,503 | 14,503 | 14,448 | 14,448 |
| Total financial liabilities | 14,503 | 14,503 | 14,448 | 14,448 |
As can be seen from the table above, there are no investments or financial liabilities whose carrying amount differs from their fair value.
With respect to the fair value hierarchy, it should be noted that the item "Financial assets measured at fair value through other comprehensive income" includes the equity investment in Mangrovia Blockchain Solutions S.r.l., allocated to Stage 3. Please refer to the "Investments" section of these notes for details.
During the year, there were no purchases or sales of the equity investment, the qualitative and quantitative measurement of which confirmed the value recognised in the 2022 annual financial statements.
The remaining securities in the "Financial assets measured at fair value through other comprehensive income" item are all allocated to Stage 1.
The security under the "Financial assets measured at FVTPL" item is allocated to Stage 2.
The following table illustrates the above information on the breakdown of assets and liabilities by fair value levels.

| (in thousands of euro) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | |||||
| Financial assets/liabilities measured at fair value | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 |
| Financial assets measured at fair value through OCI | 217,255 | 181,339 | - | - | 556 | 556 | 217,811 | 181,895 |
| Financial assets measured at fair value through profit or loss | - | - | - | - | - | - | - | - |
| a) financial assets held for trading | - | - | - | - | - | - | - | - |
| b) financial assets designated at fair value | - | - | - | - | - | - | - | - |
| c) other financial assets compulsorily measured at fair value | - | - | 2,775 | 2,620 | - | - | 2,775 | 2,620 |
| Investment property | - | - | - | - | - | - | - | - |
| Property, plant and equipment | 13,926 | 14,448 | - | - | - | - | 13,926 | 14,448 |
| Intangible assets | 88,412 | 83,071 | - | - | - | - | 88,412 | 83,071 |
| Total | 319,593 278,858 | 2,775 | 2,620 | 556 | 556 322,924 282,034 | |||
| Financial liabilities measured at fair value through profit or loss | ||||||||
| a) Financial liabilities held for trading | - | - | - | - | - | - | - | - |
| b) Financial liabilities designated at fair value | - | - | - | - | - | - | - | - |
| Total | - | - | - | - | - | - | - | - |
| (in thousands of euro) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Fair value | ||||||||||
| Assets/liabilities not measured at fair value or | Carrying amount | Level 1 | Level 2 | Level 3 | Total | |||||
| measured at fair value on a non-recurring basis | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 |
| Assets | - | |||||||||
| Financial assets measured at amortised cost | 3,088 | 4,016 | 3,088 | 4,016 | - | - | - | - | 3,088 | 4,016 |
| Investments in associates and joint ventures | - | - | - | - | - | - | - | - | - | - |
| Investment property | - | - | - | - | - | - | - | - | - | - |
| Non-current assets held for sale or disposal groups |
- | - | - | - | - | - | - | - | - | - |
| Total assets | 3,088 | 4,016 | 3,088 | 4,016 | - | - | - | - | 3,088 | 4,016 |
| Liabilities | ||||||||||
| Financial liabilities measured at amortised cost | 14,503 | 14,448 | 14,503 | 14,448 | - | - | - | - | 14,503 | 14,448 |
| Liabilities of disposal groups | - | - | - | - | - | - | - | - | - | - |
| Total liabilities | 14,503 | 14,448 | 14,503 | 14,448 | - | - | - | - | 14,503 14,448 |

| (in thousands of euro) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Financial assets measured at fair value through | Financial liabilities measured at fair value | ||||||||
| profit or loss | through profit or loss | ||||||||
| Financial assets measured at fair value through OCI |
Financial assets held for trading |
Financial assets designated at fair value |
Financial assets compulsorily measured at fair value |
Property, Investment property nt |
plant and equipme |
Intangible assets |
Financial liabilities held for trading |
Financial liabilities designated at fair value |
|
| 1. Opening balances | 556 | - | - | - | - | - | - | - | - |
| 2. Increases | - | - | - | - | - | - | - | - | - |
| 2.1. Purchases | - | - | - | - | - | - | - | - | - |
| Business combinations - external |
- | - | - | - | - | - | - | - | - |
| Business combinations - internal | - | - | - | - | - | - | - | - | - |
| Business combinations - mergers | - | - | - | - | - | - | - | - | - |
| - Other purchases |
- | - | - | - | - | - | - | - | - |
| 2.2. Profits allocated to: | - | - | - | - | - | - | - | - | - |
| 2.2.1 Income statement | - | - | - | - | - | - | - | - | - |
| of which capital gains | - | X | X | ||||||
| of which capital losses | X | X | X | X | X | X | X | ||
| 2.2.2 Statement of comprehensive income | - | X | X | X | X | X | |||
| 2.3. Transfers from other levels | - | - | - | - | - | - | - | - | - |
| 2.4. Other increases | - | - | - | - | - | - | - | - | - |
| Foreign exchange GLIIHUHQFHLQSXW | - | - | - | - | - | - | - | - | - |
| \$XWRPDWLFIRUHLJQH[FKDQJHGLIIHUHQFHV | - | - | - | - | - | - | - | - | - |
| &KDQJHLQVFRSHRIFRQVROLGDWLRQ | - | - | - | - | - | - | - | - | - |
| &KDQJHLQPHWKRGDQGRIFRQVROLGDWLRQ | - | - | - | - | - | - | - | - | - |
| - 2WKHUFKDQJHV |
- | - | - | - | - | - | - | - | - |
| 3. Decreases | - | - | - | - | - | - | - | - | - |
| 3.1. Sales | - | - | - | - | - | - | - | - | - |
| Business combinations - external |
- | - | - | - | - | - | - | - | - |
| Business combinations - internal |
- | - | - | - | - | - | - | - | - |
| - Other sales |
- | - | - | - | - | - | - | - | - |
| 3.2. Redemptions | - | - | - | - | - | - | - | - | - |
| 3.3. Losses allocated to: | - | - | - | - | - | - | - | - | - |
| 3.3.1 Income statement | - | - | - | - | - | - | - | - | - |
| of which capital losses | - | - | - | - | - | - | - | X | X |
| of which capital gains | X | X | X | X | X | X | X | ||
| 3.3.2 Statement of comprehensive income | - | X | X | X | X | X | |||
| 3.4. Transfers to other levels | - | - | - | - | - | - | - | - | - |
| 3.5. Other decreases | - | - | - | - | - | - | - | - | - |
| Foreign exchange difference input (-) | - | - | - | - | - | - | - | - | - |
| Automatic foreign exchange differences (-) | - | - | - | - | - | - | - | - | - |
| Change in scope of consolidation (-) | - | - | - | - | - | - | - | - | - |
| Change in method and % of consolidation (-) | - | - | - | - | - | - | - | - | - |
| - Other changes (-) |
- | - | - | - | - | - | - | - | - |
| 4. Closing balances | 556 | - | - | - | - | - | - | - | - |

| Items | 31.12.2023 | 31.12.2022 |
|---|---|---|
| 1 Profit for the year | 10,565 | 6,193 |
| 2. Other items not reclassified to profit or loss | ||
| 2.1 Share of valuation reserves for equity accounted investees | - | - |
| 2.2 Valuation reserve for intangible assets | - | - |
| 2.3 Valuation reserve for property, plant and equipment | - | - |
| 2.4 Financial income or expenses relating to insurance contracts written | - | - |
| Profit (loss) from non-current assets held for sale or disposal groups | - | - |
| 2.6 Actuarial gains and losses and adjustments to defined benefit plans | 2,637 | 997 |
| 2.7 Gains or losses on equity securities designated at FVOCI: | -556 | -556 |
| a) change in fair value | -556 | -556 |
| b) transfers to other components of equity | - | - |
| 2.8 Reserve deriving from changes in own creditworthiness for financial liabilities designated at | ||
| FVOCI | - | - |
| a) change in fair value | - | - |
| b) transfers to other components of shareholders' equity | - | - |
| 2.9 Other changes: | - | - |
| a) change in fair value (hedged instrument) | - | - |
| b) change in fair value (hedging instrument) | - | - |
| c) other changes in fair value | - | - |
| 2.10 Income taxes relating to other items not reclassified to profit or loss 3. Other items reclassified to profit or loss |
-641 | -136 |
| 3.1 Translation reserve: | - | - |
| a) changes in value | - | - |
| b) reclassification to profit or loss | - | - |
| c) other changes | - | - |
| 3.2 Gains/losses on financial assets (other than equity securities) measured at FV OCI: | -3,371 | -9,106 |
| a) changes in fair value | -3,371 | -9,106 |
| b) reclassification to profit or loss | - | - |
| adjustments for credit risk | - | - |
| gains/losses on disposals | - | - |
| c) other changes | - | - |
| 3.9 Other items: | - | - |
| a) changes in fair value | - | - |
| b) reclassification to profit or loss | - | - |
| c) other changes | - | - |
| 3.10 Income taxes relating to other comprehensive income reclassified to profit or loss | 1,055 | 2,806 |
| 4. Total other comprehensive expense (sum of Items 2.1 to 3.10) | -876 | -5,995 |
| 5. CRPSUHKHQVLYHLQFRPH,WHPV | 9,689 | 198 |
| o/w: attributable to the owners of the parent | 9,689 | 198 |
| o/w: attributable to non-controlling interests | - | - |
The item "Actuarial gains and losses and adjustments to defined benefit plans" includes provisions of €2,438 relating to the LTI (Long-Term Incentive) plan (see the paragraph in Section F of these documents) and €199,000 for IAS 19 valuations relating to post-employment benefits..
The item "Gains or losses on equity securities designated at FV- OCI" includes the change in the fair value recorded by the equity investment in Mangrovia S.r.l.
The item "Gains/losses on financial assets measured at FV-OCI" includes changes in the fair value of securities, which recorded a change compared with 2022 of €5,735,000.
The statement, compiled in accordance with Annex 1 to IVASS Regulation 7/2007, does not include the amount relating to the reclassification to equity of the costs of €4,160,000 incurred by REVO SPAC in 2021 for its listing. Taking this item into account, comprehensive income at 31 December 2023 was €5,529,000 (compared with -€3,962,000 at 31 December 2022).

In accordance with the provisions of IFRS 17, paragraphs 121 to 132, the following information is provided to enable an assessment of the nature, amount, timing and uncertainty of future cash flows that arise from contracts within the scope of the new international accounting standard.
The Group operates in the non-life segment only, and its business is mainly denominated in euro. Accordingly, the main insured events and the main business sectors in which insured customers operate are shown below for the purposes of calculating risk concentration.
The following tables show the information in relation to gross premiums written in 2023:
| Business sector 20 | % |
|---|---|
| Construction | 49.3% |
| Buildings and landscape services | 10.4% |
| Manufacture of means of transport | 9.2% |
| Manufacture of chemical, metal, pharmaceutical and other products | 4.5% |
| Transport activities and transport support services | 3.8% |
| Financial, insurance and pension fund services | 3.7% |
| Information technology and telecommunications services | 2.2% |
| Management, consultancy, architecture and professional activities | 4.6% |
| Arts, sports and entertainment activities | 2.5% |
| Food industries | 0.8% |
| Agriculture and production of animal products | 0.7% |
| Other | 8.2% |
| Total gross premiums written | 100% |
| Description of guarantee | % |
|---|---|
| Contracts | 20.3% |
| Incorporated into contracts | 11.6% |
| Fire of buildings, machinery and goods | 10.9% |
| Damage to direct and indirect material property resulting from the setting up of the site of a work | 8.0% |
| Marine, air and rail vehicles | 7.9% |
| Other guarantees on sureties | 6.0% |
| Professional liability | 5.9% |
| Agro - hail risk | 5.1% |
| Third-party liability (construction sites, cyber, workers and general) | 5.0% |
| Reimbursement of medical expenses | 1.9% |
| Goods in transit | 1.8% |
| Directors & officers liability | 1.4% |
| Payment and refunds of surety taxes | 1.0% |
| Medical liability | 0.9% |
| Customs duties | 0.8% |
| Land vehicles - Fire, theft and third-party fire liability | 0.7% |
| Permanent disability injuries | 0.5% |
| Other | 10.5% |
| Total gross premiums written | 100% |
20 The business sector was determined on the basis of the alphanumeric combinations set out in the Ateco Code, where the letters identify the macro-economic sector to which they belong, while the numbers represent categories and sub-categories of the relevant sectors.

The Group operates exclusively in the non-life insurance sector and the entire portfolio is valued using the premium allocation approach, as set out in previous chapters of these documents. For this reason, the sensitivity analyses were performed by analysing the change in the liability for incurred claims and the corresponding reinsurance item, "Asset for incurred claims", by amending the following measures:
7KHFKDQJHLQWKHGLVFRXQWUDWHRI- 0.5 percentage points resulted in:
The change in the undiscounted best estimate liabilities for claims ('UBEL' claims) and the Reinsurance Recoverable 8QGLVFRXQWHG&ODLPVRI-5% resulted in:
With regard to credit risk, the maximum exposures of the Group to the various credit categories related to the insurance business are shown below:
Reinsurance treaties were signed with leading reinsurance companies, significantly reducing the Group's counterparty risk. The following table sets out the ratings of the companies in the panel:
| Reinsurance company | Rating agency | Rating |
|---|---|---|
| Partner Reinsurance Europe Se - Zurich Branch | Standard & Poor's | \$ |
| 599HUVLFKHUXQJ\$J5XFNYHUVLFKHUXQJ5HLQVXUDQFH | Standard & Poor's | \$ |
| XL RE EUROPE SE, French Branch | Standard & Poor's | AA |
| Sirius International Insurance Corporation Belgian Branch | Standard & Poor's | A |
| Ccr Caisse Centrale De Reassurance | Standard & Poor's | A |
| Devk Ruckversicherung - Und Beteiligungs Ag | Standard & Poor's | \$ |
| Scor Europe Se - General Representation Office for Italy | Standard & Poor's | \$ |
| National Borg Reinsurance N.V. | Standard & Poor's | A |
| Swiss Reinsurance Company Ltd | Standard & Poor's | AA |
| Atradius Reinsurance Dac Ltd | A.M. Best | A |
| Aspen Insurance Uk Limited, London - Zurich Branch | Standard & Poor's | A |
| XL RE EUROPE SE, French Branch | Standard & Poor's | AA |
| Ms Amlin Ag | Standard & Poor's | A |
| Catlin Europe Se Italy Branch On Behalf Of Xl Re Europe Se | Standard & Poor's | AA |
| Probitas Lloyd's Syndicate Pbs 1492 | Standard & Poor's | AA |
| Credendo - Export Credit Agency | Standard & Poor's | A |
| Catlin Re Switzerland Ltd | Standard & Poor's | AA |
| Hannover Rueck Se | Standard & Poor's | AA |
| Arch Reinsurance Europe Underwriting Dac, Zurich Branch | Standard & Poor's | \$ |
| Polish Reinsurance Company | A.M. Best | A |
| Irb Re | A.M. Best | A |
| Europ Assistance Italia Spa | A.M. Best | A |
| General Reinsurance Milan Branch | Standard & Poor's | \$\$ |
| Swiss Re Europe Sa. Representation Office for Italy | Standard & Poor's | AA- |

| Aig Europe S.A. - General Representation Office for Italy | Standard & Poor's | \$ |
|---|---|---|
| Münchener Rückversicherungs-Gesellschaft, Gen. Representation Office | Standard & Poor's | AA |
| Sigurd Rück Ag | A.M. Best | % |
| Tegron Specialty Limited | A.M. Best | \$ |
| Starr Europe Insurance Limited | A.M. Best | A |
| Hdi Global Sp – Representation Office For Italy | Standard & Poor's | \$ |
| Elseco | Standard & Poor's | AA |
| Emerging Risk | Standard & Poor's | AA |
| Chubb European Group Se France | Standard & Poor's | AA |
| Atrium - Auw 5310 | Standard & Poor's | AA |
| Nexus Underwriting | Standard & Poor's | \$ |
| Hive Aero | Standard & Poor's | \$ |
| Dual Europe Gmbh | Standard & Poor's | A |
| Oman Insurance | Standard & Poor's | A |
| Misr Insurance Company | A.M. Best | % |
| Chaucer | Standard & Poor's | AA |
| Lloyd's Insurance Company SA | Standard & Poor's | AA |
| Scor Europe Se | Standard & Poor's | \$ |
| Scor Se Paris, Zurich Branch | Standard & Poor's | \$ |
| Tokio Marine Europe Sa | Standard & Poor's | \$ |
| Leopanthera | Standard & Poor's | AA |
| Tokio Marine Europe Sa - Spanish Branch | Standard & Poor's | \$ |
| Everest Reinsurance Company | Standard & Poor's | \$ |
| Liberty Mutual Reinsurance | Standard & Poor's | A |
| Lloyd's Syndicate 1609, Mosaic | Standard & Poor's | AA |
| Convex Europe Sa | Standard & Poor's | A |
| Delvag Versicherungs-AG | A.M. Best | A |
| Lloyd's Syndicate Hig 1221 | Standard & Poor's | AA |
| Everest Insurance (Ireland) Dac | Standard & Poor's | \$ |
| Probitas Managing Agency 5327 | Standard & Poor's | AA |
| Anv Specialty Europe S.L.U. | Standard & Poor's | AA |
| Sompo International Insurance Europe - (Si Insurance Europe | Standard & Poor's | \$ |
| Aviva Insurance Ireland Dac | Standard & Poor's | AA |
| Drave Underwriting | Standard & Poor's | \$ |
| Lloyd's Insurance Company SA - Syndicate 5310, pseudonym AUW | Standard & Poor's | AA |
| Lloyd's Insurance Company SA - Syndicate 5324, pseudonym IGO | Standard & Poor's | AA |
| Lloyd's Insurance Company SA - Syndicate 5319, pseudonym AMA | Standard & Poor's | AA |
| Cincinnati - Cin 5302 | Standard & Poor's | AA |
| Argenta - Arg 5353 | Standard & Poor's | AA |
| Flagstone Re | Standard & Poor's | A |
| Innovisk Europe Srl 4877 | Standard & Poor's | AA |
| Innovisk Europe Srl 9204 | Standard & Poor's | AA |
| Innovisk Europe Srl Trading As Leopanthera | Standard & Poor's | AA |
| Lloyd's Insurance Company S.A. No. 7761 | Standard & Poor's | AA |
| Markel - Mkl 5368 | Standard & Poor's | AA |
| Qbe Representation Office for Italy | Standard & Poor's | \$ |
| Stewart Title Europe Ltd | Fitch Ibca | A |
| Ascot 5325 | Standard & Poor's | AA |
| Beazley Insurance Dac - Spanish Branch | Fitch Ibca | \$ |
| Brit | A.M. Best | \$ |
| Arch Aal 5348 | Standard & Poor's | AA |
| Allianz Global Corporate & Specialty Se | Standard & Poor's | AA |
| Arch Asl 5339 | Standard & Poor's | AA |
| Arch D&O Consortium 9013 | Standard & Poor's | AA |
| QBE Reinsurance Syndicate 566 | Standard & Poor's | AA |
| Chubb European Group Se | Standard & Poor's | AA |
| TransRe Europe SA | Standard & Poor's | \$\$ |
| Mapfre Re S.A. | Standard & Poor's | \$ |
| Peak Reinsurance AG | A.M. Best | A |
| ALLIANZ SE - REINSURANCE BRANCH SWITZERLAND | Standard & Poor's | AA |

| Everest Syndicate | Standard & Poor's | AA |
|---|---|---|
| Sukoon Insurance | A.M. Best | A |
| Swiss Pool for the insurance of nuclear risks | Standard & Poor's | AA |
| STARR Europe Insurance Limited, Spanish Branch | A.M. Best | A |
| Lloyd's Insurance Company S.A – Beazley | Standard & Poor's | AA |
| Lloyd's Insurance Company S.A. Beazley ESG Cyber Consortium | Standard & Poor's | AA |
| AXA XL - Syndicate 2003 | Standard & Poor's | AA |
| AXIS SPECIALITY EUROPE SE | Standard & Poor's | AA |
| Global Aerospace Underwriting Managers (Europe) SAS | Standard & Poor's | \$ |
| Lloyds Syndicate KLN510 80% - TMK1880 20% | Standard & Poor's | AA |
| Swiss Re International SE, DE | Standard & Poor's | AA |
| Rokstone Underwriting Managers | Standard & Poor's | AA |
| Apollo – Lloyd's Insurance Company S.A. | Standard & Poor's | AA |
| Faraday – Lloyd's Insurance Company S.A. | Standard & Poor's | AA |
| Korean Reinsurance Company | Standard & Poor's | A |
| Tokio Marine HCC - Lloyds Syndicate | Standard & Poor's | AA |
| XL RE EUROPE SE, Zurich Branch | Standard & Poor's | AA |
| Specialty MGA UK | A.M. Best | % |
| Fidelis Insurance Holdings Limited | Standard & Poor's | A |
| Canopius | Standard & Poor's | AA |
| PARK LANE PCC LTD | Other | NA |
| Lloyd's Insurance Company SA - Lancashire Syndicate LRE 5370 | Standard & Poor's | AA |
| AIG Europe SA | Standard & Poor's | \$ |
| Berkshire Hathaway European Insurance DAC | Standard & Poor's | \$\$ |
| Reaseguradora Patria, S.A. | A.M. Best | A |
| Hyundai Marine & Fire Insurance | A.M. Best | A |
| Lloyd's Underwriter Syndicate No. 1856 IQU | Standard & Poor's | AA |
| Everest Reinsurance (Bermuda) Ltd (UK Branch) | A.M. Best | \$ |
| Geo Underwriting Europe B.V., | Standard & Poor's | AA/ |
| AXIS Syndicate 1686 | Standard & Poor's | AA |
| Travelers Syndicate 5384 | Standard & Poor's | AA |
| American International Group UK Limited | Standard & Poor's | \$ |
| International General Insurance Co. Ltd | Standard & Poor's | A |
| Chubb – Lloyd's Syndicate 2488 | Standard & Poor's | AA |
| Tokyo Marine Kiln | Standard & Poor's | \$ |
| Insurance Company of the West Inc | A.M. Best | A |
| Eurasia Insurance Company | Standard & Poor's | BBB |
| General Insurance Corporation of India | A.M. Best | % |
| Lloyd's Syndicate AML 2001 | Standard & Poor's | AA |
| Zavarovalnica Triglav d.d. | Standard & Poor's | A |
| Ki Lloyd's Syndicate | Standard & Poor's | AA |
| Ensuro | Duff & Phelps Credit Rating Co. | NA |
| Liberty Mutual Insurance Europe SE | Standard & Poor's | A |
| Zurich Insurance Company LTD | Standard & Poor's | AA |
| MAPFRE RE, COMPAÑÍA DE REASEGUROS, S.A. | Standard & Poor's | \$ |
| Great Lakes Insurance SE | Standard & Poor's | AA |
| Markel Insurance SE | A.M. Best | A |
| Chaucer Insurance Company DAC | A.M. Best | A |
| Sirius Point Ltd | A.M. Best | A |
| Flux syndicate 1985 - LIC 5411 | Standard & Poor's | AA |
| Mosaic LIC 5399 | Standard & Poor's | AA |
| Abu Dhabi National Takaful Company | A.M. Best | A |
| Beazley Facilities Syndicate LIC 5410 | Standard & Poor's | AA |
| Best Meridian International Insurance Company | A.M. Best | A |
| GIC of India – UK, London Branch | A.M. Best | % |
| Travelers 5000 | Standard & Poor's | AA |
| Abu Dhabi National Insurance Company | Standard & Poor's | A |
| The New India Assurance Co. Ltd | Other | AAA |
| Westfield 1200 | Standard & Poor's | AA |
| SiriusPoint, Zurich Branch | Standard & Poor's | A- |
| Great Lakes Insurance SE, London Branch | Standard & Poor's | AA |
|---|---|---|
| CHI23 | Standard & Poor's | \$ |
| Lloyds Syndicate Hiscox - HIS33 | Standard & Poor's | AA |
| Allianz Insurance PLC | Fitch Ibca | AA |
| CNA Hardy | A.M. Best | A |
| Partner Re Lloyds Syndicate | Standard & Poor's | AA |
| Samsung Fire and Marine Insurance Company of Europe Ltd | A.M. Best | \$ |
| Volkswagen Insurance Company DAC | Standard & Poor's | \$ |
| Redbridge Insurance Company Ltd | A.M. Best | % |
| Zurich Insurance PLC, UK | Standard & Poor's | AA |
| Lloyd's syndicate (TAL 1183) - Talbot | Standard & Poor's | AA |
| PVI Insurance Corporation | A.M. Best | A |
| Lloyd's Syndicate EVE 5363 - Everest | Standard & Poor's | AA |
| Lloyd's Syndicate 5361 (AFB 2623) - A F Beazley and Others | Standard & Poor's | AA |
| Lloyd's Syndicate AFB 5311 - A F Beazley and Others | Standard & Poor's | AA |
| Lloyd's Syndicate AFB 5373 - Beazley A&H non life | Standard & Poor's | AA |
| Lloyd's Syndicate AES 5322 - Aegis | Standard & Poor's | AA |
| Lloyd's Syndicate NOA 5375 - Ark | Standard & Poor's | AA |
| Lloyd's Syndicate AUL 5323 - Antares | Standard & Poor's | AA |
| Lloyd's Syndicate WRB 5340 - W. R. Berkley | Standard & Poor's | AA |
| Lloyd's syndicate KII 5396 - Ki | Standard & Poor's | AA |
| Fidelis Insurance Ireland DAC | A.M. Best | A |
| Lloyd's Syndicate QBE 5334 | Standard & Poor's | AA |
| Lloyd's Syndicate HDU 5303 - CNA Hardy | Standard & Poor's | AA |
| Lloyd's Syndicate HDU 4690 | Standard & Poor's | AA |
| Sava Re | A.M. Best | A |
| Lloyd's Syndicate TMK 1880 (5332) | Standard & Poor's | AA |
| Xl Catlin Services SE | Standard & Poor's | AA |
| MSIG Insurance Europe AG - Italy Branch | Standard & Poor's | \$ |
| Lloyd's Syndicate 5380 (CNP 4444) - Canopius | Standard & Poor's | AA |
| Lloyd's Syndicate CSL 1084 - Chaucer | Standard & Poor's | AA |
| Lloyd's Syndicate AMA 5319 - Argo | Standard & Poor's | AA |
| Lloyd's Syndicate ASP 5383 - Aspen | Standard & Poor's | AA |
Liquidity risk arises from the risk of not having sufficient cash and cash equivalents to meet commitments arising from contracts within the scope of application of IFRS 17, or of not being able to meet cash outflows (both expected and unexpected) according to cost-effectiveness criteria without prejudicing daily operations or the financial situation. This risk due to uncertainty about the amounts and timing of the cash flows associated with insurance contracts may mainly arise:
Liquidity risk management takes place through the monitoring and definition of tolerance thresholds for the liquidity coverage ratio (LCR), which quantifies as a percentage the coverage of the expected cash outs, according to this formula:
/&5 ,QLWLDOFDVKEDODQFHɇ incoming flows) / ɇ outgoing flows These thresholds are monitored on a quarterly basis with reference to a short-term time horizon (90 days) and a mediumterm time horizon (24 months) based on forecast cash flows from the approved rolling business plan. Monitoring is performed by means of stress analysis.
If the thresholds are breached and according to the severity of the breach, the Company decides on the actions to take, according to their cost-effectiveness:

The action referred to in the first point is carried out as a priority, but not exclusively, in order to rebalance net cash flows in a manner commensurate with the magnitude of the mismatch and on the basis of the powers and levels of autonomy of the persons delegated by senior management to perform monitoring and on the basis of what is defined in the relevant internal policy.
For the purposes of analysing the maturities of cash outflows, the table below sets out the liability for incurred claims by maturity, gross of the discounting effect and without considering the risk adjustment component, broken down by IFRS 17 portfolio:
| Maturity | up to 1 year | 2 to 5 years | 6 to 10 years | 11 to 20 years | over 20 years |
|---|---|---|---|---|---|
| Suretyship | 3,090 | 12,332 | 7,825 | 8,047 | - |
| Property | 365 | 8,862 | 1,876 | 16,935 | - |
| General Liability | 989 | 3,388 | 2,192 | 1,610 | - |
| Accident & Health | - | 63 | - | 947 | - |
| MAT Specialty Lines | 28 | 3,949 | 54 | 14,639 | - |
| Land Vehicles | - | - | - | 430 | - |
| Credit | - | 4 | - | 12 | - |
| Agro | - | - | - | 1,276 | - |
| Property CAT | - | 50 | - | 526 | - |
| Parametric | - | - | - | 4 | - |
| Total | 4,472 | 28,648 | 11,947 | 44,422 | - |
During the year, in accordance with Article 2427, paragraph 13, of the Italian Civil Code, exceptional costs of €1,288,000 were incurred, mainly linked to the voluntary tender offer (takeover bid), the request for authorisation from IVASS to operate in the 17-Legal expenses class and tax assistance for the facilitation of New Patent Box.
On 4 April 2022, the Company's Shareholders' Meeting approved a performance share plan entitled the "2022-2024 Performance Share Plan" (hereinafter, the "Plan"), the rules of which were defined and approved by the Board of Directors of REVO Insurance S.p.A. on 26 May 2022.
The Plan is a valuable tool for retaining and motivating the individuals who play a key role in achieving the Group's objectives, and for aligning the interests of key company personnel with those of other stakeholders, with a view to the long term and the pursuit of sustainable development.
In particular, the Plan sets out the following main terms and conditions:

responsible, as identified, without prejudice to the overall maximum limit; all of this being in accordance with the procedural requirements for transactions with related parties;
Overall, the shares allotted and accruing to service the Plan amount to approximately 678,000, for a total value of €5,239,000, of which €2,438,000 has already been recognised in the income statement.
At 31 December 2023, the Group did not record any contingent liabilities, purchase commitments or guarantees.
Although not reported in the statement of financial position, for some insurance contracts written, collateral guarantees were obtained (mainly pledges on life policies and bank guarantees) to be used, in the event of enforcement of the policy, to ensure the recovery of any sums paid to policyholders.
The table below shows the carrying amount of right-of-use assets at year-end for each class of underlying asset.
| Item | 31.12.2023 | 31.12.2022 |
|---|---|---|
| Property | 13,198 | 12,440 |
| Company cars | 233 | 246 |
| Total | 13,431 | 12,686 |
Lease liabilities at 31 December amounted to €14,503,000 and are recognised under financial liabilities measured at amortised cost in the statement of financial position.
The table below provides a breakdown of lease liabilities by maturity:
| Maturity | 31.12.2023 | 31.12.2022 |
|---|---|---|
| maturing within 1 year | - | 330 |
| 2-3 years | 239 | 300 |
| after 5 years | 14,264 | 13,905 |
| Total | 14,503 | 14,535 |
| Item | 31.12.2023 | 31.12.2022 |
|---|---|---|
| depreciation of rights-of-use assets | 1,767 | 783 |
| lease interest expense | 450 | 62 |
| other costs | - | 137 |
| Total | 2,217 | 982 |
The "depreciation of right-of-use assets" item consists of €57,000 for leased company cars and €889,000 for properties, including the property at Via Monte Rosa 91, Milan, for which lease payments will start being paid from the second quarter of 2024.
The changes during the year concerned, in particular:

In 2022 the average Group headcount was 175 (19 executives, 152 employees and 4 contract staff), with a total cost of €15,765,000. In the previous year, the average headcount was 128 (18 executives, 107 employees and 4 contract staff), with a total cost of €13,418,000.
At 31 December 2023, the Company's Board of Directors consisted of a chairman, a chief executive officer and five directors. The remuneration payable for 2023 amounts to €700,000 (€512,000 at 31 December 2022).
The Company's Board of Statutory Auditors consists of a chairman, two standing auditors and two alternate auditors. The fees payable for 2023 amount to €214,000 (€132,000 at 31 December 2022).
The following table, pursuant to Article 149 of the Issuers' Regulation, sets out the fees accrued during the year for services provided by the Independent Auditors and entities in its network (the amounts shown do not include expenses, Consob contributions and VAT):
| Type of service | Company | Remuneration |
|---|---|---|
| Statutory audit | KPMG S.p.A. | 139 |
| Solvency II review | KPMG S.p.A. | 70 |
| Attestation services | KPMG S.p.A. | 75 |
| 284 |
REVO Insurance S.p.A. Chief Executive Officer
(Alberto Minali) dhbml .

Jacopo Tanaglia Alberto Minali Financial Reporting Officer Chief Executive Officer
REVO Insurance S.p.A. REVO Insurance S.p.A. billiard.

-
-
-
-
-
-
-


KPMG S.p.A. Revisione e organizzazione contabile Via Vittor Pisani, 25 20124 MILANO MI Telefono +39 02 6763.1 Email [email protected] PEC [email protected]
(The accompanying translated consolidated financial statements of the Revo Insurance Group constitute a non-official version which is not compliant with the provisions of Commission Delegated Regulation (EU) 2019/815. This independent auditors' report has been translated into English solely for the convenience of international readers. Accordingly, only the original Italian version is authoritative.)
To the shareholders of Revo Insurance S.p.A.
We have audited the consolidated financial statements of the Revo Insurance Group (the "group"), which comprise the statement of financial position as at 31 December 2023, the income statement and the statements of comprehensive income, changes in equity and cash flows for the year then ended and notes thereto, which include material information on the accounting policies.
In our opinion, the consolidated financial statements give a true and fair view of the group's financial position as at 31 December 2023 and of its financial performance and cash flows for the year then ended in accordance with the International Financial Reporting Standards endorsed by the European Union and the Italian regulations implementing article 90 of Legislative decree no. 209 of 7 September 2005.
We conducted our audit in accordance with the International Standards on Auditing (ISA Italia). Our responsibilities under those standards are further described in the "Auditors' responsibilities for the audit of the consolidated financial statements" section of our report. We are independent of Revo Insurance S.p.A. (the "parent") in accordance with the ethics and independence rules and standards applicable in Italy to audits of financial statements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Ancona Bari Bergamo Bologna Bolzano Brescia Catania Como Firenze Genova Lecce Milano Napoli Novara Padova Palermo Parma Perugia Pescara Roma Torino Treviso Trieste Varese Verona
Società per azioni Capitale sociale Euro 10.415.500,00 i.v. Registro Imprese Milano Monza Brianza Lodi e Codice Fiscale N. 00709600159 R.E.A. Milano N. 512867 Partita IVA 00709600159 VAT number IT00709600159 Sede legale: Via Vittor Pisani, 25 20124 Milano MI ITALIA

Key audit matters are those matters that, in our professional judgement, were of most significance in the audit of the consolidated financial statements of the current year. These matters were addressed in the context of our audit of the consolidated financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.
Notes to the consolidated financial statements "Part B – Accounting policies", paragraph "Insurance liabilities"
Notes to the consolidated financial statements "Part C - Information on the statement of financial position "Item 3. Insurance liabilities"
| Key audit matter | Audit procedures addressing the key audit matter | |
|---|---|---|
| The consolidated financial statements at 31 December | Our audit procedures included: | |
| 2023 include insurance liabilities of about €156 million, accounting for about 78% of total liabilities. |
understanding the process for the measurement of insurance liabilities and the related IT environment and assessing the design and implementation of controls and performing procedures to assess the operating effectiveness of material controls; |
|
| They comprise the liabilities for remaining coverage and for claims incurred of roughly €93 million and approximately €63 million, respectively, measured using the premium allocation approach (PAA). |
||
| Insurance liabilities reflect the expected cash flows from insurance contracts, adjusted to take into account the time value of money and non-financial risks. |
• analysing the significant changes in insurance liabilities compared to the previous year's figures, analysing the key summary indicators and discussing the results with the relevant internal |
|
| The group measures this caption including by using | departments; | |
| actuarial valuation techniques which entail a high level of complex and subjective judgement relating to past and future internal and external variables with respect to which any changes in the underlying assumptions may have a significant impact on the measurements of these liabilities. |
• checking the actuarial techniques adopted by the parent and the reasonableness of the data and parameters used for estimation purposes; we carried out these procedures with the assistance of actuarial experts of the KPMG network; |
|
| For the above reasons, we believe that the measurement of insurance liabilities is a key audit matter. |
• checking the compliance of the calculation of the overall insurance liabilities with the reference accounting standard, including by assessing their reasonableness on the basis of the ratios and trends of the main indicators; we carried out this procedure with the assistance of actuarial experts of the KPMG network; |
|
| • assessing the appropriateness of the disclosures about insurance liabilities. |

Notes to the consolidated financial statements "Part A - General basis of preparation" paragraph "IFRS 17 - Insurance contracts"
| Key audit matter | Audit procedures addressing the key audit matter | |
|---|---|---|
| IFRS 17, which was applied on 1 January 2023 for the | Our audit procedures included: • |
|
| first time, has modified the group's accounting policies for insurance contracts. |
gaining an understanding of the group's IFRS 17 transition processes and related IT environment, especially in relation to the calculation of insurance liabilities; |
|
| The group applied the new standard retrospectively, which affected its opening balances at 1 January 2022 and, therefore, its equity. As a consequence of |
||
| adopting a retrospective approach, the group restated its consolidated financial statements figures at 31 December 2022. |
analysing the process for the identification of insurance contracts and checking, on a sample basis, their aggregation; we carried out these procedures with the assistance of actuarial experts of the KPMG network. |
|
| During the transition to the new standard, the parent was required to use a high level of judgement to |
||
| develop and implement accounting policies. | analysing how the group applied the insurance contracts' measurement model; we carried out these procedures with the assistance of actuarial experts of the KPMG network; |
|
| The application of the new standard led to a reduction of about €1 million in equity at 1 January 2022, net of the related tax. |
||
| It has also significantly changed the group's processes, organisation and measurement of insurance liabilities. |
checking the actuarial techniques adopted by the group and the reasonableness of the data and parameters used; we carried out these procedures with the assistance of actuarial experts of the KPMG network; |
|
| For the above reasons, we believe that the transition to IFRS 17 is a key audit matter. |
||
| • checking the appropriateness of the methods adopted and the reasonableness of the assumptions used to calculate the insurance liabilities; we carried out these procedures with the assistance of actuarial experts of the KPMG network; |
||
| • assessing the appropriateness of the disclosures |
The directors are responsible for the preparation of consolidated financial statements that give a true and fair view in accordance with the International Financial Reporting Standards endorsed by the European Union and the Italian regulation implementing article 90 of Legislative decree no. 209 of 7 September 2005 and, within the terms established by the Italian law, for such internal control as they determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
about the transition to IFRS 17.
The directors are responsible for assessing the group's ability to continue as a going concern and for the appropriate use of the going concern basis in the preparation of the carve-out consolidated financial statements and for the adequacy of the related disclosures.

The use of this basis of accounting is appropriate unless the directors believe that the conditions for liquidating the parent or ceasing operations exist, or have no realistic alternative but to do so.
The Collegio Sindacale is responsible for overseeing, within the terms established by the Italian law, the group's financial reporting process.
Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors' report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISA Italia will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial statements.
As part of an audit in accordance with ISA Italia, we exercise professional judgement and maintain professional scepticism throughout the audit. We also:
We communicate with those charged with governance, identified at the appropriate level required by ISA Italia, regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with the ethics and independence rules and standards applicable in Italy and communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, the measures taken to eliminate those threats or the safeguards applied.
From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the consolidated financial statements of the current year and are, therefore, the key audit matters. We describe these matters in this report.
On 6 April 2017, the shareholders of Revo Insurance S.p.A. (formerly Elba Assicurazioni S.p.A.) appointed us to perform the 2017-2025 statutory audit. We declare that we did not provide the prohibited non-audit services referred to in article 5.1 of Regulation (EU) no. 537 of 16 April 2014 and that we remained independent of the parent in conducting the statutory audit.
We confirm that the opinion on the consolidated financial statements expressed herein is consistent with the additional report to the Collegio Sindacale, in its capacity as audit committee, prepared in accordance with article 11 of the Regulation mentioned above.
The parent's directors are responsible for the application of the provisions of Commission Delegated Regulation (EU) 2019/815 with regard to regulatory technical standards on the specification of a single electronic reporting format (ESEF) to the consolidated financial statements at 31 December 2023 to be included in the annual financial report.
We have performed the procedures required by Standard on Auditing (SA Italia) 700B in order to express an opinion on the compliance of the consolidated financial statements with Commission Delegated Regulation (EU) 2019/815.
In our opinion, the consolidated financial statements at 31 December 2023 have been prepared in XHTML format and have been marked up, in all material respects, in compliance with the provisions of Commission Delegated Regulation (EU) 2019/815.
Due to certain technical limitations, some information included in the notes to the consolidated financial statements when extracted from the XHTML format to an XBRL instance may not be reproduced in an identical manner with respect to the corresponding information presented in the consolidated financial statements in XHTML format.
The parent's directors are responsible for the preparation of the group's reports on operations and on corporate governance and ownership structure at 31 December 2023 and for the consistency of such reports with the related consolidated financial statements and their compliance with the applicable law.

We have performed the procedures required by Standard on Auditing (SA Italia) 720B in order to express an opinion on the consistency of the report on operations and the specific information presented in the report on corporate governance and ownership structure indicated by article 123-bis.4 of Legislative decree no. 58/98 with the group's consolidated financial statements at 31 December 2023 and their compliance with the applicable law and to state whether we have identified material misstatements.
In our opinion, the report on operations and the specific information presented in the report on corporate governance and ownership structure referred to above are consistent with the group's consolidated financial statements at 31 December 2023 and have been prepared in compliance with the applicable law.
With reference to the above statement required by article 14.2.e) of Legislative decree no. 39/10, based on our knowledge and understanding of the entity and its environment obtained through our audit, we have nothing to report.
Milan, 27 March 2024
KPMG S.p.A.
(signed on the original)
Maurizio Guzzi Director of Audit

The remuneration required by the entity to bear the uncertainty as to the amount and timing of cash flows arising from non-financial risk at the time when the entity will fulfil insurance contracts.
The party entitled under the insurance contract to be indemnified if an insured event occurs.
A profitability indicator calculated as the ratio of net claims incurred to net earned premiums.
A profitability indicator calculated as the ratio of claims-related expenses gross of reinsurance and insurance revenues gross of commissions and VoBA.
A profitability indicator calculated as the ratio of claims-related expenses net of reinsurance and insurance revenues gross of commissions and VoBA and net of the cost of reinsurance.
A profitability indicator calculated as the ratio of the sum of the costs of insurance services issued, the result of reinsurance and insurance revenues gross of VoBA.
A profitability indicator calculated as the ratio of the sum of gross expenses relating to claims, operating expenses and other technical income/expenses to net earned premiums.
Net combined ratio excluding, in the numerator, costs relating to the liquidation of the TFM fund, LTIP incentive plans, material depreciation other than the rents provided for in IFRS16 and other extraordinary costs incurred for one-off projects, as well as other technical income and expenses.
A contract under which one party (the issuer) accepts significant insurance risk from another party (the insured) by agreeing to indemnify the insured if the latter suffers damage as a result of a specified uncertain future event (the insured event).
An insurance contract written by an entity (the reinsurer) in order to indemnify another entity for claims under one or more insurance contracts issued by the latter (underlying contracts).
Cash flows generated by the costs of selling, underwriting and commencing a group of insurance contracts (written or expected to be written) directly attributable to the portfolio of insurance contracts to which the group belongs. These include cash flows that are not directly attributable to individual insurance contracts or groups of insurance contracts in the portfolio.

Current value of future cash outflows minus the current value of future cash inflows that will be realised when the entity fulfils insurance contracts (PVFCF), including the adjustment for non-financial risk (RA).
A set of insurance contracts deriving from the division of a portfolio of insurance contracts, at a minimum, into contracts issued over a period not exceeding one year and which, at the time of initial recognition:
(a) are onerous if they exist;
(b) have no significant possibility of becoming onerous
subsequently, if they exist; or
(c) do not fall under either point (a) or point (b), if they exist.
The Long Term Incentive Plan is a three-year plan for a portion of the company's staff; it recognises variable share-based remuneration on reaching certain strategic objectives.
a) ascertain and pay valid claims under insurance contracts in force for insured events that have already occurred (i.e. the obligation relating to the unexpired portion of the insurance cover); and
(b) amounts under existing insurance contracts which are not included in point (a) and which relate to: insurance services not yet provided (i.e. obligations related to the future provision of insurance services or other amounts not related to the provision of insurance services that have not been transferred to liabilities for incurred claims.
a) ascertain and pay valid claims for insured events that have already occurred, including events that have occurred but for which the claim has not been submitted, and other insurance costs incurred; and
(b) amounts which are not included in point (a) and which relate to: insurance services which have already been provided or any investment components or other amounts not related to the provision of insurance services that are not covered by the liability for remaining coverage.
The period during which the entity provides insurance services. The period includes insurance services relating to all premiums falling within the scope of the insurance contract.
Insurance contracts subject to similar risks and managed jointly.
A simplified method for the valuation of insurance contracts applicable to contracts with a duration of less than one year or for which the valuation of the liability for remaining coverage resulting from the application of the simplified model does not deviate significantly from the valuation that would result from the application of the GM.
The amount of gross premiums written during the year from direct and indirect business.

The risk of a possible future change in one or more of the following specified variables: interest rate, financial instrument price, commodity price, exchange rate, price or rate index, credit rating or credit index or other specified variable, provided that, in the case of non-financial variables, the variable is not specific to one of the parties to the contract.
The ordinary measure of profitability which, starting from the result of insurance services:
An ordinary profitability measure which, starting from the operating result:
The ordinary measure of profitability which, starting from the result of insurance services:
The ratio of eligible own funds to the Group's solvency capital requirement, calculated according to the Solvency II legislation. The indicator submitted will be communicated to the Supervisory Authority according to the timescales established by law and in any case subsequent to the approval of these financial statements.
The ordinary net result which, starting from net profit:

x includes the tax effect arising from the above adjustments.
The ordinary net result which, starting with net profit, is subject to the same adjustments as already shown in the respective IFRS 4 indicator.
The Value Of Business Acquired represents the goodwill paid to acquire portfolios, the amount of which is determined by estimating the present value of the future profits of the policies in place at the time of acquisition. It consists of the difference between the carrying amount of technical provisions net of reinsurance, valued in accordance with IFRS 4 and the corresponding fair value. The VoBA is amortised on the basis of the actual life of the contracts acquired.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.